Departmental Poster and Platform Presentations

Click on the Expand plus sign sign to list the poster and platform presentations by year. Then click on the link to view that presentation.

2018

Collapse All | Expand All

 

    American Academy of Neurology (AAN)
    70th Annual Meeting in Los Angeles, Calif. (April 21-27, 2018)
    American Stroke Association
    2018 International Stroke Conference in Los Angeles, Calif. (Jan. 24-26, 2018)
    • Targeting toxic effects of blood in intracranial hemorrhage models with a novel nano-antioxidant/chelator: A ferroptosis specific treatment?
      [Oral Presentation]

      Derry PJ, Dharmalingam P, Mitra J, Hegde ML, Nilewski LG, Mendoza K, et al.

    • Prevalence of undiagnosed risk factors in patients with first-ever ischemic stroke.

      Jasne A, Khoury J, Madsen T, Alwell K, Moomaw C, Flaherty M, et al.

    • Endovascular therapy eligibility in the advent of DAWN and DEFUSE-3 results.

      Khatri P, Jovin T, Noqueira R, Albers GW, Jadhav A, Moomaw C, et al.

    • A nurse dyad model for collaborative action planning and goal attainment to support patient self-management of stroke risk factors.

      Kimmel B, Burns J, George S, Roux K, Mbue N, Shegog R, et al.

    • Potential impact of triage using non-contrast head CT and stroke severity on a regional stroke system of care: A population-based study.

      Kircher CE, Kleindorfer D, Moomaw C, Alwell K, Sucharew H, Woo D, et al.

    • Acute ischemic stroke emergency department arrival times in the extended time window within a population.

      Kleindorfer DO, Moomaw CJ, Alwell K, Khatri P, Woo D, Flaherty ML, et al.

    • Sex differences in severity of stroke risk factors in the greater Cincinnati/northern Kentucky stroke study.

      Madsen TE, Khoury JC, Jasne A, Alwell K, Moomaw CJ, Flaherty ML, et al.

    • Temporal trends of sex differences in transient ischemic attack incidence within a population.

      Madsen TE, Khoury JC, Munir A, Alwell K, Moomaw CJ, Flaherty M, et al.

    • Prior antiplatelet use and baseline stroke severity: A population-based study.

      Mistry EA, Sucharew H, Alwell K, Moomaw CJ, Flaherty M, Woo D, et al.

    • Systematic review identified some early phase promising therapeutics for subarachnoid hemorrhage.
      [Oral Presentation]

      Shah N, Shah V, Venkatasubba Rao CP, Kent TA, Mandava P

    National Aeronautics and Space Administration (NASA)
    2018 Human Research Program Investigators' Workshop in Galveston, Texas (Jan. 22-25, 2018)
    • SPACE-CENT: Studying the physiological and anatomical cerebral effects of centrifugation and head down tilt.

      Bershad E, Venkatasubba Rao C, Cohen H, Lazaridis C, Clark J, Sangi-Haghpeykar H, et al.

    • Assessment of artificial gravity as a countermeasure to cephalad fluid shifting.

      Marshall-Goebel K, Bershad E, Zhang Q

    • Mechanical countermeasures to cephalad fluid shifts.
      [Oral Presentation]

      Marshall-Goebel K, Ivkovic V, Baggish A, Cohen A, Nahed B, Rosenthal E, et al.

    • Zero G and ICP: Invasive and noninvasive ICP monitoring and VIIP biomarker identification.

      Williams M, Bershad E, Levine B, Clark J, Malm J, Eklund A, et al.

    • SANS/VIIP biomarker identification: RNA-SEQ technology and expression analysis on ground biofluid samples.

      Zanello S, Bershad E, Calvillo E, Enderle D, Valentino M, Yu S, et al.

2017

Collapse All | Expand All

 

    American Epilepsy Society (AES)
    71st Annual Meeting in Washington, DC (Dec. 1-5, 2017)
    • Prevention of postictal ventilatory arrest with amygdala lesions in mice.

      Bravo E, Marincovich A, Kim U-Y, Massey C, Dlouhy B, Richerson G

    • Outpatient smartphone videos in epilepsy (OSmartViE): Initial results of video quality.

      Coonan EE, Hirsch LJ, Duckrow RB, Chen D, Gelfand M, Blum A, et al.

    • Responsive neuro-stimulation (RNS) versus vagus nerve stimulation (VNS) in focal epilepsy.

      Haneef Z, Englot DJ

    • Tau loss modifies network excitability in glioma-associated epilepsy.

      Hatcher A, Yu K, Aiba I, Deneen B, Noebels J

    • Evidence for brainstem network disruption in focal epilepsy and sudden unexplained death in epilepsy: A first validation study.

      Mueller SG, Nei M, Bateman L, Knowlton R, Laxer K, Friedman D, et al.

    • Kv7.2 as a therapeutic target in Dravet Syndrome.

      Park S, Tarkunde Y, Akbar A, Marks R, Lee M, Soh H, et al.

    • Autism with benzodiazepine-responsive electrical status epilepticus in sleep (ESES) caused by KCNQ3 gain-of-function variants.

      Sands TT, Miceli F, Lesca G, Beck A, Cimino M, Strong N, et al.

    • Infantile spasms: ACTH dose response relationships.

      Swann JW, Le JT, Frost Jr JD

    • Outpatient smartphone videos for classifying epileptic and non-epileptic seizures.

      Tatum W, Hirsch LJ, Duckrow RB, Chen D, Gelfand M, Blum A, et al.

    Society for Neuroscience (SFN)
    47th Annual Meeting in Washington, DC (Nov. 11-15, 2017)
    • mTORC2 dysfunction underlies the neuronal physiological and behavioral abnormalities in Pten-deficient mouse model of autism.

      Chen C-J, Sgritta M, Lucero RD, Noebels JL, Costa-Mattioli M

    • Systems biology resource for Alzheimer's disease target prioritization: The AMP-AD Knowledge Portal.

      Daily K, Logsdon B, Peters M, Al-Ouran R, Wan YW, Shulman JM, et al.

    • Tau-mediated disruption of the spliceosome in Alzheimer's disease models.

      Hsieh Y-C, Guo C, Yalamanchili HK, Li Y, Lasagna-Reeves CA, Xu Y, et al.

    • Development of T-type calcium channel bursting in thalamic association pathway precedes sensory pathways.

      Miao Q, Noebels JL

    • Adrenergic signaling promotes T-type Ca2+ channel mediated oscillatory discharges in nucleus ambiguus neurons.

      Noebels JL, Aiba I

    American Congress of Rehabilitation Medicine (ACRM)
    94th Annual Conference in Atlanta, Ga. (Oct. 23-28, 2017)
    Neurocritical Care Society (NCS)
    15th Annual Meeting in Waikoloa, Hawaii (Oct. 10-13, 2017)
    32nd International Epilepsy Congress (IEC)
    Barcelona, Spain (Sept. 2-6, 2017)
    • Diurnal variation of potential ictal onsets detected by a responsive neurostimulation device.

      Van Ness P, Chen DK, Haneef Z, Yoshor D

    • Classification of neonatal seizures: The results from a recent test of the ILAE commission on classification and terminology proposed neonatal seizure framework.

      Yozawitz E, Cilio MR, Lahorgue Nunes M, Vanhatalo S, Zuberi S, Plouin P, et al.

    Movement Disorder Society (MDS)
    21st International Congress of Parkinson's Disease and Movement Disorders in Vancouver, BC, Canada (June 4-8, 2017)
    • Whole exome sequencing in essential tremor.

      Alfradique-Dunham I, Robak LA, Kaw A, Fagbongbe OI, Ternes K, Young E, et al.

    • Effect of deutetrabenazine on QTcF interval in the AIM-TD study: A 12-week, phase III, randomized, double-blind, placebo-controlled study.

      Anderson K, Stamler D, Davis M, Factor S, Hauser R, Isojärvi J, et al.

    • Long-term safety of deutetrabenazine for the treatment of tardive dyskinesia: Results from an open-label, long-term study.
      [Previous presented]

      Anderson K, Stamler D, Davis M, Factor S, Hauser R, Isojärvi J, et al.

    • Addressing involuntary movements in tardive dyskinesia (aim-td): Efficacy, safety, and tolerability of fixed-dose deutetrabenazine for the treatment of tardive dyskinesia.
      [Previous presented]

      Anderson K, Stamler D, Davis M, Factor S, Hauser R, Isojärvi J, et al.

    • Predictive ability of clinical timed tests for postural instability and gait difficulty in Parkinson's disease.

      Bryant M, Hou J-G, Jamal F, Jackson G, Workman C, Protas E

    • A phase 2, open-label, dose-escalating study to evaluate the safety and preliminary efficacy of daxibotulinumtoxinA for injection (RT002) in isolated cervical dystonia.
      [Previously Presented]

      Comella C, Jankovic J, Truong D, Brashear A, Patel A, Evatt M, et al.

    • Clinical relevance of treatment with onabotulinumtoxinA in patients with cervical dystonia: Results from the CD probe study.

      Dashtipour K, Mari Z, Jankovic J, Adler C, Schwartz M, Brin M

    • Effect of deutetrabenazine on quality of life in patients with tardive dyskinesia in AIM-TD, a 12-week double-blind, placebo-controlled study.
      [Previous presented]

      Factor S, Anderson K, Stamler D, Davis M, Hauser R, Isojärvi J, et al.

    • Effect of deutetrabenazine by body region score of the abnormal involuntary movement scale in tardive dyskinesia: ARM-TD and AIM-TD studies.
      [Previous presented]

      Fernandez H, Stamler D, Davis M, Factor S, Hauser R, Isojärvi J, et al.

    • Evaluation of patient-reported outcomes in tardive dyskinesia patients with underlying psychotic and mood disorders in the ARM-TD and AIM-TD trials.
      [Previous presented]

      Fernandez H, Stamler D, Davis M, Factor S, Hauser R, Isojärvi J, et al.

    • Improvements in clinical global impression of change with deutetrabenazine treatment in tardive dyskinesia from the ARM-TD and AIM-TD studies.
      [Previous presented]

      Fernandez H, Stamler D, Davis M, Factor S, Hauser R, Isojärvi J, et al.

    • Treatable rare movement disorders.

      Gatto E, Jinnah H, Espay A, Jankovic J, Bhatia K, Rodriguez M, et al.

    • A randomized, double-blind, placebo-controlled study of the D1 receptor antagonist ecopipam for children and adolescents with Tourette syndrome.

      Gilbert D, Murphy T, Jankovic J, Budman C, Black K, Kurlan R, et al.

    • Vitamin D and clinical phenotypes of Parkinson's disease in veterans.

      Jamal F, Jackson GR, Moore S, Sarwar AI

    • Results from a phase 1b multiple ascending-dose study of prx002, an anti-alpha-synuclein monoclonal antibody, in patients with Parkinson's disease.

      Jankovic J, Goodman I, Safirstein B, Schenk D, Kinney G, Koller M, et al.

    • Leg stereotypy disorder: Phenomenology and prevalence.

      Jankovic J, Lotia M, York MK, Strutt AM

    • Addressing involuntary movements in tardive dyskinesia (AIM-TD): Improvements in clinical global impression of change (CGIC) with deutetrabenazine treatment in tardive dyskinesia (TD).
      [Previous presented]

      Jimenez-Shahed J, Fernandez H, Hauser R, Davis M, Factor S, Isojärvi J, et al.

    • Deutetrabenazine is associated with an improvement in involuntary movements in patients with tardive dyskinesia (TD) as seen by the high proportion of responders to deutetrabenazine treatment in the AIM-TD study.
      [Previous presented]

      Jimenez-Shahed J, Fernandez HH, Stamler D, Davis MD, Factor SA, Hauser RA, et al.

    • Deutetrabenazine treatment response by concomitant dopamine-receptor antagonists in the phase III, randomized, double-blind, placebo-controlled AIM-TD trial in tardive dyskinesia (TD).
      [Previous presented]

      Jimenez-Shahed J, Fernandez HH, Stamler D, Davis MD, Factor SA, Hauser RA, et al.

    • Emotion regulation and neuropsychological status in psychogenic subtypes.

      Scott B, Strutt A, Lundberg-Love P, Schmitt A, Jankovic J, Bowers D

    • Hemidystonia associated with Alexander disease.

      Vijayakumar D, Lewis RA, Fuller GN, Dhar SU, Machol K, Robak L, et al.

    Consortium of Multiple Sclerosis Centers (CMSC)
    31st Annual Meeting in New Orleans, La. (May 24-27, 2017)
    American Psychiatric Association (APA)
    170th Annual Meeting in San Diego, Calif. (May 20-24, 2017)
    • Long-term safety of deutetrabenazine for the treatment of tardive dyskinesia: Results from an open-label, long-term study.

      Anderson K, Stamler D, Davis M, Factor S, Hauser R, Isojärvi J, et al.

    • Effect of deutetrabenazine on quality of life in patients with tardive dyskinesia in AIM-TD, a 12-week double-blind, placebo-controlled study.

      Factor S, Anderson K, Stamler D, Davis M, Hauser R, Isojärvi J, et al.

    • Effect of deutetrabenazine by body region score of the abnormal involuntary movement scale in tardive dyskinesia: ARM-TD and AIM-TD studies.

      Fernandez H, Stamler D, Davis M, Factor S, Hauser R, Isojärvi J, et al.

    • Evaluation of patient-reported outcomes in tardive dyskinesia patients with underlying psychotic and mood disorders in the ARM-TD and AIM-TD trials.

      Fernandez H, Stamler D, Davis M, Factor S, Hauser R, Isojärvi J, et al.

    • Improvements in clinical global impression of change with deutetrabenazine treatment in tardive dyskinesia from the ARM-TD and AIM-TD studies.

      Fernandez H, Stamler D, Davis M, Factor S, Hauser R, Isojärvi J, et al.

    6th World Intracranial Hemorrhage Conference (WICH)
    Baltimore, Md. (May 1-3, 2017)
    • Oxidative toxicity and DNA damage in experimental hemorrhage models: targeting with a novel carbon nano-antioxidant.
      [Oral Presentation]

      Kent TA, Dharmalingam P, Tour JM, Fabian RH, Derry PJ, Nilewski LG, et al.

    • Testing treatments for intracranial hemorrhage compared to a pooled outcome model accounts for variability in baseline conditions and identifies potentially positive, neutral, and harmful interventions.
      [Oral Presentation]

      Mandava P, Murthy SB, Samson Y, Kent TA

    • Resumption of anticoagulant therapy after intracranial hemorrhage: a systematic review and meta-analysis.

      Murthy SB, Gupta A, Merkler AE, Navi BB, Mandava P, Iadecola C, et al.

    Baylor College of Medicine (BCM)
    Annual Quality Improvement and Patient Safety Conference 2017 in Houston, Texas (April 26, 2017)
    American Academy of Neurology (AAN)
    69th Annual Meeting in Boston, Mass. (April 22-28, 2017)
    American Stroke Association
    2017 International Stroke Conference in Houston, Texas (Feb. 22-24, 2017)
    • Unexpected conformational change of platelet glycoprotein Ib (GPIb) receptor after rt-PA treatment of large vessel ischemic stroke.

      Da Q, Mandava P, Cruz M, Thiagarajan P, Kent TA

    • Incorporating biological variability in experimental stroke to better mimic human stroke.

      Kent TA, Rea HC, Dalmeida W, Fabian RH, Ayata C, Mandava P

    • A novel catalytic antioxidant carbon nanoparticle improves outcome in hyperglycemic stroke in rats at clinically relevant recanalization times.
      [Platform Presentation]

      Kent TA, Rea HC, Dalmeida W, Fabian RH, Tour JM, Nilewski LG, et al.

    • Simulation training is a feasible implementation strategy for evidence based stroke swallowing screening.

      Stonecypher K, Garrett R, Kimmel B, Daniels S, Anderson J

    American Clinical Neurophysiology Society (ACNS)
    2017 Annual Meeting in Phoenix, Ariz. (Feb. 8-12, 2017)
    • Clinical classification of post anoxic myoclonic status.

      Mikhaeil-Demo Y, Gavvala J, Bellinski I, Macken M, Narechania A, Templer J, et al.

    International Neuropsychological Society (INS)
    45th Annual Meeting in New Orleans, La. (Feb. 1-7, 2017)
    • Longitudinal cognitive asymmetry and decline in Alzheimer's disease patients.

      Alverson WA, Massman PJ, Doody RS

    • Performance on the Rey Auditory Verbal Learning Test (RAVLT) in neurologically intact Spanish-speaking older adults.

      Estevis E, Scott BM, Strutt AM

    • Assessment of language fluency and confrontation naming in monolingual Spanish speaking older adults.

      Strutt AM, Lafosse J, Mahoney M

2016

Collapse All | Expand All

 

    American Epilepsy Society (AES)
    70th Annual Meeting in Houston, Texas (Dec. 2-6, 2016)
    • Center for SUDEP Research: Brainstem atrophy in SUDEP.

      Bateman L, Nei M, Goldman A, Mueller S

    • Temporal and spectral characteristics of dynamic functional connectivity between resting-state networks in temporal lobe epilepsy.

      Chiang S, Vankov E, Yeh H, Guindani M, Vannucci M, Haneef Z, et al.

    • Provocative induction of psychogenic nonepileptic seizure: Effectiveness of placebo vs. non-placebo techniques.

      Dave H, Alobaidy A, Chen D

    • SUDEP rate in patients with medically intractable partial onset seizures treated with brain responsive neurostimulation.

      Devinsky O, Kapur R, Duckrow R, Fountain N, Gwinn R, Leiphart J, et al.

    • Combined EEG-MEG source localization: A pilot study using a cloud based database.

      Gavvala J, Krueger, Bellinski I, Millichap J, Schuele S

    • The role of tau in modulating hyper excitability in an emerging model of tumor associated epilepsy.

      Hatcher A, Yu K, Lalonde J, Deneen B, Noebels J

    • Functional characterization of three de novo KCNQ2 encephalopathy variants in the pore helix and responses to SF0034 and ICA-069673.

      Ji Z, Tran B, Li L, Xu M, Cooper E

    • An informatics infrastructure for KCNQ2 encephalopathy research including a patient registry, database, curation platform, and website.

      Joshi N, Taglialatela M, Weckhuysen S, Nesbitt G, Cooper E

    • Dynamics of gamma oscillations in a mouse model of absence epilepsy.

      Maheshwari A, Marks R, Davalos-Balderas A, Wang M, Noebels J

    • Clinical utility of genetic testing in adults with epilepsy: Pilot experience of the Baylor genetic epilepsy clinic.

      Marafie D, Rosenfeld J, Van Ness P, Zohrevand P, Haneef Z, Chen D, et al.

    • Asynchronous suppression of superficial cortex during absence seizures.
      [Platform Presentation]

      Meyer J, Maheshwari A, Noebels J, Smirnakis S

    • A survey of neurophysiology fellows in the United States.

      Rutherford H, Chiang S, Antony A, Haneef Z

    • Correlation of illness perception and clinical outcome in patients with psychogenic non-epileptic events.

      Rutherford H, Majmudar S, Ram A, Chen D

    • The diagnostic yield of epilepsy monitoring unit evaluation for veterans with apparent syncope of unknown origin.

      Saipetch C, Chen D

    • A critical developmental window for 17β-estradiol antiepileptogenic effect in a mouse model of X-linked infantile spasms.

      Siehr M, Lucero R, Lalonde J, Noebels J

    • Infantile spasms and encephalopathy without preceding neonatal seizures caused by KCNQ2 R198Q, a gain-of-function variant.

      Taglialatela M, Millichap J, Miceli F, De Maria M, Keator C, Joshi N, et al.

    • Genotype-phenotype relationships In KCNQ2 related epilepsy and encephalopathy caused by variants in the pore region.

      Wang X, Li L, Xu M, Mays J, Joshi N, Cooper E

    American Heart Association
    2016 Scientific Sessions in New Orleans, La. (Nov. 12-16, 2016)
    Society for Neuroscience (SFN)
    46th Annual Meeting in San Diego, Calif. (Nov. 12-16, 2016)
    • Characterization of a polysynaptic microcircuit involved in sensory vagal afferent activation of dorsomotor vagal neurons in mouse.

      Aiba I, Noebels JL

    • Effects of tau peptide aggregation inhibitor in human tau transgenic models.

      Frautschy SA, Hu S, Jones MR, Yang F, Chen P, Jackson GR, et al.

    • The role of tau in modulating hyper-excitability in an emerging model of tumor associated epilepsy.

      Hatcher A, Yu K, Lalonde J, Deneen B, Noebels J

    • αII-spectrin-dependent cytoskeletons are essential for axon function, domain assembly and integrity.

      Huang Y, Zhang C, Zollinger D, Lalonde J, Leterrier C, Noebels J, et al.

    • Early development of thalamic low-threshold T-type calcium current in the VPM of C57BL/6 mice.

      Miao Q, Noebels JL

    • A critical developmental window for 17β-estradiol antiepileptogenic effect in a mouse model of X-linked infantile spasms.

      Siehr M, Lucero R, Lalonde J, Noebels J

    American Neurological Association (ANA)
    141st Annual Meeting in Baltimore, Md. (Oct. 16-18, 2016)
    • Propranolol-induced psychosis in a pediatric patient.

      Alobaidy AM, Parker A, Angelo JR, Nassif LM

    • Prevalence and character of severe epileptic encephalopathy in patients affected by MECP2 duplication syndrome.

      Marafie D, Schultz R, Glaze D, Suter B, Goldman A

    • Dynamic participation patterns of superficial cortex during absence seizures.

      Meyer JF, Maheshwari A, Noebels JL, Smirnakis SM

    • Hypothyroidism presenting with dysarthria and intermittent weakness of the extremities.

      Parker AS, Alobaidy AM, Kakker E, Tajuddin N, Nguyen SV, Pacheco VH, et al.

    European Society of Intensive Care Medicine (ESICM)
    29th Annual Congress in Milan, Italy (Oct. 1-5, 2016)
    • Physiologic monitoring for neurocritically-ill patients: An international survey of intensivists.

      Sivakumar S, Taccone FS, Desai KA, Lazaridis C

    Neurocritical Care Society (NCS)
    14th Annual Meeting in National Harbor, Md. (Sept. 15-18, 2016)
    • Bilateral recurrent artery of Heubner infarction after extensive resection of a large olfactory groove meningioma.

      Desai KA, Spiegel L, Reyes R, Vedantam A, Damani R, Bershad E

    • CNS post-transplant lymphoproliferative disorder presenting as de novo status epilepticus: Case report.

      Kapadia AM, Kesari N, Sivakumar S, Venkatasubba Rao C

    • Intravenous rt-PA use prior to endovascular thrombectomy increases probability of good outcome in acute ischemic stroke.

      Mandava P, Martini S, Shah V, Fabian R, Kent T

    • Modeling outcome after intracerebral hemorrhage indicates no benefit and potential harm from aggressive blood pressure management.
      [Platform Presentation]

      Mandava P, Murthy S, Samson Y, Kent T

    • Novel noninvasive detection of increased intracranial blood volume induced by head-down tilt using volumetric induction phase-shift spectroscopy (VIPS).

      Rao CP, Bershad E, Stevens B, Donoviel D, Pohlen M, Clarke C, et al.

    • Intensivist practices in the management of severe traumatic brain injury: A hemodynamic and neuromonitoring survey.

      Sivakumar S, Rehman M, Hinson H, Naval N, Lazaridis C

    2016 Alzheimer's Association International Conference (AAIC)
    Toronto, Canada (July 22-28, 2016)
    • Advancing therapeutics for neuroinflammation in Alzheimer's disease: Clinical development considerations.

      Margolin RA, Schneider LS, Cutter GR, Breitner JCS, Doody RS, Landreth G, et al.

    Federation of American Societies for Experimental Biology (FASEB)
    Science Research Conference (Neural Mechanisms in Cardiovascular Regulation: Novel Research and Disease Treatment Strategies) in Saxtons River, Vt. (July 17-22, 2016)
    • Polysynaptic activation of dorsomotor vagal neurons by sensory afferent nerve.

      Aiba I, Noebels JL

    ICP Conference
    16th International Symposium on Intracranial Pressure and Neuromonitoring in Boston, Mass. (June 28 - July 2, 2016)
    • Evaluation of a non-invasive intracranial pressure meter (Vittamed) for spaceflight.

      Bershad E, Marshall-Goebel K, DeSantis S, Yang M, Sangi-Haghpeykar H, Calvillo E, et al.

    • Cerebrovascular and intracranial effects of 12 degree head-down tilt and hypercapnia: A preliminary study using phase-contrast, volumetric and diffusion tensor MR imaging.

      Kramer L, Hasan K, Higashi S, Bershad E, Rittweger J, Gerlach D

    • Cerebral blood pulsatility during head-down tilt and CO2 exposure.

      Strangman G, Zhang Q, Stevens B, Clark J, Bershad E

    Canadian Neurological Sciences Federation (CNSF)
    51st Annual Meeting in Quebec City, Canada (June 21-24, 2016)
    • CNS Andre Barbeau Memorial Prize: Two definite unexpected deaths in epilepsy in a family with a DEPDC5 mutation.
      [Previously Presented]

      Nascimento FA, Borlot F, Cossette P, Minassian B, Andrade D

    Movement Disorder Society (MDS)
    20th International Congress of Parkinson's Disease and Movement Disorders in Berlin, Germany (June 19-23, 2016)
    • Understanding, predicting, and preventing falls in progressive supranuclear palsy.

      Bluett BR, Litvan I, Cheng S, Juncos J, Bordelon Y, Riley DE, et al.

    • A randomized, double-blind, placebo-controlled trial of deutetrabenazine for the treatment of tardive dyskinesia (ARM-TD).

      Fernandez HH, Factor SA, Hauser RA, Jimenez-Shahed J, Ondo W, LeDoux MS, et al.

    • Objectives of the MDS rare movement disorders study group.

      Gatto EM, Albanese A, Bathia K, Cardoso F, Cesarini M, Chade A, et al.

    • The National Parkinson Foundation mentoring and networking program: Phase I the process.

      Hunter CB, Palmentera PR, Vernon B, Silver A, Arney K, Fleisher J, et al.

    • A pilot study of SD-809 (deutetrabenazine) in tics associated with Tourette syndrome.

      Jankovic J, Jimenez-Shahed J, Budman C, Coffey B, Murphy TK, Shprecher D, et al.

    • Predictors of onabotulinumtoxinA treatment response in patients with cervical dystonia.

      Jankovic J, Marc S, Aubrey A

    • Apraclonidine in blepharospasm.

      Jankovic J, Vijayakumar D, Wijemanne S

    • One to 40 years later: Delayed effects of brain radiation presenting as parkinsonism.

      Jimenez-Shahed J, Itin I, Mehanna R

    • Globus pallidus interna oscillatory activity differentiates tics from voluntary movements and the Parkinsonian resting state.

      Jimenez-Shahed J, Telkes I, Viswanathan A, Ince NF

    • Apraclonidine in the treatment of ptosis.

      Wijemanne S, Vijayakumar D, Jankovic J

    American Headache Society
    58th Annual Scientific Meeting in San Diego, Calif. (June 9-12, 2016)
    • Headache as the only clinical manifestation of cerebral venous thrombosis: a series of 24 cases.

      Faro Santos P, Nascimento FA, Back Merida K, Luana Bayer D, Silva Marques M, Rizelio V, et al.

    Consortium of Multiple Sclerosis Centers (CMSC)
    30th Annual Meeting in National Harbor, Md. (June 1-4, 2016)
    • Prevalence of dysphagia in multiple sclerosis and correlation with disability.
      [Platform Presentation]

      Mahmoud R, Hutton GJ, Altman KW, Carter F, Dunham SR

    • Five-year outcomes of HALT-MS: High-dose immunosuppressive therapy and autologous hematopoietic cell transplantation for severe relapsing-remitting multiple sclerosis.
      [Platform Presentation]

      Nash RA, Hutton GJ, Racke MK, Popat U, Devine SM, Georges GE, et al.

    2016 American Society of Neurophysiological Monitoring (ASNM)
    Annual Meeting in Chicago, Ill. (May 12-15, 2016)
    • Irreversible electroporation-induced sciatic neuropathy observed with intraoperative somatosensory evoked potential monitoring.

      Chu J, Nagata M, Chen X, Solomon S, Gonzalez-Aguirre A, Garcia-Aguilar J, et al.

    American Academy of Neurology (AAN)
    68th Annual Meeting in Vancouver, BC, Canada (April 15-21, 2016)
    • Sporadic Creutzfeldt-Jakob disease presenting as non-convulsive status epilepticus: A case report.

      Alobaidy A, Parker A, Bershad E

    • Time-dependence of graph theory metrics in functional connectivity analysis.

      Chiang S, Cassese A, Guindani M, Vannucci M, Yeh H, Haneef Z, et al.

    • Pre-surgical PET mapping predicts surgical outcome after anterior temporal lobectomy.

      Chiang S, Guindani M, Vannucci M, Yeh H, Haneef Z, Stern J

    • Success of targeting rationale in deep brain stimulation for Parkinson's disease.

      Farcas A, Jimenez Shahed J

    • A pilot study of SD-809 (deutetrabenazine) in tics associated with Tourette syndrome.

      Jankovic J, Jimenez-Shahed J, Budman C, Coffey B, Murphy T, Shprecher D, et al.

    • Comparison of three stroke severity scales with mortality within an intracerebral hemorrhage population: A population-based study.

      Katz B, Khoury J, Alwell K, Moomaw C, Kissela B, Flaherty M, et al.

    • Stroke incidence rates in a biracial metropolitan population: The importance of county-level data.

      Kissela B, Khoury J, Alwell K, Moomaw C, Flaherty M, Woo D, et al.

    • Impact of IDH-1 mutation status on outcome in clinical trials for recurrent glioblastoma.

      Mandel J, Cachia D, Liu DD, Aldape K, Fuller G, De Groot J

    • Severe epileptic encephalopathy is a frequent neurological comorbidity of children affected by the MECP2 duplication syndrome.
      [Oral Presentation]

      Marafie D, Schultz R, Glaze D, Goldman A, Suter B

    • Two definite cases of sudden unexpected death in epilepsy in a family with a DEPDC5 mutation.
      [Previously Presented]

      Nascimento FA, Borlot F, Cossette P, Minassian BA, Andrade DM

    • Progressive myoclonus epilepsy caused by SACS mutations.
      [Previously Presented]

      Nascimento FA, Muona M, Aljaafari D, Tarnopolsky M, Lehesjoki A-E, Faghfoury H, et al.

    • Promising response to vemurafenib salvage therapy in a patient with clinically and radiographically progressing pleomorphic xanthoastrocytoma (PXA): Our experience with one patient.

      Nasseri M, Butt B, Shah V, Peveler J, Szlaczky M, Barger G

    • Safety profile of unblinded internal pallidal deep brain stimulation for medically refractory Tourette syndrome.

      Niemann N, Strutt A, Viswanathan A, Jimenez Shahed J

    • A case of neurosarcoidosis masquerading as subacute inflammatory demylelinating polyneuropathy.

      Rizk C, Savitt D, Jain S, Kass J

    • Chronotypes, nocturnal melatonin level and excessive daytime sleepiness in Parkinson's disease (PD).

      Sarwar A, Moore S, Hirshkowitz M

    • Reasons for prolonged length of stay in the epilepsy monitoring unit.

      Seals S, Dewar S, Haneef Z, Eliashiv D, Stern J, Moseley B

    • Rare and fulminant presentation of adult Moyamoya disease: A case report.

      Shah V, Kass J

    • PRISM II: Effectiveness of dextromethorphan 20 mg/quinidine 10 mg (Nuedexta®) for treatment of pseudobulbar affect secondary to dementia, stroke, or traumatic brain injury: Combined results of a multicenter open-label study.

      Siffert J, Hammond F, Alexander D, Cutler A, D'Amico S, Doody R, et al.

    • Paradoxical worsening dystonia after deep brain stimulation in a patient with neurodegeneration with brain iron accumulation.

      Tarakad A, Jimenez Shahed J

    • Long-term outcome of adults with medically intractable mesial temporal lobe seizures treated with responsive neurostimulation.
      [Oral Presentation]

      Van Ness P, Skarpaas TC, Morrell M, the RNS System Investigators

    • Randomized, double-blind, placebo-controlled studies to evaluate treatment with aducanumab (BIIB037) in patients with early Alzheimer's disease: Phase 3 study design.
      [Oral Presentation]

      Viglietta V, O'Gorman J, Williams L, Tian Y, Sandrock A, Doody R, et al.

    American Stroke Association
    2016 International Stroke Conference in Los Angeles, Calif. (Feb. 17-19, 2016)
    • Admission systemic inflammatory response syndrome and outcome following intracerebral hemorrhage in a multicenter study.

      Boehme AK, Comeau M, Langefeld C, Lord A, Moomaw C, Osborne J, et al.

    • Predictors of in-hospital speech therapy referral in aphasic acute ischemic stroke patients within a population.

      Coleman ER, Sucharew H, Alwell K, Moomaw CJ, Kissela BM, Woo D, et al.

    • Degree of functional independence after an ischemic stroke affects quality of life similarly in men and women.

      Demel SL, Khoury J, Moomaw CJ, Sucharew H, Alwell K, Kissela BM, et al.

    • Bacterial endocarditis and acute stroke: A population-based study.

      Flaherty ML, Kleindorfer DO, Khoury JC, Alwell K, Moomaw CJ, Woo D, et al.

    • Comparison of three stroke severity scales with mortality within an intracerebral hemorrhage population: A population-based study.

      Katz BS, Khoury JC, Alwell K, Moomaw CJ, Haverbusch M, Kissela BM, et al.

    • A projection of endovascular therapy eligibility in the United States: A population-based analysis.

      Khatri P, Moomaw CJ, Alwell KS, Khoury JC, Heldner M, Fischer U, et al.

    • Incidence and temporal trends in in-hospital stroke: A preliminary analysis from the Greater Cincinnati/Northern Kentucky Stroke Study.

      Kissela BM, Khoury JC, Alwell K, Moomaw CJ, Woo D, Flaherty ML, et al.

    • A retrospective comparison of medical eligibility for acute ischemic stroke clinical trials compared with hospital enrollment rates: Greater Cincinnati/Northern Kentucky Population.

      Kleindorfer D, Moomaw CJ, Khoury J, Alwell K, Saver JL, Khatri P, et al.

    • Stroke incidence in the Greater Cincinnati/Northern Kentucky Stroke Study is decreasing significantly in men but not women.
      [Oral Presentation]

      Madsen TE, Khoury JC, Alwell KA, Moomaw CJ, Flaherty ML, Woo D, et al.

    • Factors influencing differential outcomes in stent retriever trials: Comparison to a new outcome model based on percent utilization of rt-PA.

      Mandava P, Martini SR, Shah VA, Fabian RH, Kent TA

    • Analysis of outcomes from the endovascular treatment of posterior circulation strokes in the modern era of stent retriever thrombectomy.

      Mokin M, Sonig A, Sananthan S, Kan P, Duckworth E, Venkatasubba Rao C, et al.

    • Selective serotonin reuptake inhibitors and risk of intracerebral hemorrhage.
      [Oral Presentation]

      Obeidat AZ, Sekar P, Moomaw CJ, Martini SR, Osborne J, Woo D, et al.

    • The impact of specific neuroanatomical location in deep supratentorial intracerebral hemorrhage (ICH): Findings from the ethnic/racial variations of ICH study.

      Sheth KN, Moomaw CJ, Osborne J, Martini S, Katz B, Charidimou A, et al.

    • Association of ischemic stroke location and demographic variables with percutaneous endoscopic gastrostomy placement.
      [Oral Presentation]

      Star M, Sucharew H, Ruland S, Moomaw CJ, Alwell K, Kissela BM, et al.

    • Prevalence of positive troponins and association with abnormal echocardiograms in acute ischemic stroke.

      Wrigley P, Alwell K, Eckerle B, Moomaw CJ, De Los Rios La Rosa F, Flaherty M, et al.

    • Impact of metformin on survival following ischemic stroke in patients with diabetes: The Greater Cincinnati Northern/Kentucky Stroke Study (GCNKSS).

      Yeramaneni S, Kleindorfer D, Sucharew H, Alwell K, Moomaw C, Flaherty M, et al.

    • Dementia treatment was associated with reduced risk of intacerebral hemorrhage.

      Yim E, Sekar P, Moomaw CJ, Osbourne J, Martini SR, Xiong L, et al.

    American Clinical Neurophysiology Society (ACNS)
    2016 Annual Meeting in Orlando, Fla. (Feb. 10-14, 2016)
    • Postanoxic myoclonus and generalized tonic-clonic seizures.

      Mikhaeil-Demo Y, Gerard E, Bellinski I, Schuele S, Gavvala J

    National Aeronautics and Space Administration (NASA)
    Human Research Program Investigators' Workshop in Galveston, Texas (Feb. 10, 2016)
    International Neuropsychological Society (INS)
    44th Annual Meeting in Boston, Mass. (Feb. 3-6, 2016)
    • Comparative patient satisfaction and efficacy of a Parkinson's Disease Enrichment Program (PEP).

      Choudhury TK, Crist K, Harris CG, Satterwhite TK, Treece B, York MK

    • Deep brain stimulation (DBS) for treatment of therapy-refractory obsessive compulsive disorder (OCD): A case study highlighting neurocognitive and psychiatric changes.

      Choudhury TK, Davidson JE, Viswanathan A, Strutt AM

    • Errors on the first 10 items of the Test of Memory Malingering predicts failure on later trials of the Test of Memory Malingering.

      Grabyan JM, Collins R, Alverson WA, Chen D

    • Performance validity in deep brain stimulation candidates.

      Rossetti M, Collins R, York MK

    • Cognitive, somatic, and emotional changes in patients with mild traumatic brain injury (mTBI) and orthopedic injuries at baseline and three months post-injury.

      Samarina V, Merkley TL, Wilde EA, McCauley S, Barnes A, Hanten G, et al.

    • Logopenic progressive aphasia in patient with meningioma: Neuropsychological evaluations over time.

      Stinson JM, Martin R, Chang JE, Collins R

<2015

Collapse All | Expand All

 

    American Epilepsy Society (AES)
    69th Annual Meeting in Philadelphia, Penn. (Dec. 4-8, 2015)
    • Leaky ryanodine receptor-2 mutation lowers threshold for hypoxic spreading depolarization.

      Aiba I, Noebels JL

    • Time-dependence of graph theory metrics in functional connectivity analysis.

      Chiang S, Cassese A, Yeh SJ, Haneef Z, Stern J

    • An international, curated KCNQ2 registry, database and website.

      Joshi N, Cooper EC, Taglialatela M, Weckhuysen S

    • KCNQ2 encephalopathy: Novel single amino acid deletion variants strongly suppress currents and are responsive to SF0034.

      Li L, Cooper EC

    • Interictal relative gamma power as a biomarker for anti-epileptic drug response in absence epilepsy.

      Maheshwari A, Marks R, Yu K, Noebels J

    • MECP2 duplication is associated with severe epileptic encephalopathy in the presence of permissive genetic background.

      Marafie D, Suter B, Pacheco VH, Glaze D, Drabek J, Goldman A

    • KCNQ2 p.Arg198Gln, a gain-of-function variant presenting recurrently as West syndrome without preceding neonatal seizures.

      Millichap J, Miceli F, Tran B, Keator C, Joshi N, Virginia Soldovieri M, et al.

    • Novel clinical features of KCNQ2 encephalopathy associated with the gain-of-function variant, R201C.

      Mulkey SB, Ben-Zeev B, Cooper EC, Cilio M

    • Progressive myoclonus epilepsy caused by SACS mutations.

      Nascimento FA, Muona M, Aljaafari D, Tarnopolsky M, Lehesjoki A-E, Faghfoury H, et al.

    • A critical developmental window for 17β-estradiol anti-epileptogenic effect in a mouse model of x-linked infantile spasms.

      Siehr MS, Lucero RD, Lalonde JW, Noebels J

    • Pharmacological rescue of KCNQ2 channels carrying early-onset epileptic encephalopathy mutations.

      Soldovieri M, Ambrosino P, De Maria M, Mosca I, Miceli F, Striano P, et al.

    • Electrographic seizure detection and effectiveness of responsive neurostimulation in periventricular nodular heterotopias.

      Van Ness P, Arcot Desai S, Sun F, Kapur R, King-Stephens D, Bergey G, et al.

    • Long-term outcome of adults with medically intractable mesial temporal lobe seizures treated with responsive neurostimulation.

      Van Ness P, Mizrahi E, King-Stephens D, Nair D, Bazil C, Goodman R, et al.

    XXII World Congress of Neurology (WCN)
    Santiago, Chile (Oct. 31 - Nov. 5, 2015)
    • Unusual presentation of reversible vasoconstriction syndrome in post-partum woman.

      Jalali N, Chu J, Kass J

    American Society for Bioethics and Humanities (ASBH)
    17th Annual Meeting in Houston, Texas (Oct. 22-25, 2015)
    • Ethics, professionalism and health policy program (EP3): Creating a longitudinal curriculum linked to ACGME milestones in training.

      Allen N, Antonio J, Fedson S, Malek J, Kass J, McCullough L, et al.

    Society for Neuroscience (SFN)
    45th Annual Meeting in Chicago, Ill. (Oct. 17-21, 2015)
    • Cardiac arrhythmogenic leaky ryanodine receptor 2 mutation increases cortical excitability and lowers threshold for spreading depolarization in mouse brain.

      Aiba I, Noebels JL

    • Excessive Ras-MAPK-dependent synaptic clustering drives enhanced motor learning in the MECP2-duplication mouse model of syndromic autism.

      Ash RT, Buffington SA, Fahey PG, Park J, Lu H, Costa-Mattioli M, et al.

    • Characteristics of seizure termination in primary and secondarily generalized seizures.

      Borzello M, Maheshwari A, Chu C, Kramer M, Westover BM, Cash SS

    • Validation of olfactory identification deficit as a biomarker of Alzheimer's disease.

      Lazar E, Woodward M, Amrutkar C, Hagemeier J, Shah H, Benedict R, et al.

    • Population receptive field changes in hV5/MT+ of healthy subjects with simulated visual field scotomas.

      Papanikolaou A, Keliris GA, Lee S, Logothetis NK, Smirnakis SM

    Canadian Epilepsy Research Initiative (CERI)
    2015 Annual Retreat in Toronto, Ontario, Canada (Oct. 2-4, 2015)
    • Two definite cases of sudden unexpected death in epilepsy in a family with a DEPDC5 mutation.

      Nascimento FA, Borlot F, Cossette P, Minassian BA, Andrade DM

    American Neurological Association (ANA)
    140th Annual Meeting in Chicago, Ill. (Sept. 27-29, 2015)
    • Safety of treadmill exercise testing in Parkinson disease.

      Jackson GR, Bryant M, Zaheer F, Protas E

    • Results of a double-blind placebo-controlled study of 3,4-diaminopyridine (DAP) in Lambert-Eaton Myasthenic Syndrome (LEMS).

      Sanders DB, Juel VC, Harati Y, Smith AG, Peltier A, Marburger T, et al.

    31st International Epilepsy Congress (IEC)
    Istanbul, Turkey (Sept. 5-9, 2015)
    • Neonatal estradiol prevents infantile spasms and seizures in arx-linked infantile spasms syndrome.
      [Platform Presentation]

      Noebels JL

    • Utilization of fMRI in patients with epilepsy and right hemispheric dominance.
      [Platform Presentation]

      Van Ness PC

    2015 Alzheimer's Association International Conference (AAIC)
    Washington, DC (July 18-23, 2015)
    North American Primary Care Research Group (NAPCRG)
    2015 Practice-Based Research Network Conference in Bethesda, Md. (June 29-30, 2015)
    • Selection of resources from a vaccination standing order program toolkit during a randomized trial to improve vaccination rates in a PBRN.

      Brown A, Pavlik V, Zimmerman R, Danek L, Lacour-Chestnut F, Lateef M, et al.

    • Content of patient instructions section of an EHR generated after visit summary affects patient satisfaction.

      Pavlik V, Nash SG, Laufman L

    American Headache Society
    57th Annual Scientific Meeting in Washington, DC (June 18-21, 2015)
    • OnabotulinumtoxinA for trigeminal neuralgia: a review of the available data.
      [Oral Presentation]

      Utiumi MAT,Nascimento FA, Piovesan EJ, Teive HAG, Kowacs PA

    Hospital Universitário Evangélico de Curitiba (HUEC)
    IX Congresso de Pediatria in Curitiba, Paraná, Brazil (June 2015)
    • Bronquiolite obliterante pós-infecciosa: perfis espirométricos e tomográficos segundo o número de internamentos hospitalares no primeiro ano de evolucão da doenca.

      Nery J, Nascimento FA, Riedi CA

    • Síndrome hematofagocítica secundária a neuroblastoma em lactente: uma associacão in comum.
      [Previously Presented]

      Nery J, Nascimento FA, Trennepohl J, Pianovski MAD

    Movement Disorder Society (MDS)
    19th International Congress of Parkinson's Disease and Movement Disorders in San Diego, Calif. (June 14-18, 2015)
    American Association of Neuropathologists, Inc. (AANP)
    91st Annual Meeting in Denver, Colo. (June 11-14, 2015)
    • An unusual case of central nervous system Rosai-Dorfman disease.

      Chu J, Goodman JC, Jalali N, Kass J

    Academia Brasileira de Neurocirurgia
    XVI Congresso in Atibaia, Brazil (June 2-6, 2015)
    • Série de calosotomias no HC-UFPR em 6 anos.

      Gatto LAM, Nascimento F, Silvado C, Araujo JC

    American Society of Clinical Oncology (ASCO)
    51st Annual Meeting in Chicago, Ill. (May 29 - June 2, 2015)
    IX Congresso Internacional de Especialidades Pediátricas
    Curitiba, Paraná, Brazil (May 2015)
    • Síndrome hematofagocítica secundária a neuroblastoma em lactente: uma associacão in comum.

      Nery J, Nascimento FA, Trennepohl J, Pianovski MAD

    University of Toronto
    3rd International Conference on Knowledge Gaps in Parkinson's disease and Other Movement Disorders in Toronto, Canada (May 8-10, 2015)
    • Reticular myoclonus in type I myotonic dystrophy.

      Chu J, Luo L, Harati Y

    American Stroke Association
    Quality of Care and Outcomes Research Scientific Sessions in Baltimore, Md. (April 29 - May 1, 2015)
    • The use of thrombolysis among acute ischemic stroke patients with limited English proficiency.

      Mejia N, Siddiqui KA, Erfe B, Schwamm LH

    • Increased frequency of early dispensed but unused tPA shortens door to needle times in potentially eligible thrombolysis patients presenting to a tertiary stroke center.

      Siddiqui KA, Ali SF, Anderson CD, Rost N, Schwamm LH

    • Patient characteristics and outcomes among early-arriving acute stroke patients for whom alteplase was dispensed but not administered.
      [Oral Presentation]

      Siddiqui KA, Syed FA, Anderson CD, Rost N, Schwamm LH

    American Academy of Neurology (AAN)
    67th Annual Meeting in Washington, DC (April 18-25, 2015)
    Experimental Biology
    2015 Annual Meeting in Boston, Mass. (March 28 - April 1, 2015)
    • Differential Ankyrin-G binding of voltage-gated sodium and KCNQ2/3 potassium channels is mediated by an overlapping N-terminal binding site.

      Xu M, Cooper E

    American Stroke Association
    2015 International Stroke Conference in Nashville, Tenn. (Feb. 11-13, 2015)
    • Baseline clinical and infarct characteristics as predictors of poor outcomes in patients not thrombolysed due to mild or resolving symptoms ("too good to treat").

      Ali SF, Siddiqui KA, Cohen AS, Ay H, Singhal AB, Schwamm LH

    • Admission hemoglobin and sodium values are important factors associated with good outcome after acute ischemic stroke.

      Cohen AS, Siddiqui KA, Ali SF, Anderson CD, Silverman SB, Schwamm LH

    • Sustained reliability in dysphagia screening by registered nurses.
      [Oral Presentation]

      Daniels SK, Pathak S, Morgan RO, Anderson JA

    • Incidence of new or worsening renal insufficiency (RI) among stroke patients receiving IV contrast dye: A population-based study.

      Demel SL, Moomaw CJ, Khoury JS, Alwell KA, Kissela BM, Grossman AG, et al.

    • Reasons why rt-PA was not given: Physician documentation vs. chart abstraction.

      Eckerle B, Khoury J, Alwell K, Moomaw C, Kissela B, Flaherty M, et al.

    • Trends in anticoagulant-associated intracerebral hemorrhage and cardioembolic ischemic stroke.
      [Oral Presentation]

      Flaherty ML, Sekar P, Alwell K, Moomaw CJ, Ferioli S, Adeoye O, et al.

    • Using simulation mannequins to train nurses in stroke dysphagia screening.

      Freeland T, Garrett R, Pathak S, Anderson JA, Daniels SK

    • Temporal trends of emergency department arrival times after acute ischemic stroke: A population-based study.

      Katz BS, Khoury J, Alwell K, Moomaw CJ, Kissela BM, Flaherty ML, et al.

    • Racial differences in ischemic stroke subtypes: The Greater Cincinnati/Northern Kentucky Stroke Study (GCNKSS).

      Kissela B, Khoury J, Alwell K, Moomaw CJ, Woo D, Flaherty ML, et al.

    • Population-based eligibility for a stroke prevention trial evaluating novel anticoagulants and embolic strokes of uncertain etiology: Similar eligibility as for IV rt-PA.

      Kleindorfer D, Kasner S, Moomaw CJ, Alwell K, Adeoye O, Woo D, et al.

    • Analysis of gender and time to arrival among ischemic stroke patients in the Greater Cincinnati/Northern Kentucky Stroke Study.

      Madsen TE, Sucharew H, Katz B, Alwell KA, Moomaw CJ, Kissela BM, et al.

    • Multi-center experience with low dose intravenous abciximab in large vessel posterior circulation stroke.

      Mandava P, Rosso C, Samson Y, Kent TA

    • Modeling outcome after intracerebral hemorrhage indicates no benefit from lowering blood pressure.
      [Oral Presentation]

      Mandava P, Samson Y, Kent TA

    • Early improvement in NIHSS is common during inter-hospital transfer and is associated with lower in-hospital mortality.

      Siddiqui KA, Cohen AS, Ali SF, Schwamm LH

    International Neuropsychological Society (INS)
    43rd Annual Meeting in Denver, Colo. (Feb. 4-7, 2015)
    • Chaining likelihood ratios to detect psychogenic non-epileptic events (PNEE).

      Booth JE, Wisdom NM, Robinson J, Chen D, Collins R

    • The relation between the WMT and CVLT-2 in a sample of patients evaluated for dementia.

      Collins R, Miller B, Robinson J, Pacheco V

    • Neuropsychological improvement following a novel inpatient treatment for OEF/OIF veterans with PTSD and multiple comorbidities.

      McCauley S, Menefee D, Tran J, Wanner J, Hickey J, Leopoulos W, et al.

    • Prospective memory in OEF/OIF veterans with PTSD with or without mild traumatic brain injury using virtual week.

      McCauley S, Tran J, Menefee D, Wanner J, Hickey J, Leopoulos W, et al.

    • Persistent post-concussive symptoms and cortical thinning in mild traumatic brain injury.

      Merkley TL, Wilde EA, McCauley S, Barnes A, Li X, Bigler ED, et al.

    • Added value of neuropsychological assessment to the Clinical Dementia Rating Scale in assessing mild cognitive impairment.

      Miller B, Robinson J, Pacheco V, Collins R

    • Examination of the severe impairment profile in dementia evaluations.

      Robinson J, Collins R, Miller B, Pacheco V

    • Comparison of psychogenic movement disorder patients with non-epileptic seizures vs other hyperkinetic motor manifestations: an integrated model of psychosocial and neuropsychological functioning.

      Scott BM, Strutt AM, Lundberg-Love P, Schmitt AL, Trifilio E, Bowers D

    • Psychometric properties of the Patient Competency Rating Scale in a seizure disorder population.

      Stinson JM, Grabyan J, Robinson J, Proto D, Chen D, Collins R

    • Improvement in psychiatric status following a novel inpatient treatment for OEF/OIF veterans with PTSD and multiple comorbidities.

      Wilde EA, Menefee D, Tran J, Wanner J, Leopoulos W, Hickey J, et al.

    • An examination of cognitive deficits after controlling for respondent validity in veterans with chronic PTSD.

      Wisdom NM, Booth JE, Tang R, Miller B, Collins R, Pastorek NJ

    • Volumetric and DTI analyses of sports concussion.

      Wu TC, Merkley TL, Wilde EA, Barnes A, Li X, Shin BC, et al.

    • White matter integrity and its relationship to PTSD symptoms and sleep quality in OEF/OIF veterans.

      Zilberfayn I, Wilde EA, Tran J, Menefee D, Sanyal R, Hickey J, et al.

    American Clinical Neurophysiology Society (ACNS)
    2015 Annual Meeting in Houston, Texas (Feb. 3-8, 2015)
    • Paroxysmal generalized electrographic delta activity with confusion during natalizumab infusion.

      Kadiwala H, Hays RS, Van Ness PC, Agostini M, Greenberg B, Ding K

    • A complex epileptogenic network involving periventricular nodular heterotopia.

      Templer J, Gavvala J, Gerard E, Macken M, Narechania A, Van Haerents SA, et al.

    American Epilepsy Society (AES)
    68th Annual Meeting in Seattle, Wash. (Dec. 5-9, 2014)
    • Hepatic safety of eslicarbazepine acetate: Summary of five Phase II and three Phase III adjunctive trials.

      Blum D, Van Ness P, Krauss G, Chung S, Elger C, Galimberti CA, et al.

    • Characteristics of seizure termination in focal and generalized seizures.

      Borzello M, Maheshwari A, Chu C, Brandon Westover M, Kramer M, Cash S

    • Computer-automated focus lateralization of temporal lobe epilepsy using fMRI.

      Chiang S, Levin H, Haneef Z

    • Impact of psychogenic non-epileptic seizure (PNES) diagnosis on acute care resource utilization, role for psychiatric consultation, and follow-up within a Dallas county hospital system.

      Culver C, Konikkara J, Howe-Martin L, Van Ness P, Agostini M, Hays R, et al.

    • Rhythmic ictal nonclonic extremity movements in temporal lobe epilepsy: A reappraisal.

      Ding K, Agostini M, Gupta P, Hays R, Van Ness P, Modur P

    • Autoimmune epilepsy: Clinical features, management and outcomes.

      Dubey D, Hays R, Gupta P, Ding K, Agostini M, Van Ness P, et al.

    • Brain graph theory topology changes associated with anti-epileptic drug use.

      Haneef Z, Levin H, Chiang S

    • Responsive stimulation of eloquent cortex.

      Kapur R, Duckrow R, Heck C, Eisenschenk S, Gwinn R, Geller E, et al.

    • Unique characteristics of patients with comorbid epileptic and psychogenic nonepileptic seizures.

      Konikkara J, Pacheco J, Van Ness P, Agostini M, Hays R, Howe-Martin L, et al.

    • (1-3)insulin-like growth factor 1 suppresses seizures and hypsarrhythmia in an animal model of infantile spasms.
      [Platform Presentation]

      Lee C, Frost Jr. J, Le J, Hrachovy R, Swann J

    • Correlation of pre-diagnosis illness perception and clinical outcome in patients with psychogenic non-epileptic seizures.

      Majmudar S, Chen D

    • KCNQ2-deficiency: Clinical spectrum of epilepsy, encephalopathy, and response to ezogabine.

      Park K, Millichap J, Cooper E

    • Responsive neurostimulation in patients with periventricular nodular heterotopia (PNH).

      Rutecki P, Herekar A, Van Ness P, Bergey G, Bazil C, King-Stephens D, et al.

    • A KCNQ2/3 mutation causing severe epilepsy disrupts channel targeting to the axon initial segment.

      Tran B, Xu M, Cooper E

    • Treatment resistance correlates with ECG abnormalities in a pilot clinical surveillance of epilepsy patients.

      Zohrevand P, Diaz M, Amador A, Goldman A

    North American Primary Care Research Group (NAPCRG)
    42nd Annual Meeting in New York, N.Y. (Nov. 21-25, 2014)
    • Provider survey of attitudes toward and uses of an electronic after visit summary.

      Almutairi A, Nash SG, Laufman LE, Pavlik V

    • Patterns of glycemic control with exclusive oral hypoglycemic agent use in a community health care setting.

      Vaughan E, Aggarwal A, Pavlik V

    Society for Neuroscience (SFN)
    44th Annual Meeting in Washington, DC (Nov. 15-19, 2014)
    • Increased risk of hypoxic depolarization of the brainstem autonomic circuit in a mouse SUDEP model.

      Aiba I, Noebels JL

    • Neural mechanisms of circuit homeostasis failure in MeCP2 disorders.

      Lu H, Ash RT, Wang W, Yu D, Arenkiel BR, Smirnakis SM, et al.

    • Organization of human area V5/MT+ and sensitivity to motion coherence after lesions of the primary visual cortex.

      Papanikolaou A, Keliris GA, Lee S, Papageorgiou TD, Schiefer U, Logothetis NK, et al.

    Canadian League Against Epilepsy (CLAE)
    2014 Biennial Meeting in London, Ontario, Canada (Oct. 17-19, 2014)
    • Deep brain stimulation for the management of seizures in MECP2 duplication syndrome.
      [Previously Presented]

      Nascimento FA, Faghfoury H, Krings T, Ali A, Fridhandler J, Lozano A, et al.

    Congresso Paranaense de Pediatria
    Curitiba, Paraná, Brazil (October 2014)
    • Bronquiolite obliterante pós-infecciosa: relacão da idade de início e com padrões espirométricos e número de internamentos.

      Nery J, Nascimento FA, Riedi CA

    American Neurological Association (ANA)
    139th Annual Meeting in Baltimore, Md. (Oct. 12-14, 2014)
    • WIP safety, tolerability, and effectiveness of dextromethorphan/quinidine for pseudobulbar affect in patients with Alzheimer's disease/dementia: PRISM-II.

      Doody RS, D'Amico S, Cutler AJ, Shin P, Ledon F, Yonan C, et al.

    • Antioxidant biomarkers predict annualized change in MMSE score in MCI and AD patients in the TARCC cohort.

      Majid T, Chan W, Darby E, Pavlik V, Doody R

    Neurocritical Care Society (NCS)
    12th Annual Meeting in Seattle, Wash. (Sept. 11-14, 2014)
    • Volumetric integral phase-shift spectroscopy (VIPS), in detecting early cerebral edema: Hemodialysis as a proof of principle model.
      [Platform Presentation]

      Damani R, Maldonado N, Bershad E, Calvillo E, Smirnakis S, Georgiadis A, et al.

    • Human albumin (HA) usage in subarachnoid hemorrhage (SAH) patients at US academic medical centers: Analysis of the University Healthsystem Consortium (UHC) database.

      Suarez JI, Martin RH, Calvillo E, Hohmann SF, Bershad EM, Rao CPV, et al.

    2014 Alzheimer's Association International Conference (AAIC)
    Copenhagen, Denmark (July 12-17, 2014)
    North American Primary Care Research Group (NAPCRG)
    2014 Practice-Based Research Network Conference in Bethesda, Md. (June 30 - July 1, 2014)
    • Development of a codebook to describe the content of the patient instructions section of an EHR-generated after visit summary.

      Pavlik V, Campbell-Voytal K, Nash SG, Laufman L, Neale V

    Movement Disorder Society (MDS)
    18th International Congress of Parkinson's Disease and Movement Disorders in Stockholm, Sweden (June 8-12, 2014)
    American Society for Stereotactic and Functional Neurosurgery (ASSFN)
    2014 Biennial Meeting in Washington, DC (May 31 - June 3, 2014)
    American Society of Clinical Oncology (ASCO)
    50th Annual Meeting in Chicago, Ill. (May 30 - June 3, 2014)
    • Adverse effects of bevacizumab in brain tumor patients.

      Pawar T, Ladha H, Mandel J, Gilbert M, O'Brien B, Hamza M, et al.

    • Venous thromboembolism (VTE) and glioblastoma.

      Yust-Katz S, Mandel J, Ying Y, Wu J, Courtney C, Ladha H, et al.

    American Academy of Neurology (AAN)
    66th Annual Meeting in Philadelphia, Penn. (April 26 - May 3, 2014)
    Texas Scottish Rite Hospital for Children
    36th Annual Carrell-Krusen Neuromuscular Symposium in Dallas, Texas (Feb. 13-14, 2014)
    • A distinctive delayed form of exertional rhabdomyolysis.

      Sharp L, Haller RG

    • Fixed weakness in McArdle disease.

      Sharp L, Haller RG

    • Exercise intolerance with congenital anomalies.

      Sharp L, Haller RG, Heinicke K, Phillips L, Romain N, Park S, et al.

    International Neuropsychological Society (INS)
    42nd Annual Meeting in Seattle, Wash. (Feb. 12-15, 2014)
    • Progression and stability of cognitive asymmetry in a large sample of Alzheimer's disease patients.

      Alverson WA, Massman PJ, Grabyan JM, Doody RS

    • Perceived competency and quality of life deficits in individuals experiencing psychogenic non-epileptic events.

      Collins R, Robinson J, Plasencia M, Franks R, Chen D

    • A longitudinal investigation of sleep quality following mild traumatic brain injury: Comparison with orthopedic and non-injured controls.

      Faber J, Adam S, Li X, McCauley S, Levin H

    • Patients with sports-related mTBI return to activities more rapidly than patients with motor vehicle crash-related mTBI.

      Rabinowitz AR, Li X, McCauley SR, Wilde EA, Hanten GR, Levin HS

    • The relation of postconcussive symptom report and cognitive testing in an mTBI population: The effect of performance validity test results.

      Stinson JM, Pastorek NJ, Miller B, Linck J, Sim A, Romesser J

    • Serial diffusion tensor imaging in subacute uncomplicated mild traumatic brain injury.

      Wilde EA, Bigler ED, Pedroza C, Barnes A, Wu TC, McCauley SR

    • Effects of PTSD, mild traumatic brain injury, and alcohol abuse on sleep quality in OEF/OIF veterans.

      Zilberfayn I, Wilde EA, Tran JK, Menefee DS, Sanyal R, Leopoulos WS, et al.

    American Stroke Association
    2014 International Stroke Conference in San Diego, Calif. (Feb. 12-14, 2014)
    • ICD-9 code positive predictive value for stroke subtype in a population-based epidemiology study.

      Alwell K, Khoury JC, Kleindorfer DO, Moomaw CJ, Eilerman J, Woo D, et al.

    • Use of emergency medical services by stroke patients.
      [Oral Presentation]

      Anderson AM, Sucharew H, Alwell K, Moomaw CJ, Adeoye O, Woo D, et al.

    • Combination argatroban and TPA for acute ischemic stroke: A matched case-control analysis.

      Barreto AD, Mandava P, Guerrero W, Shen L, Grotta JC, Kent TA

    • Prevalence of echocardiographic abnormalities in acute ischemic stroke.

      Eckerle B, Sucharew H, Alwell K, Moomaw CJ, Flaherty M, Martini S, et al.

    • Impact of substance abuse on timely treatment with rt-PA: A population-based study.

      Goodall EB, Kimmel PL, Sucharew H, Alwell K, Moomaw CJ, de los Rios La Rosa F, et al.

    • Prevalence of unsuspected renal insufficiency in stroke patients presenting to the emergency department: A population-based assessment.
      [Oral Presentation]

      Grossman AW, Khoury JC, Alwell K, Moomaw CJ, Khatri P, Woo D, et al.

    • Predictors of platelet transfusion in patients with intracerebral hemorrhage.

      Guerrero WR, Gonzales NR, Sekar P, Castillo J, Moomaw CJ, Worrall BB, et al.

    • Stroke in the young: Preliminary results for temporal trends in the age of stroke incidence in a large, bi-racial population.
      [Oral Presentation]

      Kissela BM, Alwell K, Khoury J, Moomaw C, Woo D, Adeoye O, et al.

    • Temporal trends in stroke incidence over the past twenty years: Stroke incidence has stabilized, racial disparity is not improving.

      Kleindorfer D, Alwell K, Khoury J, Moomaw CJ, Woo D, Adeoye O, et al.

    • Moderate alcohol use protects from intracerebral hemorrhage: Findings from the ethnic/racial variations of intracerebral hemorrhage (ERICH) study.

      Koch S, Brown MW, Moomaw CJ, Langefeld CD, Martini SR, Braimah J, et al.

    • Migraine and risk of intracerebral hemorrhage in the ethnic/racial variations of intracerebral hemorrhage (ERICH) study.

      Koch S, Elkind MS, Moomaw CJ, Brown MW, Martini SR, Osborne J, et al.

    • Racial-ethnic blood pressure differences in acute intracerebral hemorrhage.
      [Oral Presentation]

      Koch S, Elkind MS, Testai FD, Brown MW, Martini SR, Sheth KN, et al.

    • Does intraventricular hemorrhage lead to a normal pressure hydrocephalus-like syndrome?

      Kruger AJ, Flaherty M, Sekar P, Haverbusch M, Moomaw CJ, Martini S, et al.

    • Stroke recurrence rates are not changing over time.
      [Oral Presentation]

      Lee I, Sucharew H, Alwell K, Moomaw CJ, Woo D, Ferioli S, et al.

    • A pooled analysis indicates the promise and pitfalls of improving upon intravenous rt-PA for ischemic stroke.

      Mandava P, Shah SD, Sarma AK, Dalmeida D, Kent TA

    • Improving quality of care and outcomes in the community through the inclusive collaboration between a certified comprehensive stroke center and regional hospitals.

      Mazabob JM, Styron S, Brown G, Jones-Brown M, Suarez J, Bershad E, et al.

    • Clinical outcomes following thrombolysis for acute ischemic stroke in patients with systemic malignancy: A nationwide case-control study.

      Murthy S, Karanth S, Shah S, Shastri A, Rao C, Bershad E, et al.

    • Clinical outcomes following thrombolysis for acute ischemic stroke in patients with primary brain tumors: A nationwide population study.

      Murthy SB, Shah S, Karanth S, Shastri A, Bershad E, Suarez JI

    • Treatment of ischemic stroke with recombinant tissue plasminogen-activator in pregnancy: A population study.

      Shah S, Murthy S, Karanth S, Bershad EM, Venkatasubba Rao CP, Suarez J

    • ICH & FUNC scores in the ethnic/racial variations of intracerebral hemorrhage (ERICH) study.

      Sheth KN, Sung G, Langefeld CD, Moomaw CJ, Osborne J, Elkind MSV, et al.

    • Prior use of statins may reduce hematoma growth in intracerebral hemorrhage patients.

      Siddiqui FM, Olson DM, Sekar P, Moomaw CJ, Rosand J, Kidwell C, et al.

    • Utilization of vascular imaging in stroke: A population based study.

      Vagal A, Sucharew H, Alwell K, Khoury J, Khatri P, Woo D, et al.

    • Is obesity a marker of good or bad functional outcome after ischemic stroke?

      Yeramaneni S, Kissela BM, Kleindorfer DO, Alwell K, Moomaw CJ, McCarthy M, et al.

    American Epilepsy Society (AES)
    67th Annual Meeting in Washington, DC (Dec. 6-10, 2013)
    • Longitudinal feasibility testing of the MINDSET vers 2.1: A clinic-based decision support system for epilepsy self-management.

      Begley C, Shegog R, Harding A, Newmark M, Goldsmith C, Hope O

    • Predictors of postoperative seizure outcome: a longitudinal study of temporal and extratemporal resections.

      Chen H, Agostini M, Ding K, Gupta P, Hays R, Van Ness P, et al.

    • Right hemispheric ictal asystole - Report of two cases.

      Chu J, Majmudar S, Chen D

    • Discordance between functional magnetic resonance imaging (fMRI) and Wada test for language lateralization.

      Ding K, Yetkin Z, Van Ness P, Agostini M, Hays R, Gupta P, et al.

    • Lateralization of temporal lobe epilepsy with long-term ambulatory intracranial monitoring using the RNS system: Experience in 82 patients.

      King-Stephens D, Mirro E, Weber P, Laxer K, Van Ness P, Salanova V, et al.

    • STOP SUDEP Program: Application of visual automated fluorescence electrophoresis in the qualitative profiling of archived SUDEP samples.

      Klassen TL, Tomson T, Sveinsson O, von Dobeln U, Drabek J, Noebels J, et al.

    • Practical implications of methodological differences in the Wada test protocols.

      Konikkara JJ, Frol AB, Agostini M, Ding K, Gupta P, Hays R, et al.

    • Pore loop KCNQ2 mutations causing epileptic encephalopathy strongly suppress wild type KCNQ2 currents when co-expressed in mammalian cells.

      Li L, Tran B, Xu M, Millichap J, Porter B, Cooper E

    • In vivo 2-photon confocal microscopy of cortical absence epilepsy.

      Meyer JF, Maheshwari A, Noebels J, Smirnakis S

    • Long-term safety and efficacy of responsive brain stimulation in adults with medically intractable partial onset seizures.

      Morrell M, Sun F, King-Stephens D, Murro A, Barkley GL, Gwinn R, et al.

    • How long is long enough? The utility of prolonged inpatient video EEG monitoring.

      Moseley B, Dewar S, Haneef Z, Stern J

    • Deep brain stimulation for the management of seizures in MECP2 duplication syndrome.
      [Previously Presented]

      Nascimento FA, Faghfoury H, Krings T, Ali A, Fridhandler J, Lozano A, et al.

    • Diagnoses of neurobehavioral paroxysms in veterans of Operation Enduring Freedom/Operation Iraqi Freedom (OEF/OIF) - Experiences from a VA epilepsy center.

      Satpute S, Franks R, Chen D

    • KCNQ2 targeting to the axon initial segment is disrupted in a mutant form causing severe epilepsy.

      Tran B, Xu M, Cooper E

    • Ankyrin-G as a potential molecular mechanism linking epilepsy and comorbid mood disorder.

      Xu M, Cooper E

    • Antiepileptic drugs and movement disorders: A frequently neglected story.

      Zaheer F, Jones K, Bensalem-Owen M, Slevin JT

    Society of Neuro-Oncology (SNO)
    18th Annual Meeting in San Francisco, Calif. (Nov. 21-24, 2013)
    • Survival outcomes of patients with recurrent anaplastic glioma treated with bevacizumab.

      Hamza M, O'Brien B, Mandel J, de Groot J

    • Glioblastoma and leptomeningeal dissemination.

      Mandel J, Yust-Katz S, de Groot J, Yung A, Gilbert M

    Society for Neuroscience (SFN)
    43rd Annual Meeting in San Diego, Calif. (Nov. 9-13, 2013)
    • Bexarotene decreases hyperexcitability in two mouse models with epilepsy.

      Bomben VC, Holth JK, Cramer PE, Landreth GE, Noebels JL

    • Paranodal ankyrins: Enigmatic glial anchors.

      Chang K-J, Zollinger DR, Susuki K, Ho TS, Cooper EC, Bennett V, et al.

    • State dependence of noise correlations in monkey primary visual cortex.

      Ecker AS, Berens P, Cotton RJ, Subramaniyan M, Denfield GH, Smirnakis SM, et al.

    • The roles of ankyrin-G in node of Ranvier formation in vivo.

      Ho T, Zollinger DR, Xu M, Cooper EC, Stankewich MC, Bennett V, et al.

    • Estimation of average single-unit receptive field size by fMRI.

      Keliris GA, Shao Y, Papanikolaou A, Logothetis NK, Smirnakis SM

    • Human area V5/MT+ organization changes following lesions of the primary visual cortex.

      Papanikolaou A, Keliris GA, Papageorgiou DT, Shao Y, Krapp E, Papageorgiou E, et al.

    • Peripheral nerve graft implants into the substantia nigra of subjects with Parkinson's disease undergoing deep brain stimulation surgery: a safety study.

      Quintero JE, Asfahani WSZ, Zaheer F, Gurwell JA, Gerhardt GA, Slevin JT, et al.

    • Population receptive field measurements in the visual cortex of macaque monkeys with and without retinal lesions.

      Shao Y, Keliris GA, Schmid MC, Papanikolaou A, Logothetis NK, Smirnakis SM

    • Genetic ablation of betaII-spectrin in the central nervous system results in axon degeneration, epilepsy and postnatal lethality.

      Zhang C, Huang Y-M, Zhu P, Reed JG, Costa-Mattioli M, Noebels JL, et al.

    22nd International Epilepsy Surgery Symposium
    Campinas, São Paulo, Brazil (Oct. 26-29, 2013)
    • Modified Wada test for temporal lobe epilepsy using an etomidate protocol with a loading dose followed (or not) by booster dose(s).

      da Rocha SFB, Nascimento FA, Leal AG, Simao CA, Meneses M, Kowacs PA

    • Deep brain stimulation for the management of seizures in MECP2 duplication syndrome.
      [Previously Presented]

      Nascimento FA, Faghfoury H, Krings T, Ali A, Fridhandler J, Lozano A, et al.

    Universidade Federal do Paraná
    21th Scientific Initiation Event (EVINCI) in Curitiba, Paraná, Brazil (October 2013)
    • Bronquiolite obliterante pós-infecciosa: idade de início e número de internamentos no primeiro ano.
      [Oral Presentation]

      Nascimento FA, Nery J, Riedi CA

    American Neurological Association (ANA)
    138th Annual Meeting in New Orleans, La. (Oct. 13-15, 2013)
    Neurocritical Care Society (NCS)
    11th Annual Meeting in Philadelphia, Penn. (Oct. 1-4, 2013)
    • Generation of a pooled outcome model for traumatic brain injury to use for prediction of potential trial success.

      Mandava P, Murthy SB, Dalmeida W, Hannawi Y, Wu EY, Kent TA

    • Takotsubo cardiomyopathy increases mortality in traumatic brain injury patients: analysis of the nationwide inpatient sample.

      Murthy SB, Shah S, Karanth S, Venkatasubba Rao C, Bershad EM, Suarez JI

    • Clinical outcomes of venous thromboembolism in subarachnoid hemorrhage patients: a U.S. population study.

      Murthy SB, Shah S, Shastri A, Karanth S, Venkatasubba Rao C, Bershad E, et al.

    • Profound olfactory impairment in idiopathic intracranial hypertension.

      Urfy MZ, Chen D, Calvillo E, Suarez JI, Rao CPV, Tang RA, et al.

    • Distortion product otoacoustic emissions for non-invasive intracranial pressure assessment.

      Urfy MZ, Voss S, Rao CPV, Suarez JI, Calvillo E, Pechacek A, et al.

    Parkinson Study Group (PSG)
    27th Annual Symposium on Etiology, Pathogenesis, and Treatment of Parkinson Disease and Other Movement Disorders in Montreal, Quebec, Canada (Oct. 1, 2013)
    Frischmann Aisengart Laboratory
    VI Jornada de Clínica Médica Universidade Federal do Paraná in Curitiba, Paraná, Brazil (Sept. 27-28, 2013)
    • A decade without diagnosis: Sheehan's syndrome.

      Nascimento FA, Nery J, Marques GL, dos Santos FD, de Carvalho M

    XXI World Congress of Neurology (WCN)
    Vienna, Austria (Sept. 21-26, 2013)
    Alzheimer's Association, Houston and Southeast Texas Chapter
    7th Annual Research Symposium on Alzheimer's Disease (Sept. 12, 2013)
    Federal Health Care Center (FHCC)
    Department of Endocrinology Educational Seminar in North Chicago, Ill. (August 2013)
    • A review of pituitary incidentalomas.
      [Oral Presentation]

      Kesari N

    2013 Alzheimer's Association International Conference (AAIC)
    Boston, Mass. (July 13-18, 2013)
    30th International Epilepsy Congress (IEC)
    Montreal, Quebec, Canada (June 23-27, 2013)
    • Deep brain stimulation for the management of seizures in MECP2 duplication syndrome.
      [Previously Presented]

      Nascimento FA, Faghfoury H, Krings T, Ali A, Fridhandler J, Lozano A, et al.

    Movement Disorder Society (MDS)
    17th International Congress of Parkinson's Disease and Movement Disorders in Sydney, Australia (June 16-20, 2013)
    European Neurological Society (ENS)
    23rd Annual Meeting in Barcelona, Spain (June 8-11, 2013)
    • Tosedostat and posterior reversible encephalopathy syndrome (PRES).
      [Oral Presentation]

      Mandel J, Tremont-Lukats I, Tummala S

    • Severe neurological disability in cancer patients acutely infected with the West Nile virus (WNV).

      Mandel J, Woodman K, Tummala S, Tremont-Lukats I

    Baylor College of Medicine (BCM)
    Resident Research Day Symposium in Houston, Texas (June 5, 2013)
    • Therapeutic utility of long-term monitoring diagnosis in psychogenic nonepileptic events (PNEE) on patient illness perception and hospital resource utilization.
      [Previously Presented]

      Nunez-Wallace K, Murphey D, Chen D

    American Society of Clinical Oncology (ASCO)
    49th Annual Meeting in Chicago, Ill. (May 31 - June 4, 2013)
    • Survival outcome of early versus delayed bevacizumab treatment in patients with recurrent glioblastoma.

      Hamza MA, Mandel J, Conrad CA, Gilbert MR, Yung WKA, Puduvalli VK, et al.

    Consortium of Multiple Sclerosis Centers (CMSC)
    27th Annual Meeting in Orlando, Fla. (May 29 - June 1, 2013)
    Toronto Western Hospital
    Research Day in Toronto, Ontario, Canada (May 2013)
    • Deep brain stimulation for the management of seizures in MECP2 duplication syndrome.
      [Previously Presented]

      Nascimento FA, Faghfoury H, Krings T, Ali A, Fridhandler J, Lozano A, et al.

    Society for Industrial and Applied Mathematics (SIAM)
    13th International Conference on Data Mining in Austin, Texas (May 2-4, 2013)
    • Classification and diagnosis of myopathy from EMG signals.
      [Platform Presentation]

      Bue B, Merényi E, Killian J

    Texas A&M College of Medicine
    Clinical Neurology to First Year Medical Students in Bryan, Texas (April 2013)
    • Neurological exam pearls: MSI lecture and workshop.
      [Oral Presentation]

      Kapadia A, Clark J

    Society for Neuroscience - Bluegrass Chapter (BGSFN)
    29th Annual Spring Neuroscience Research Meeting in Lexington, Ky. (April 8, 2013)
    American Academy of Neurology (AAN)
    65th Annual Meeting in San Diego, Calif. (March 16-23, 2013)
    Texas Scottish Rite Hospital for Children
    35th Annual Carrell-Krusen Neuromuscular Symposium in Dallas, Texas (Feb. 14-15, 2013)
    • Glycogen breakdown is preserved during exercise.

      Sharp L, Heinicke K, Ren J, Newby M, Wyrick P, Rice G, et al.

    • Not PFK deficiency.
      [Oral Presentation]

      Sharp L, Romain N, Haller RG

    American Heart Association/American Stroke Association
    2013 International Stroke Conference in San Diego, Calif. (Feb. 12-14, 2013)
    • Secondary stroke prevention program: Effect on stroke specific quality of life.

      Damush T, Anderson J, Yu Z, Ofner S, Myers L, Schmid A, et al.

    • Implementation of a secondary stroke prevention program: Effect on medication adherence.

      Damush T, Myers L, Anderson J, Yu Z, Ofner S, Schmid A, et al.

    • Novel carbon-based particle antioxidants in reversible hyperglycemic MCA occlusion.

      Fabian RH, Marcano D, Samuel EL, Tour J, Kent TA

    • Outcomes after tPA in African American women with explicit consideration of baseline factors.

      Mandava P, Martini S, Albright KC, Boehme AK, Martin-Schild S, Alexandrov AV, et al.

    • Extending the time window with low dose IV abciximab in acute non-lacunar stroke.

      Mandava P, Weir RU, Shah SD, Hannawi Y, Murthy SB, Anderson JA, et al.

    • Comparison of clinical characteristics of neurogenic stunned myocardium in patients with subarachnoid hemorrhage and acute ischemic stroke.

      Murthy SB, Shah S, Hannawi Y, Georgiadis A, Smirnakis S, Bershad E, et al.

    • High utilization of CAS procedures among the elderly in the post CREST era.

      Rayes M, Bhattacharya P, Damani R, Chaturvedi S

    • Increased carotid stenting for nonspecific symptoms in the post-CREST era.

      Rayes M, Bhattacharya P, Damani R, Chaturvedi S

    International Neuropsychological Society (INS)
    41st Annual Meeting in Montreal, Waikoloa, Hawaii (Feb. 6-9, 2013)
    American Stroke Association
    2013 International Stroke Conference in Honolulu, Hawaii (Feb. 6-8, 2013)
    • Racial differences in perceived risk, self-efficacy, and fear of stroke.

      Anderson AM, Khoury J, Frankel M, Kissela BM, Rademacher E, Flaherty ML, et al.

    • Public perceived risk of stroke, myocardial infarction, and cancer.

      Anderson AM, Khoury J, Frankel M, Kissela BM, Rademacher E, Flaherty ML, et al.

    • Location of intracerebral hemorrhage in a tri-ethnic cohort: the ERICH study.

      Birnbaum L, Leonard A, Andino J, Moomaw CJ, Langfeld C, Brown WM, et al.

    • Novel carbon-based particle antioxidants in reversible hyperglycemic MCA occlusion.

      Fabian RF, Marcano D, Samuel EL, Tour J, Kent TA

    • Risk of intracerebral hemorrhage with combined antiplatelet and anticoagulant use.
      [Oral Presentation]

      Flaherty ML, Ding L, Woo JG, Martin L, Haverbusch M, Moomaw CJ, et al.

    • Classification of periventricular white matter disease (WMD) in clinical radiology reports vs. direct film review in ischemic stroke patients.

      Hancher J, Eilerman J, Alwell K, Sucharew H, Moomaw CJ, Woo D, et al.

    • Outcomes after tPA in African American women with explicit consideration of baseline factors.

      Mandava P, Martini S, Albright KC, Boehme AK, Martin-Schild S, Alexandrov AV, et al.

    • Extending the time window with low dose IV abciximab in acute non-lacunar stroke.

      Mandava P, Weir RU, Shah SD, Hannawi Y, Murthy SB, Anderson JA, et al.

    • Comparison of clinical characteristics of neurogenic stunned myocardium in patients with subarachnoid hemorrhage and acute ischemic stroke.

      Murthy SB, Shah S, Hannawi Y, Georgiadis A, Smirnakis S, Bershad E, et al.

    • Withdrawal of care in the ethnic/racial variations of intracerebral hemorrhage (ERICH) study.
      [Oral Presentation]

      Sheth KN, Martini SR, Tirschwell DL, Becker KJ, Worrall BB, James ML, et al.

    • Apolipoprotein E and use of statins in intracerebral hemorrhage.
      [Oral Presentation]

      Woo D, Deka R, Woo JG, Martini S, Flaherty M, Haverbusch M, et al.

    American Clinical Neurophysiology Society (ACNS)
    2013 Annual Meeting in Miami, Fla. (Feb. 5-10, 2013)
    • cEEG monitoring: A survey of neurophysiologists and neurointensivists.

      Gavvala J, Abend NS, LaRoche SM, Garic I, Herman ST, Claassen J, et al.

    Keystone Symposium
    New Frontiers in Neurodegenerative Disease Research Meeting in Santa Fe, N.M. (Feb. 5, 2013)
    • Casein kinase Iε phosphorylation of TDP-43 causes oligomerization and enhances toxicity in vivo.

      Jackson GR, Choksi DK, Roy B, Chatterjee S, Sengupta E, Kayed R

    American Epilepsy Society (AES)
    66th Annual Meeting in San Diego, Calif. (Nov. 30 - Dec. 4, 2012)
    • Clustering of mutations in a North American series supports a dominant-negative mechanism of KCNQ2 encephalopathy.

      Cooper EC, Carmant L, Flamini R, Kendall FD, Levisohn PM, Millichap JJ, et al.

    • Regional atrophy in temporal lobe epilepsy: Correlations with cognitive impairment.

      Ding K, Gong Y, Frol A, Gupta P, Van Ness P, Agostini M, et al.

    • Seizure ending signs in focal seizures with loss of awareness and/or responsiveness.

      Gavvala J, Kennedy J, Garic I, Sen-Gupta I, Macken M, Gerard E, et al.

    • SUDEP Tissue Donation Program (STOP): Collaborative network in support of SUDEP registry, tissue repository and human translational research.

      Goldman AM

    • Universal DNA extraction protocol for the utilization of alternative tissue sources in downstream epilepsy genetic analysis.

      Goldman AM, Klassen TL, von Rueden EL, Drabek JM, Noebels JL

    • SUDEP research consortium: A new collaborative network to discover predictive genes, mechanisms and biomarkers of SUDEP.
      [Investigators' Workshop]

      Goldman AM, Richerson G, Parent JM, Bateman L, Nordli DR, Noebels JL

    • Loss of tau protein reduces hyperexcitability in mouse and drosophila genetic models of epilepsy.

      Holth J, Reed JG, Inoue T, Pautler R, Botas J, Noebels JL

    • Myotonia in brain: 'Skeletal' chloride channel ClC-1 linked to idiopathic generalized epilepsy with focal myotonia.

      Klassen TL, Chen TT, Reed JG, Kole MJ, Goldman AM, Marini C, et al.

    • Channotyping epilepsy: Profiling personal variation in ion channel genes.

      Klassen TL, Goldman A, Davis C, Chen T, Gibbs R, Noebels J

    • An abbreviated support group therapy for psychogenic nonepileptic events: A neurologist-initiated program in an epilepsy center.

      Maheshwari A, Trolley G, Franks R, Chen DK

    • Treatment of KCNQ2 encephalopathy with ezogabine.

      Millichap JJ, Levisohn PM, Tsuchida TN, Cooper EC

    • 17?-estradiol decreases seizure and interictal spike frequency in a genetic mouse model of X-linked infantile spasms.

      Olivetti PR, Noebels JL

    • Electrocorticographic events preceding sudden unexplained death in epilepsy (SUDEP).

      Van Ness PC, Fountain NB, Duckrow RB, Gwinn RP, Liephart JW, Morrell MJ, et al.

    University of Toronto
    Neurology Faculty Research Day and the 26th McEwan-Jones Visiting Professorship in Toronto, Ontario, Canada (November 2012)
    • Deep brain stimulation for the management of seizures in MECP2 duplication syndrome.
      [Previously Presented]

      Nascimento FA, Faghfoury H, Krings T, Ali A, Fridhandler J, Lozano A, et al.

    National Academy of Neuropsychology (NAN)
    32nd Annual Meeting in Nashville, Tenn. (Nov. 7-10, 2012)
    • Mexican American normative references on tasks of memory and language: The Texas Mexican American normative studies.

      Edwards M, Balldin V, Hall J, Strutt A, Pavlik V, Marquez de la Plata C, et al.

    • Normative data for Mexican American on tasks of executive and physiometric functions: The Texas Mexican American normative studies.

      Hall J, Edwards M, Balldin V, Strutt A, Pavlik V, Marquez de la Plata C, et al.

    • Normative performance on the RBANS in a multi-ethnic bilingual cohort: The Texas Mexican American normative studies.

      Hobson Balldin V, Menon C, Younes S, Hall J, Strutt A, Pavlik V, et al.

    • Adaptation and norming of the Boston Naming Test for Spanish-speaking older adults in the USA.

      Resendiz C, Scott B, Farias G, York M, Lozano V, Mahoney M, et al.

    Baylor College of Medicine (BCM)
    Current Neurology 2012 in Houston, Texas (Nov. 3-4, 2012)
    American Autonomic Society (AAS)
    23rd International Symposium on the Autonomic Nervous System in Paradise Island, Bahamas (Oct. 31 - Nov. 3, 2012)
    • Glucoregulation and autonomic function in older male patients with diabetes mellitus and obstructive sleep apnea.

      Gilden JL, Cheng J, Theckedath B, Hung P, Farahani M, Azul J, et al.

    Houston Neuropsychological Society
    2012 Annual Symposium in Houston, Texas (October 2012)
    • Factor structure of the Zarit Burden Interview and relation to dementia severity and patient neuropsychological performance.

      Stinson JM, Collins RL, Maestas K, Pacheco V, LeMaire A

    Society for Neuroscience (SFN)
    42nd Annual Meeting in New Orleans, La. (Oct. 13-17, 2012)
    • Neuronal Elavl proteins regulate RNA splicing and abundance to control brain glutaminase expression and neuronal excitability.

      Ince Dunn G, Okana HJ, Okana H, Jensen K, Park W-Y, Mele A, et al.

    • Visualization of the population receptive field structures in human visual cortex.

      Lee S, Keliris GA, Papanikolaou A, Smirnakis SM, Logothetis NK

    • Impact of single cell firing on in vivo cortical activity.

      Meyer JF, Golshani P, Smirnakis SM

    • Pattern motion and direction selectivity in mouse V1.

      Palagina GS, Torsky S, Smirnakis SM

    • Population activity in the motor cortex of the MeCP2 duplication mouse.

      Suter B, Meyer JFH, Ash RT, Zoghbi HY, Smirnakis SM

    World Stroke Organization (WSO)
    8th World Stroke Congress in Brasilia, Brazil (Oct. 10-13, 2012)
    American Neurological Association (ANA)
    137th Annual Meeting in Boston, Mass. (Oct. 7-9, 2012)
    • Clinical assessment of the effect of tetrabenazine on motor function in moderate Huntington disease.

      Fekete R, Davidson A, Jankovic J

    • A prospective, observational trial evaluating Xeomin (incobotulinumtoxinA) for cervical dystonia (CD) or blepharospasm in the United States - Preliminary baseline results on the health impact of CD on patients using the cervical dystonia impact profile (CDIP).

      Jankovic J, Thomas M, Vasquez A, Sethi KD, Verma A, Pappert EJ, et al.

    • A prospective, observational trial evaluating Xeomin [IncobotulinumtoxinA] for cervical dystonia or blepharospasm in the US - Preliminary baseline results for patients with blepharospasm.

      LeDoux MS, Jankovic J, Sethi KD, Verma A, Pappert EJ, Fernandez HH

    • Mutations in the novel protein PRRT2 cause infantile convulsions with paroxysmal kinesigenic dyskinesia.

      Lee H-Y, Huang Y, Bruneau N, Roll P, Roberson EDO, Hermann M, et al.

    • Protective association between ACE inhibitors and lobar intracerebral hemorrhage.

      Martini SR, Flaherty ML, Brown WM, Moomaw CJ, Comeau ME, Haverbusch M, et al.

    • Widely used clinical predictors do not account for outcome variability in mild traumatic brain injury.

      Moretti P, McCauley S, Wilde E, Levin H

    • Genetic susceptibility for amyloid pathology in Alzheimer's disease.

      Shulman JM, Chen K, Keenan BT, Chibnik LB, Thiyyagura P, McCabe C, et al.

    • Integrating human and fly genetics to understand Alzheimer's disease susceptibility.

      Shulman JM, Imboywa S, Diamond AE, Chipendo P, De Jager PL, Feany MB

    • Genome-wide scan for copy number variation association with age at onset of Alzheimer's disease.
      [Platform Presentation]

      Szigeti K, Lal D, Li Y, Doody RS, Yan L

    • Incidence of Lewy body negative parkinsonism in a community based sample.

      Zaheer F, Slevin JT, Abner EL , Nelson PT, Jicha GA

    • Inclusion of axial rigidity may improve diagnostic accuracy for dementia with Lewy bodies.

      Zaheer F, Slevin JT, Abner EL , Nelson PT, Jicha GA

    Neurocritical Care Society (NCS)
    10th Annual Meeting in Denver, Colo. (Oct. 4-7, 2012)
    • Prior statin use reduces rate of delayed cerebral ischemia after subarachnoid hemorrhage.

      Abhishek F, Damani R, Mohamed W, Suchdev K, Varade P, Atkinson B, et al.

    • Angiogram-negative subarachnoid hemorrhage (aN-SAH): Not as benign as you would think.

      Damani R, Abhishek F, Mohamed W, Suchdev K, Varade P, Norris G, et al.

    • Post surgical cerebral venous sinus thrombosis: A rare surgical complication and challenging management case.

      Hannawi Y, Shah S, Bershad EM, Suarez JI, Shaltoni HM, Yoshor D, et al.

    • Low dose IV Abciximab for acute ischemic stroke patients ineligible for IV rt-PA.
      [Platform Presentation]

      Mandava P, Shah S, Murthy SB, Kent TA

    • Comparing perfusion computed tomography to digital subtraction angiography in detecting delayed cerebral ischemia.

      Mohamed W, Varade P, Damani R, Abhishek F, Suchdev K, Norris G, et al.

    • The utility of DynaCT in evaluation of subarachnoid hemorrhage: A case report.

      Shah S, Hannawi Y, Urfy MZ, Venkatasubba Rao CP

    American Psychological Association (APA)
    120th Annual Convention in Orlando, Fla. (Aug. 2-5, 2012)
    • Assessing quality of life in pain populations: Utility of a single-item measure.

      Stinson JM, Szafranski D, Sloan PA, York KM

    Alzheimer's Association International Conference (AAIC)
    Annual Meeting in Vancouver, British Columbia, Canada (July 14-19, 2012)
    AREADNE Foundation, Inc.
    Conference in Santorini, Greece (June 21-24, 2012)
    • Population receptive field mapping in human subjects after lesions of the visual pathway.

      Papanikolaou A, Keliris GA, Papageorgiou DT, Shao Y, Krapp E, Schiefer U, et al.

    • Population receptive field measurements in the visual cortex of macaque monkeys.

      Shao Y, Keliris GA, Papanikolaou A, Fischer DM, Nagy D, Jaegle H, et al.

    Movement Disorder Society (MDS)
    16th International Congress of Parkinson's Disease and Movement Disorders in Dublin, Ireland (June 17-21, 2012)
    34th Brazilian Epilepsy Congress
    Ribeirão Preto, São Paulo, Brazil (June 6-9, 2012)
    • Autismo e epilepsia.

      Wehmut M, Antoniuk SA, Nascimento e Silva FA

    Canadian Neurological Sciences Federation (CNSF)
    47th Annual Congress in Ottawa, Ontario, Canada (June 6-8, 2012)
    • Deep brain stimulation for the management of seizures in MECP2 duplication syndrome.
      [Oral Presentation]

      Nascimento FA, Faghfoury H, Krings T, Ali A, Fridhandler J, Lozano A, et al.

    American Society of Hypertension (ASH)
    27th Annual Scientific Meeting and Exposition in New York, N.Y. (May 19-22, 2012)
    • Pooled analysis of three cluster randomized hypertension control trials in African-Americans.

      Pavlik V, Chan W, Hyman D, Feldman P, Tobin J, Ogedegbe G, et al.

    Vision Sciences Society (VSS)
    12th Annual Meeting in Naples, Fla. (May 11-16, 2012)
    • Population receptive field measurements in macaque visual cortex.
      [Platform Presentation]

      Smirnakis SM, Keliris GA, Shao Y, Papanikolaou A, Logothetis NK

    Parkinson Study Group (PSG)
    26th Annual Symposium on Etiology, Pathogenesis, and Treatment of Parkinson Disease and Other Movement Disorders in Irving, Texas (May 11, 2012)
    American Academy of Neurology (AAN)
    64th Annual Meeting in New Orleans, La. (April 21-28, 2012)
    Texas Scottish Rite Hospital for Children
    34th Annual Carrell-Krusen Neuromuscular Symposium in Dallas, Texas (Feb. 23-24, 2012)
    • Progressive weakness in a patient with static encephalopathy and colpocephaly.

      Phillips L, Sharp L, Herndon E, Pascual J, Trivedi J

    International Neuropsychological Society (INS)
    40th Annual Meeting in Montreal, Quebec, Canada (Feb. 15-18, 2012)
    American Clinical Neurophysiology Society (ACNS)
    2012 Annual Meeting in San Antonio, Texas (Feb. 7-12, 2012)
    • Can EEG sampling be used as an effective tool for detecting clinically significant seizures?

      Pacheco V, Cherian V, Izadyar S, Hrachovy R

    American Stroke Association
    2012 International Stroke Conference in New Orleans, La. (Feb. 1-3, 2012)
    • Has patient selection for carotid endarterectomy and stenting changed over time? Carotid revascularization in the post CREST era.

      Bhattacharya P, Damani R, Rayes M, Chaturvedi S

    • Carotid revascularization in elderly asymptomatic patients: Are the results optimal?

      Damani R, Rayes M, Bhattacharya P, Chaturvedi S

    • Acute hyperglycemia induces functional cerebrovascular uncoupling associated with worsened outcome and impaired reperfusion.

      Fabian RH, Dalmeida W, Kent TA

    • Antioxidant carbon-based nanomaterials: In-vitro protection and in-vivo effects on the neurovascular unit.
      [Platform Presentation]

      Kent TA, Bitner BR, Berlin JM, Robertson CR, Marcano DC, Fabian RH, et al.

    • Error rate estimates for the modified Rankin Score "Shift Analysis" using information theory modeling.

      Krumpelman CS, Mandava P, Kent TA

    • A new more sensitive method to assess balance among stroke trial populations.

      Mandava P, Brooks ME, Krumpelman CS, Kent TA

    • A systematic analysis of endovascular and intravenous therapy for ischemic stroke based on time window using a novel outcome model.

      Mandava P, Shah S, Sarma AK, Murthy SB, Kent TA

    • Differential effect of high cholesterol by intracerebral hemorrhage location.
      [Moderated Poster]

      Martini SR, Brown WM, Comeau ME, Flaherty M, Haverbusch M, Moomaw C, et al.

    • Protocol for rapid acquisition and interpretation of head CT in acute stroke patients eligible for thrombolysis.

      Mazabob JM, Brown G, Livesay S, Nguyen T, Hu B-B, Suarez J, et al.

    • Rate of inappropriate statin use after intracerebral hemorrhage.

      Woo D, Comeau M, Flaherty ML, Brown M, Haverbusch M, Moomaw C, et al.

    2011 International Society for Zinc Biology (ISZB)
    Meeting in Melbourne, Australia (Jan. 15-19, 2012)
    • Intracellular dialysis can be exploited to distinguish sources of intracellular Zn2+ accumulation in hippocampal neurons.

      Aiba I, Shuttleworth CW

    Dhaka Hospital
    International Centre for Diarrhoeal Disease Research Meeting in Dhaka, Bangladesh (January 2012)
    • Kwashiorkor malnutrition: a case report.
      [Oral Presentation]

      Khan A

    Biochemical Society
    Conference: The biology and pathology of tau and its role in tauopathies II in Cambridge, U.K. (Jan. 8-9, 2012)
    • Dissection of tauopathy mechanisms using unbiased genetic screening in the Drosophila retina.
      [Invited Plenary Speaker]

      Jackson GR

    Texas A&M College of Medicine
    Seminar Week in Bryan, Texas (December 2011)
    • Alzheimer's disease.
      [Oral Presentation]

      Kapadia A

    American Epilepsy Society (AES)
    65th Annual Meeting in Baltimore, Md. (Dec. 2-6, 2011)
    Society for Neuroscience (SFN)
    41st Annual Meeting in Washington, DC (Nov. 12-16, 2011)
    • NMDA receptor activation prolongs the duration of ionic dyshomeostasis following spreading depolarization in murine brain slices.

      Aiba I, Shuttleworth CW

    • Blue cheese/Alfy affects autophagy activation and tau toxicity in a Drosophila model of tauopathy.

      Bakhoum MF, Jackson GR

    • Propagation of spreading depolarizations is limited by the synaptic release and extracellular actions of Zn2+.

      Carter RE, Aiba I, Carlson AP, Sheline CT, Shuttleworth CW

    • Flupirtine reverses hyperexcitability in Kv1.1 potassium channel deficient myelinated vagal axons.

      Glasscock E, Qian J, Kole MJ, Noebels JL

    • Tau loss regulates excitability in mouse and Drosophila genetic models of epilepsy.

      Holth J, Reed JG, Inoue T, Pautler R, Botas J, Noebels J

    • RNA binding protein hnRNP K/bancal and its intronic microRNA miR-7 exert opposite effects on tau toxicity through regulation of Insulin Receptor Substrate/chico and GSK-3beta activity.

      Jackson GR, Ambegaokar S

    • ADAM11 is responsible for trafficking of Kv1 subunits to cerebellar basket cell terminals.

      Kole MJ, Waase MP, Klassen TL, Chen TT, Breslow JL, Noebels JL

    • Delayed postnatal loss of P/Q-type calcium channels recapitulates the absence epilepsy, dyskinesia, and ataxia.

      Mark MD, Maejima T, Kuckelsberg D, Woo JW, Hyde RA, Shah V, et al.

    • Early 17-beta-estradiol treatment decreases seizure and interictal spike frequency in the ARX(GCG)10+7 genetic mouse model of X-linked infantile spasms.

      Olivetti PR, Noebels JL

    • Population receptive field mapping in human subjects with lesions of the visual cortex.

      Papanikolaou A, Keliris GA, Shao Y, Krapp E, Papageorgiou E, Schiefer U, et al.

    • Transformation of visual sensory information from cortical layer 4 to layer 2/3: The second stage of visual cortical processing.

      Polack P-O, Chow D, Sharim J, Friedman J, Gruver R, Smirnakis S, et al.

    • Horizontal and vertical eye movements in Huntington's disease patients and age matched controls.

      Red S, Ing J, Jeter CB, Hood AJ, Patel SS, Jankovic J, et al.

    • Population receptive field measurements in visual cortex of macaque monkeys.

      Shao Y, Keliris GA, Papanikolaou A, Augath M, Logothetis NK, Smirnakis SM

    • Suppression of the protein kinase PKR promotes network hypersynchrony and enhanced cognition.

      Zhu P, Huang W, Kalikulov D, Yoo J, Placzek A, Stoica L, et al.

    World Congress on Insulin Resistance, Diabetes, and Cardiovascular Disease (WCIRDC)
    9th Annual Meeting in Hollywood, Calif. (Nov. 3-5, 2011)
    • Glucoregulation in diabetic patients with obstructive sleep apnea.

      Cheng J, Gilden J, Theckedath B, Stoll J, Shankar S, Azul J, et al.

    Honor Society of Nursing, Sigma Theta Tau International (STTI)
    41st Biennial Convention in Grapevine, Texas (Oct. 29 - Nov. 2, 2011)
    • Evaluation of video teleconferencing technology to provide chronic disease self-management access for rural veterans.

      Anderson J, Willson P

    Rosalind Franklin University
    Summer Research Presentation in North Chicago, Ill. (Oct. 5, 2011)
    • Glucoregulation and chronic complications in patients with diabetes mellitus.

      Kandavel P, Azul JJ, Kesari N, Shankar S, Farahani M

    American Neurological Association (ANA)
    136th Annual Meeting in San Diego, Calif. (Sept. 25-27, 2011)
    • Comparison of subthalamic (STN) and pallidal (GPI) deep brain stimulation (DBS) on gait and balance in patients with Parkinson's disease (PD).

      Hou JG, Thant M, Sarwar A, Fincher L, Bryant MS, Atassi F, et al.

    • Association of PSP with chemical occupational exposure factors.

      Litvan I, Cunningham CR, Lees P, Jackson L, Juncos J, Riley D, et al.

    • Neurological outcome scale for traumatic brain injury: Predictive validity and sensitivity to change.

      Moretti P, McCauley SR, Wilde EA, Scott JN, Clifton GL

    • Visuospatial construction measures and their utility in identifying dementia of the Alzheimer's type.

      Scott BM, Duncan G, Carlson H, Nance M, York MK, Larery A, et al.

    • Integrating genome-wide association and functional validation to understand susceptibility for Alzheimer's pathology.
      [Platform Presentation]

      Shulman JM, Chipendo PI, Chibnik LB, Keenan BT, Tran D, Huentelman MA, et al.

    Neurocritical Care Society (NCS)
    9th Annual Meeting in Montreal, Quebec, Canada (Sept. 21-24, 2011)
    • Clinical utility of continuous electroencephalogram (CEEG) monitoring in hypothermia after cardiac arrest.

      Livesay S, Bershad E, Suarez J, Hrachovy R, Manian P, Herlihy JP, et al.

    Michael J. Fox Parkinson's Research Foundation
    Genetic Epidemiology of Parkinson's Disease Consortium Meeting in Evanston, Ill. (Sept. 18-21, 2011)
    • What can endophenotypes teach us about Parkinson's disease?
      [Oral Presentation]

      Shulman JM

    European Federation of Neurological Societies (EFNS)
    15th Congress in Budapest, Hungary (Sept. 10-13, 2011)
    • A systematic analysis of intravenous and endovascular therapy for ischemic stroke using a novel predictive outcome model.

      Mandava P, Sarma AK, Shah S, Kent TA

    • Leptomeningeal metastases presenting exclusively with ocular disturbance in 34 patients.

      Mayer RR, Maharaj AS, Schiffman JS, Debnam JM, Kass JS, Weinberg JS

    • Sustained efficacy of long-term incobotulinumtoxin-a (Xeomin®; botulinum neurotoxin type-a, free from accessory proteins) treatment for cervical dystonia, blepharospasm and upper limb post-stroke spasticity.

      Truong DD, Brodsky MA, LeWitt PA, Gollomp SM, Kanovsky P, Pulte I, et al.

    American Psychological Association (APA)
    119th Annual Convention in Washington, DC (Aug. 4-7, 2011)
    • Predicting women's feminist perspectives: The effects of internalization of masculine role norms and attitudes toward men.

      Stinson JM, McDermott RC, Trevathan-Minus M, Petho-Robertson K, Schwartz J

    2011 International Conference on Alzheimer's Disease (ICAD)
    Paris, France (July 16-21, 2011)
    • Serum granulocyte colony stimulating factor and Alzheimer's disease.

      Barber R, O'Bryant S, Reisch J, Doody R, Fairchild T, Adams P, et al.

    • The impact of depression on cognition varies by APOE4 status.

      Dentino A, Hall J, Barber R, Doody R, Royall D, O'Bryant S

    • Biomarkers associated with cardiovascular risk in the Texas Alzheimer's Disease Research and Care Consortium (TARCC) Cohort: LpPla2 and homocysteine.

      Doody R, Chan W, Ballantyne C, Pavlik V, Barber R, O'Bryant S, et al.

    • Inflammatory biomarkers in the Texas Alzheimer's Research and Care Consortium (TARCC) Cohort.

      Doody R, Chan W, Barber R, Ballantyne C, Pavlik V, O'Bryant S, et al.

    • A candidate causal variant in the CR1 locus.

      Keenan B, Shulman J, Chibnik L, Corneveaux J, Allen A, Myers A, et al.

    • Plasma sphingomyelin is associated with cognitive progression in Alzheimer's disease.

      Mielke M, Haughey N, Bandaru VVR, Weinberg D, Zaidi N, Pavlik V, et al.

    • Refinement and expansion of the Texas Alzheimer's research consortium serum-based diagnostic algorithm for Alzheimer's disease.

      O'Bryant S, Xiao G, Barber R, Hall J, Doody R, Reisch J, et al.

    • A serum protein-based algorithm for the detection of Alzheimer's disease.

      O'Bryant S, Xiao G, Robert B, Hall J, Doody R, Reisch J, et al.

    • Racial/ethnic group differences in the association of APOE ε4 genotype and visuospatial test performance in a non-demented sample.

      Pavlik V, Massman P, Rustveld L, Doody R

    • Alzheimer's disease susceptibility loci: Evidence for natural selection and altered gene expression.

      Raj T, Shulman J, Chibnik L, Keenan B, Stranger B, Evans D, et al.

    • Factors that influence survival in Alzheimer's patients.

      Rountree S, Chan W, Pavlik V, Darby E, Doody R

    • The cognitive correlates of functional status: a new approach to dementia.

      Royall DR, Doody R, Barber R, Palmer R, O'Bryant S, Reisch J, et al.

    • Genetic factors associated with the rate of cognitive decline in Alzheimer's disease.

      Sherva R, Tripodis Y, Shulman J, Chibnik L, Crane P, Bennett D, et al.

    • A genome-wide association scan for episodic memory decline in aging.

      Shulman J, Chibnik L, Keenan B, Destefano A, Leurgans S, Wilson R, et al.

    • Integrating genome-wide association and functional validation to understand susceptibility for Alzheimer's pathology.
      [Platform Presentation]

      Shulman J, Chipendo P, Chibnik L, Keenan B, Tran D, Aubin C, et al.

    • Genome-wide association scan replication for biomarker endophenotypes of Alzheimer's disease.

      Wilhelmsen K, Chasse S, Griffin N, Diaz-Arrastia R, Barber R, Royall D, et al.

    • Developing and validating of diagnostic algorithm for Alzheimer's disease.

      Xiao G, Barber R, Reisch J, Doody R, Fairchild T, Adams P, et al.

    Gordon Research Conferences
    Excitatory Synapses & Brain Function Meeting in Easton, Mass. (June 26 - July 1, 2011)
    • NMDA-R activation contributes to metabolic burden following spreading depolarization in murine hippocampal slices.

      Aiba I, Shuttleworth CW

    Movement Disorder Society (MDS)
    15th International Congress of Parkinson's Disease and Movement Disorders in Toronto, Canada (June 5-9, 2011)
    International Society for Cerebral Blood Flow and Metabolism (ISCBFM)
    Brain 2011, 25th International Symposium on Cerebral Blood Flow, Metabolism, and Function in Barcelona, Spain (May 25-28, 2011)
    • Antioxidant carbon nanotubes: In-vitro characterization and in-vivo effects on cerebrovascular regulation.

      Kent TA, Bitner BR, Berlin JB, Marcado D, Robertson CR, Fabian RH, et al.

    European Stroke Conference (ESC)
    20th Annual Meeting in Hamburg, Germany (May 24-27, 2011)
    • How gender and race interact to influence outcome of ischemic stroke after treatment with rt-PA.
      [Previously Presented]

      Mandava P, Sarma A, Anderson J, Wehner B, Kent T

    • Hyperglycemia is an independent risk factor for poor outcome after rtPA only in the large artery stroke subtype.

      Mandava P, Sarma AK, Dalmeida W, Anderson JA, Kent TA

    • Novel analysis methodology indicates extended window low-dose IV abciximab improves outcome.

      Mandava P, Sarma AK, Dalmeida W, Anderson JA, Kent TA

    American College of Physicians (ACP)
    Michigan Chapter Scientific Meeting in Ann Arbor, Mich. (May 20, 2011)
    • A case report of cryptosporidium diagnosed by small bowel biopsy in an AIDS patient.

      Hiploylee J, Damani R, Khokhar S

    American Heart Association
    2011 Quality of Care and Outcomes Research Meeting (QCOR) in Washington, DC (May 12-14, 2011)
    • Mind the time: a quality improvement project to increase the percent of ischemic stroke patients receiving intravenous t-PA within 60 minutes after emergency department arrival.

      Mazabob J, Livesay S, Meade A, Brown G, Suarez JI, Bershad EM, et al.

    Plasticise
    2nd Annual Meeting in Stresa, Italy (May 4-6, 2011)
    • Population receptive field mapping in human subjects with visual cortical lesions.

      Papanikolaou A, Keliris GA, Shao Y, Krapp E, Papageorgiou E, Schiefer U, et al.

    • Population receptive field measurements in a macaque monkey with macular degeneration.

      Shao Y, Keliris GA, Papanikolaou A, Fischer DM, Jaegle H, Seeliger MW, et al.

    Society of Behavioral Medicine (SBM)
    32nd Annual Meeting in Washington, DC (April 27-30, 2011)
    • Predictors and consequences of depressive symptoms in polytrauma patients 10 or more years after injury.

      Fedele KM, Steel JL, Marsland A, Youssef M, Ramirez J, Probst C, et al.

    The Southern Group on Educational Affairs
    Meeting in Houston, Texas (April 14-16, 2011)
    • Teaching communication skills to learners: A faculty development workshop.

      Mian A, Friedland J, Loboprahbu S, Blakely-Harris T, Kass J, Singhal G, et al.

    American Academy of Neurology (AAN)
    63rd Annual Meeting in Honolulu, Hawaii (April 9-16, 2011)
    AD/PD
    10th International Congress on Alzheimer's and Parkinson's Diseases in Barcelona, Spain (March 9-13, 2011)
    Keystone Symposium
    Symposium on Neurodegenerative Diseases in Taos, N.M. (Feb. 21-26, 2011)
    • Enhancing power for gene discovery in Alzheimer's disease: Intermediate phenotypes and functional validation in drosophila.
      [Platform Presentation]

      Shulman JM

    Texas Scottish Rite Hospital for Children
    33rd Annual Carrell-Krusen Neuromuscular Symposium in Dallas, Texas (Feb. 17-18, 2011)
    American Stroke Association
    2011 International Stroke Conference in Los Angeles, Calif. (Feb. 8-11, 2011)
    • Implementation of the American Stroke Association Sharegiver Program (Peer Support).

      Damush TM, Anderson J, Nicholas G, Kimmel B, Kent T, Williams LS

    • Hyperglycemia worsens outcome after rt-PA in the large artery stroke subtype.

      Mandava P, Munoz M, Dalmeida W, Sarma K, Brooks MA, Anderson J, et al.

    • Gender and race interact to influence outcome of ischemic stroke after treatment with rt-PA.

      Mandava P, Munoz M, Sarma K, Brooks MA, Dalmeida W, Anderson J, et al.

    • A multidisciplinary quality improvement project to address delays in CT imaging and thrombolytic treatment in acute stroke patients.

      Mazabob JM, Brown G, Stewart P, Livesay S, Freeborg S, Suarez JI, et al.

    International Neuropsychological Society (INS)
    39th Annual Meeting in Boston, Mass. (Feb. 2-5, 2011)
    Texas Brain and Spine Institute (TBSI)
    Research Symposium in Bryan, Texas (January 2011)
    • Klüver-Bucy secondary to normal pressure hydrocephalus.

      Kapadia A, Simpson E, Roman G

    The University of Texas, Medical School
    Student Research Forum in Houston, Texas (January 2011)
    • Selection of a thioaptamer targeted to human IgE.

      Sung A, Li X, Somasundaram A, Gorenstein D, Volk D

    Aga Khan University
    Annual Research Assembly in Karachi, Pakistan (2011)
    • A mechanistic study on the medicinal use of mint in diarrhea.

      Siddiqui KA, Mahmood H, Khawja A

    • Pharmacological basis for the medicinal use Mentha Arvensis in airway disorders.

      Siddiqui KA, Mahmood H, Khawja A

    Rush University
    ROS/MAP Investigator Meeting in Chicago, Ill. (2011)
    • Genomics of cognitive decline and neuropathology.
      [Oral Presentation]

      Shulman JM

    2010 American Society for Cell Biology (ASCB)
    Annual Meeting in Philadelphia, Penn. (Dec. 11-15, 2010)
    • An unbiased genetic screen for modifiers of tauopathy using both loss and gain of function approaches.

      Jackson GR, Ambegaokar S

    American Epilepsy Society (AES)
    64th Annual Meeting in San Antonio, Texas (Dec. 3-7, 2010)
    • Simultaneous EEG and fMRI of sleep spindles and K-complexes.

      Caporro M, Haneef Z, Yeh H, Buttinelli C, Lenartowicz A, Stern J

    • High resolution copy number variation of ion channel genes in epilepsy.

      Goldman A, Klassen T, Gu W, Zhang F, Bomben V, Chen T, et al.

    • Hippocampal networks in temporal lobe epilepsy: A seed-based fMRI study.

      Haneef Z, Yeh H, Lenartowicz A, Mumford J, Stern J

    • Induction of psychogenic non-epileptic events: Success rates vary with ictal semiology and neuropsychological profile.

      Izadyar S, Chen D, Collins R, Benge J, LeMaire A, Hrachovy R

    • Lateralization of temporal lobe epilepsy with long-term ambulatory intracranial monitoring using the RNS system: Experience at four centers.

      King-Stephens D, Mirro E, Van Ness P, Salanova V, Spencer D

    • Effect of temporal lobe epilepsy on the default mode network.

      Stern J, Yeh H, Haneef Z, Lenartowicz A, Mumford J

    • How helpful are repeat epilepsy monitoring unit admissions after an initial nondiagnostic evaluation?

      Taneja A, Gupta P, Van Ness P

    Society for Neuroscience (SFN)
    40th Annual Meeting in San Diego, Calif. (Nov. 13-17, 2010)
    • Metabolic dependence of zinc effects on spreading depression in murine brain slices.

      Aiba I, Shuttleworth CW

    • Modulation of tau oligomers by passive vaccination.

      Castillo DL, Lasagna-Reeves C, Guerrero-Munoz MJ, Estes DM, Barrett A, Dineley K, et al.

    • MeCP2 deficiency in GABAergic neurons recapitulates Rett syndrome phenotypes.

      Chao H-T, Chen H, Samaco RC, Xue M, Chahrour M, Yoo J, et al.

    • Characterization of tau oligomers in Alzheimer's disease.

      Kayed R, Lasagna-Reeves C, Guerrero-Munoz M, Sengupta U, Troncoso J, Jackson GR

    • Assessing the spatio-temporal dynamics of visual receptive fields by fMRI.

      Keliris GA, Shao Y, Papanikolaou A, Peng X, Logothetis K, Smirnakis SM

    • Population receptive field mapping in human subjects with visual cortical lesions.

      Papanikolaou A, Keliris GA, Peng X, Shao Y, Krapp E, Papageorgiou E, et al.

    • Synergistic effects of tau and alpha-synuclein in dopaminergic neurons.

      Roy B, Ambegaokar SS, Jackson GR

    • Tau oligomers in Parkinson disease and dementia with Lewy bodies and their connection with alpha-synuclein oligomers.

      Sengupta U, Lasagna-Reeves C, Guerrero-Munoz M, Castillo-Carranza D, Jackson GR, Troncoso J, et al.

    • Population receptive field mapping in a macaque monkey with macular degeneration.

      Shao Y, Keliris GA, Papanikolaou A, Fischer DM, Nagy D, Jägle H, et al.

    Mission Connect/TIRR Foundation
    Scientific Meeting in Houston, Texas (Nov. 12, 2010)
    • Rehabilitation of prospective memory in children after traumatic brain injury.

      McCauley SR

    American Society of Human Genetics (ASHG)
    60th Annual Meeting in Washington, DC (Nov. 2-6, 2010)
    • Enhancing power for gene discovery in Alzheimer's disease: Intermediate phenotypes and functional validation in drosophila.
      [Platform Presentation]

      Shulman JM, Chipendo1 P, Aubin C, Kramer P, Schneider JA, Bennett DA, et al.

    29th International Congress of Clinical Neurophysiology (ICCN)
    Kobe, Japan (Oct. 28 - Nov. 1, 2010)
    • Sectional anatomy of the pelvic floor.

      Kass JS, Taber KH, Harrell JS, Zhang H, Chiou-Tan FY

    Baylor College of Medicine (BCM)
    Annual Academy of Distinguished Educators Showcase of Educational Scholarship in Houston, Texas (October 2010)
    • Teaching communication skills to learners.

      Mian AI, Friedland JA, Loboprabhu SM, Das GS, Harris TB, Kass J, et al.

    Neurocritical Care Society (NCS)
    8th Annual Meeting in San Francisco, Calif. (Sept. 15-18, 2010)
    • Neurocritical care morbidity and mortality (M&M): A multidisciplinary systems-based approach for improving patient care.

      Livesay S, Suarez J, Bershad E, Smirnakis S, Newmark M, Ansari S, et al.

    • The neurocritical care telestroke network: Extending high quality care to the underserved community for reasonable cost.

      Livesay S, Suarez J, Bershad E, Smirnakis S, Newmark M, Ansari S, et al.

    • Single brain death examination does not improve organ transplantation.

      Varelas P, Rao CV, Rehman M, Patel A, Rai V, Barber A, et al.

    American Psychological Association (APA)
    118th Annual Convention in San Diego, Calif. (Aug. 12-15, 2010)
    • Development of the Women's Traditional Attitudes of Men Scale (WTAMS).

      McDermott RC, Schwartz-Moravec M, Stinson JM, Brown AS, Petho-Robertson K

    • Gender role journey.

      McDermott RC, Schwartz-Moravec M, Stinson JM, Brown AS, Petho-Robertson K

    Honor Society of Nursing, Sigma Theta Tau International (STTI)
    21st International Nursing Research Congress in Orlando, Fla. (July 12-16, 2010)
    • Chronic disease: Framework, education and practice.

      Anderson J, Willson P

    • Chronic disease: A telehealth Transition Assistance Program (TAP) for veteran caregivers.

      Willson P, Anderson J

    2010 International Conference on Alzheimer's Disease (ICAD)
    Honolulu, Hawaii (July 10-15, 2010)
    European Neurological Society (ENS)
    20th Annual Meeting in Berlin, Germany (June 19-23, 2010)
    Movement Disorder Society (MDS)
    14th International Congress of Parkinson's Disease and Movement Disorders in Buenos Aires, Argentina (June 13-17, 2010)
    Organization of Human Brain Mapping (OHBM)
    16th International Conference in Barcelona, Spain (June 6-10, 2010)
    • Classification accuracy and spatial networks of motion coherence and direction using real-time fMRI.

      Papageorgiou TD, LaConte SM, Lisinski JM, Peng X, Smirnakis SM

    Consortium of Multiple Sclerosis Centers (CMSC)
    24th Annual Meeting in San Antonio, Texas (June 2-5, 2010)
    European Stroke Conference (ESC)
    19th Annual Meeting in Barcelona, Spain (May 25-28, 2010)
    • Rebalancing the NINDS rt-PA trial.

      Mandava P, Kent TA

    Rutgers/UMDNJ-Robert Wood Johnson Medical School
    Research Session in Piscataway, N.J. (April 2010)
    • Effects of miRNA-22 on embryonic rat cortical neurogenesis.
      [Oral Presentation]

      Chu J

    American Academy of Neurology (AAN)
    62nd Annual Meeting in Toronto, Canada (April 10-17, 2010)
    Southwestern Psychological Association (SWPA)
    2010 Annual Convention in Dallas, Texas (April 8-10, 2010)
    • Active exploration of and commitment to gender roles: A new scale.

      Nguyen NT, Petho-Robertson K, Brown AS, Schwartz-Moravec M, Stinson JM

    Howard Hughes Medical Institure (HHMI)
    Structural Plasticity in the Mammalian System Symposium at Janelia Farm in Chevy Chase, Md. (March 2010)
    • Visual cortex plasticity in adulthood: Why consensus remains elusive.
      [Platform Presentation]

      Smirnakis SM

    American Society for Neurochemistry (ASN)
    41st Annual Meeting in Santa Fe, N.M. (March 6-10, 2010)
    • Different roles of extracellular and intracellular Zn2+ in spreading depression-like events in hippocampal slice.

      Aiba I, Dietz RM, Sheline CT, Shuttleworth CW

    Texas Scottish Rite Hospital for Children
    32nd Annual Carrell-Krusen Neuromuscular Symposium in Dallas, Texas (Feb. 25-26, 2010)
    American Stroke Association
    2010 International Stroke Conference in San Antonio, Texas (Feb. 23-26, 2010)
    • No differential effect of tPA based on final stroke etiologic subtype: A reanalysis of the NINDS tPA trial.
      [Moderated Poster]

      Martini SR, Yeatts SD, Belagage SR, Khatri P

    Baylor College of Medicine (BCM)
    20th Annual Rush and Helen Record Neuroscience Forum in Galveston, Texas (Feb. 19-21, 2010)
    International Neuropsychological Society (INS)
    38th Annual Meeting in Acapulco, Mexico (Feb. 3, 2010)
    NINDS and ALS Association
    Workshop: Advances in Disease Modeling for ALS and FTD in San Diego, Calif. (2010)
    • Wing phenotypes produced by misexpression of an ALS-associated TDP-43 mutation include supernumerary veins: A possible clue to signaling pathways.

      Ambegaokar SS, Yusuff T, Choksi DK, Kayed R, Jackson GR

    Rice University and the Texas Medical Center
    Bioscience Research Collaborative in Houston, Texas (2010)
    • Real-time fMRI can decode visual mental imagery during a motion coherence task.

      Papageorgiou TD, LaConte SM, Lisinski JM, Peng X, Smirnakis SM

    Rush University
    CHAP Investigator Meeting in Chicago, Ill. (2010)
    • Genome-wide association scans for cognitive decline.
      [Oral Presentation]

      Shulman JM

    World Federation of Neurology (WFN)
    XVIII World Congress on Parkinson's Disease and Related Disorders in Miami Beach, Fla. (Dec. 13-16, 2009)
    • Rasagiline provides symptomatic benefit in early Parkinson's disease (PD).

      Jankovic J, ADAGIO Investigators

    • Multicenter, randomized, double-blind, sham surgery-controlled study of intraputaminal AAV2-neurturin (CERE-120) for advanced Parkinson's disease (PD).

      Marks Jr W, Bartus R, Siffert J, Starr P, Ostrem J, Stacy M, et al.

    • Treatment of dysautonomia associated with Parkinson's disease.

      Mostile G, Jankovic J

    • Axial symptoms and basal ganglia in Parkinson's disease. Does side matter?

      Sarwar A, Lai EC

    American Epilepsy Society (AES)
    63rd Annual Meeting in Boston, Mass. (Dec. 4-8, 2009)
    • Spontaneous epilepsy and neuronal hyperexcitability in Kv12.2 -/- mice.

      Bertaso F, Zhang X, Yoo J, Schmedt C, Clancy S, Noebels JL, et al.

    • Simultaneous EEG and fMRI of vertex sharp transients.

      Caporro M, Haneef Z, Yeh S, Buttinelli C, Stern J

    • Everyday verbal memory and pediatric epilepsy.

      Chapieski M, Evankovich K, Hiscock M, Collins R

    • High frequency EEG activity associated with ictal events in the TTX model of infantile spasms.

      Frost JD, Lee CL, Hrachovy RA, Swann JW

    • Long QT mouse model links the dual phenotype of cardiac arrhythmias and epilepsy with sudden unexplained death in epilepsy.

      Goldman A, Glasscock E, Yoo J, Chen T, Klassen T, Noebels J

    • Impact of evidence-based recommendations on referral pattern for epilepsy surgery.

      Haneef Z, Stern J, Engel Jr. J

    • Characteristics of psychogenic nonepileptic events among veterans with posttraumatic stress disorder: An association of semiology with the nature of trauma.

      Izadyar S, Chen DK

    • Epilepsy and neurocysticercosis in Houston, Texas.

      Kung D, Serpa-Alvarez J, Kass J, Friedman D

    Neurocritical Care Society (NCS)
    7th Annual Meeting in New Orleans, La. (Nov. 11-14, 2009)
    • Single brain death examination with confirmatory cerebral blood flow testing as an alternative to the standard dual brain death examination.

      Rao CV, Rehman M, Barber A, Sommerfield S, Patel A, Rai V, et al.

    Baylor College of Medicine (BCM)
    Current Neurology 2009 in Houston, Texas (Oct. 31 - Nov. 1, 2009)
    Society for Neuroscience (SFN)
    39th Annual Meeting in Chicago, Ill. (Oct. 17-21, 2009)
    • MeCP2 regulation of GABAergic neuronal function modulates behavior and synaptic plasticity.

      Chao H-T, Chen H, Samaco RC, Chahrour M, Xue M, Yoo J, et al.

    • MeCP2 regulation of GABAergic neuronal function modulates behavior and synaptic plasticity.

      Chao H-T, Chen H, Samaco RC, Chahrour M, Xue M, Yoo J, et al.

    • Internally mediated developmental desynchronization of neocortical network activity.

      Golshani P, Goncalves JT, Khoshkhoo S, Mostany R, Smirnakis S, Portera-Cailliau C

    • Functional correlation of brain loci during cognitive tasks in multiple sclerosis.

      Helekar SA, Shin JC, Mattson BJ, Bartley K, Stosic M, Saldana-King T, et al.

    • Non-convulsive seizure phenotypes and dementia in mice and humans.

      Noebels JL

    • AAV2-neurturin (CERE-120) for advanced Parkinson's disease (PD): Efficacy and safety results from a controlled Phase 2 clinical trial.

      Siffert J, Marks Jr WJ, Starr PA, Stacey MA, Boulis NM, Vitek JL, et al.

    • Spontaneous epilepsy and neuronal hyperexcitability in Kv12.2 -/- mice.

      Zhang X, Bertaso F, Yoo J, Schmedt C, Clancy S, Noebels JL, et al.

    Baylor College of Medicine (BCM)
    Annual Academy of Distinguished Educators Showcase of Educational Scholarship in Houston, Texas (October 2009)
    • Program evaluation of medical student professionalism curriculum at Baylor College of Medicine.

      Kass JS, Johnson K

    Society of Teachers of Family Medicine (STFM)
    Northeast Region Conference in Rye Brook, N.Y. (October 2009)
    • "Poetry of life" on medicine and patient relationships.
      [Oral Presentation]

      Chu J

    North American Brain Injury Society (NABIS)
    7th Annual Conference on Brain Injury in Austin, Texas (Oct. 14-17, 2009)
    • Event-based prospective memory performance during subacute recovery following moderate to severe TBI in children: Effects of monetary incentives.

      McCauley SR, Chapman S, Vasquez AC, Pedroza C, Levin HS

    • Patterns of cortical thinning in relation to event-based prospective memory performance of children with traumatic brain injury.

      McCauley SR, Merkley TL, Wilde EA, Schnelle KP, Bigler ED, Vasquez AC, et al.

    • Neural correlates of event-based prospective memory in children 3 months after moderate to severe traumatic brain injury: A volumetric study.

      McCauley SR, Wilde EA, Merkley TL, Schnelle KP, Bigler ED, Vasquez AC, et al.

    • Changes in the cingulate in acute mild TBI detectable with diffusion tensor imaging and their relation to memory function.

      Trevor Wu, Wilde EA, Yallampalli R, Bigler ED, McCauley SR, Troyanskaya M, et al.

    American Neurological Association (ANA)
    134th Annual Meeting in Baltimore, Md. (Oct. 11-14, 2009)
    American Association for the Surgery of Trauma (AAST)
    68th Annual Meeting in Pittsburgh, Penn. (Oct. 1-3, 2009)
    • Physical and psychological functioning of polytrauma patients with traumatic brain injury at 10+ years follow-up.

      Steel J, Ramirez J, Lazaroff J, Youssef M, Probst C, Krettek C, et al.

    Optical Society of America (OSA)
    Annual Vision Meeting in Seattle, Wash. (Sept. 24, 2009)
    • Neural repair at the systems level: Lessons from the visual system.
      [Platform Presentation]

      Smirnakis SM

    European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS)
    25th Congress in Dusseldorf, Germany (Sept. 9-12, 2009)
    US Department of Defense
    Military Health Research Forum 2009 in Kansas City, Mo. (Aug. 31 - Sept. 3, 2009)
    American Psychological Association (APA)
    117th Annual Convention in Toronto, Canada (Aug. 6-9, 2009)
    • Randomized controlled trials in the context of behavioral medicine.

      Steel JL, Gemmell L, Geller D, Youssef M, Likumahuwa S, Dunlavy A, et al.

    • Cultural stressors, coping mechanisms, and subjective well-being in urban adolescents.

      Vera EM, Doud K, Bena K, Langrehr K, Dick L, Hewitt A, et al.

    VA Mental Health
    3rd Annual Conference in Washington, DC (July 21-23, 2009)
    • Clinical depression, anxiety, and PTSD as risk factors for morbidity following coronary artery bypass grafting surgery.

      Dao T, Nguyen Q, Chu D, Anderson T, Springer J, Collins R, et al.

    Honor Society of Nursing, Sigma Theta Tau International (STTI)
    20th International Nursing Research Congress in Vancouver, Canada (July 13-17, 2009)
    • The Self-management TO Prevent (STOP) Stroke Tool: A final alpha testing.

      Anderson J, Willson P

    2009 International Conference on Alzheimer's Disease (ICAD)
    Vienna, Austria (July 11-16, 2009)
    28th International Epilepsy Congress (IEC)
    Budapest, Hungary (June 29 - July 2, 2009)
    • Human KvLQT1 mutations in mice link the dual phenotype of cardiac arrhythmias and epilepsy with sudden unexplained death in epilepsy.

      Goldman A, Glasscock E, Yoo J, Chen T, Klassen T, Noebels J

    • Impact of maternal anxiety and age of child on restrictions in childhood activities.

      Schutlz RJ, Chapieski ML, Evankovich KD, Wilfong AA, Collins RL

    • Summary of the U.S. National Institute of Neurological Disorders and Stroke (NINDS) Workshop on SUDEP.

      So EL, Hirsch JL, Donner JE, Noebels JL, Jacobs PM, Buchhalter RJ

    Movement Disorder Society (MDS)
    13th International Congress of Parkinson's Disease and Movement Disorders in Paris, France (June 7-11, 2009)
    American College of Sports Medicine (ACSM)
    56th Annual Meeting in Seattle, Wash. (May 27-30, 2009)
    • Diagnosis of left ventricular hypertrophy by precordial vs. limb lead criteria in the analysis of ECGs over time in young athlete.

      Ananaba I, Damani R, West JJ, Higgins JP

    • Prevalence of LVH in athletes classified by race and gender.

      Damani R, Ananaba I, West JJ, Higgins JP

    Consortium of Multiple Sclerosis Centers (CMSC)
    23rd Annual Meeting in Atlanta, Ga. (May 27-30, 2009)
    European Stroke Conference (ESC)
    18th Annual Meeting in Stokholm, Sweden (May 26-29, 2009)
    • Platelet inhibition may explain results with abciximab in the treatment of acute ischemic stroke.

      Mandava P, Anderson J, Dalmeida W, Kent TA

    • A method to generate a control population for acute ischemic stroke trials: Validation with NINDS and application to a phase 1 treatment series.

      Mandava P, Kent TA

    American Academy of Neurology (AAN)
    61st Annual Meeting in Seattle, Wash. (April 25 - May 2, 2009)
    American Heart Association
    Quality of Care and Outcomes Research in Cardiovascular Disease and Stroke Conference in Washington, DC (April 23-25, 2009)
    • Systematic bias in blood pressure measurement between health care systems - Implications for quality of care research.

      Pavlik V, Greisinger AJ, Hyman DJ

    American College of Cardiology (ACC)
    58th Annual Scientific Session in Orlando, Fla. (March 29-31, 2009)
    • Rates of abnormal screening electrocardiograms differ greatly between U.S. collegiate cohorts.

      West JJ, Higgins JP, McPherson DD, Mistry DJ, MacKnight JM, Saliba EN, et al.

    Baylor College of Medicine (BCM)
    James K. Alexander Research Symposium in Houston, Texas (March 2009)
    • Tuberculosis meningitis: Risk factors, treatments and outcomes in a case series.

      Walker GV, King C, Nord K, Goldsmith C, Kass J, Shandera W

    Center for Behavioral Neuroscience (CBN)
    Vole Meeting in Atlanta, Ga. (Feb. 28, 2009)
    • The oxytocin circuitry controlling individual variation in affiliative behaviors in female prairie voles.

      Ross HE, Spiegel LL, Young LJ

    • The opiate system modulates pair bonding in female prairie voles.

      Spiegel LL, Burkett P, Young LJ

    Association of Academic Physiatrists (AAP)
    Annual Meeting in Colorado Springs, Colo. (Feb. 24-28, 2009)
    • Optimizing the accuracy and safety of shoulder injection procedures with cross-sectional anatomic schematics.

      Harrell JS, Chiou-Tan FC, Kass JS, Taber KH

    Texas Scottish Rite Hospital for Children
    31st Annual Carrell-Krusen Neuromuscular Symposium in Dallas, Texas (Feb. 19-20, 2009)
    • Anesthesiologist with muscle cramps.

      Ansari S, Smyth S, Harati Y

    • A tale of two diseases.

      Kung D, Harati Y

    • Muscular dystrophy with subacute onset.

      Phan CL, Biliciler S, Harati Y

    • Another patient with burning feet.

      Smyth S, Harati Y

    • A case of a painful leg.

      Vullaganti M, Harati Y

    American Stroke Association
    2009 International Stroke Conference in San Diego, Calif. (Feb. 17-20, 2009)
    • VWF pathway: A new animal model of lacunar stroke.

      Kent TA, Fabian RH, Dalmeida W, Ruidong J, Dong JF

    • Restoring balance: A method to adjust for randomization imbalances in stroke clinical trials.

      Mandava P, Kent TA

    • Foundations for a successful start: lessons learned from site initiation in the antihypertensive treatment of acute cerebral hemorrhage (ATACH) trial.

      Novitzke JM, Qureshi AI, the ATACH Investigators

    • Effect of systolic blood pressure treatment on perihematomal edema. Results from the antihypertensive treatment of acute cerebral hemorrhage (ATACH) study.

      Qureshi AI, Palesch YY, the ATACH Investigators

    International Neuropsychological Society (INS)
    37th Annual Meeting in Atlanta, Ga. (Feb. 11-14, 2009)
    VA's Health Services Research & Development Service (HSR&D)
    Quality Enhancement Research Initiative (QUERI) National Meeting in Phoenix, Ariz. (Dec. 10-12, 2008)
    • Implementation of patient self-management programs among veterans in VA.

      Damush, Anderson J, Bosworth H

    American Epilepsy Society (AES)
    62nd Annual Meeting in Seattle, Wash. (Dec. 5-9, 2008)
    American Academy of Physical Medicine and Rehabilitation (AAPM&R)
    2008 Annual Assembly in San Diego, Calif. (Nov. 20-23, 2008)
    Society for Neuroscience (SFN)
    38th Annual Meeting in Washington, DC (Nov. 15-19, 2008)
    • Kcna1 is a novel candidate gene for sudden unexplained death in epilepsy (SUDEP).

      Glasscock E, Yoo JW, Noebels JL

    • Enhanced oxytocin receptor expression in the nucleus accumbens by viral vector gene transfer accelerates partner preference formation in female prairie voles.

      Ross HE, Spiegel LL, Young LJ

    National Multiple Sclerosis Society (NMSS)
    Tykeson Fellows Conference in Chicago, Ill. (Nov. 4-7, 2008)
    International Symposium on ALS/MND
    19th Annual Meeting in Birmingham, UK (Nov. 3-5, 2008)
    Society of Vascular and Interventional Neurology (SVIN)
    2nd Annual Meeting in Miami, Fla. (Oct. 24-26, 2008)
    • Endovascular stent supported coil and onyx glue embolization of carotico-cavernous fistulae.

      Rao CV, Braun C, Jones M, Xavier A

    • Stent alone treatment for anterior circulation cerebral aneurysms.

      Rao CV, Kuruvilla A, Jones M, Lee A, Tiwari A, Xavier A

    • Stent without concomitant coil embolization for dissecting external carotid aneurysms.

      Rao CV, Lee A, Jones M, Tiwari A, Kansara A, Guthikonda M, et al.

    Neurocritical Care Society (NCS)
    6th Annual Meeting in Miami, Fla. (Oct. 23-25, 2008)
    • A case of methemoglobinemia after awake fiberoptic intubation following anterior cervical discectomy with fusion (ACDF).

      Rao CV, Varelas P, Wellwood J, Seyfried D, Abdelhak T

    6th International Congress on Mental Dysfunctions and Other Non-Motor Features in Parkinson's Disease and Related Disorders
    Dresden, Germany (Oct. 16-19, 2008)
    American Neurological Association (ANA)
    133rd Annual Meeting in Salt Lake City, Utah (Sept. 21-24, 2008)
    • Coagulopathy is an independent predictor of inhospital mortality in patients with acute subdural hematoma.

      Bershad EM, Farhadi S, Suri MF, Feen ES, Hernandez OH, Selman WR, et al.

    • Altered age of onset in Alzheimer's disease with diabetes mellitus.

      Shirani P, Salamone AR, Strutt AM, Schulz PE

    • Is frontal dysfunction associated with dysarthria in patients with Amyotrophic Lateral Sclerosis (ALS)?

      Sterling LE, Salamone AR, Mosnik DM, Appel SH, Strutt AM, Schulz PE

    • Progressive DA neuron degeneration induced by targeting administration of proteasome inhibitor in SN.

      Xie W, Zhu W, Pan T, Jankovic J, Le W

    World Stroke Organization (WSO)
    10th International Symposium on Thrombolysis and Acute Stroke Therapy in Budapest, Hungary (Sept. 21-23, 2008)
    • A systematic analysis of intravenous rt-PA vs. endovascular therapy with respect to therapeutic time window in acute ischemic stroke.

      Mandava P, Kent TA

    • Low-dose intravenous abciximab and heparin for large vessel acute ischemic stroke: Comparison with natural history models.

      Mandava P, Kent TA

    World Congress on Treatment and Research in Multiple Sclerosis (ACTRIMS + ECTRIMS + LACTRIMS)
    Montreal, Quebec, Canada (Sept. 17-20, 2008)
    Rutgers/UMDNJ-Robert Wood Johnson Medical School
    Poster Session in Piscataway, N.J. (August 2008)
    • Effects of MiRNA-372 on embryonic rat cortical neurogenesis.

      Chu J, Brzustowicz L, Millonig J, DiCicco-Bloom E

    American Psychological Association (APA)
    116th Annual Convention in Boston, Mass. (Aug. 14-17, 2008)
    • Culturally specific predictors of subjective well-being in urban adolescents.

      Vera EM, Moallem BI, Bena K, Blackmon S, Corona R, Dick L, et al.

    Mechanisms of Epilepsy and Neuronal Synchronization
    Gordon Research Conference in Waterville, Maine (Aug. 3-8, 2008)
    • Kcna1 is a novel candidate gene for sudden unexplained death in epilepsy (SUDEP).

      Glasscock E, Yoo JW, Noebels JL

    2008 International Conference on Alzheimer's Disease (ICAD)
    Chicago, Ill. (July 26-31, 2008)
    Movement Disorder Society (MDS)
    12th International Congress of Parkinson's Disease and Movement Disorders in Chicago, Ill. (June 22-26, 2008)
    Jamaican League Against Epilepsy (JLAE)
    1st North American Regional Caribbean Congress on Epilepsy in Montego Bay, Jamaica (May 30-31, 2008)
    • Sensitivity and specificity of video alone versus electroencephalography alone for the diagnosis of partial seizures.

      Chen DK, Graber KD, Anderson CT, Fisher RS

    Consortium of Multiple Sclerosis Centers (CMSC)
    22nd Annual Meeting in Denver, Colo. (May 28-31, 2008)
    European Stroke Conference (ESC)
    17th Annual Meeting in Nice, France (May 13-16, 2008)
    • Improved prediction of treatment success in stroke based on pooled control arms.

      Mandava P, Kent TA

    American Academy of Neurology (AAN)
    60th Annual Meeting in Chicago, Ill. (April 12-19, 2008)
    Baylor College of Medicine (BCM)
    Research Symposium in Houston, Texas (March 2008)
    • Neurocysticercosis in Houston: An 8-year experience in a tertiary care center.

      Serpa, JA, Gravis AE, Diaz-Marchan, P, Kass JS, et al.

    American Stroke Association
    2008 International Stroke Conference in New Orleans, La. (Feb. 20-22, 2008)
    • The self-management to prevent stroke clinic: teaching, translational research and technology.

      Anderson JA, Willson P

    • Platelet aggregation unit inhibition to guide abciximab therapy in acute ischemic stroke: preliminary results.

      Mandava P, Anderson J, Thiagarajan P, Kent TA

    • A method to predict stroke trial success based on pooled control arms.

      Mandava P, Kent TA

    • Antihypertensive treatment of acute cerebral hemorrhage (ATACH) trial.

      The ATACH Investigators

    Texas Scottish Rite Hospital for Children
    30th Annual Carrell-Krusen Neuromuscular Symposium in Dallas, Texas (Feb. 20-22, 2008)
    • A case of FSH?

      Ansari S, Biliciler S, Mytu S, Harati Y

    • A case of nemaline myopathy masquerading as fascioscapulohumeral dystrophy.

      Ansari S, Harati Y

    • A case of Ehlers-Danlos.

      Biliciler S, Smyth S, Harati Y

    • Progressive ascending weakness in an acquired immunodeficiency syndrome patient.

      Kung D, Kuo S-H, Kwan J

    • Peau d'Orange skin changes and muscle weakness.

      Kuo S-H, Kung D, Kwan JY

    • Diffuse painful muscle spasms.

      Satija P, Clark G, Killian J

    • Why does my patient have camptocormia?

      Smyth S, Biliciler S, Kwan J, Harati Y

    American Stroke Association
    International Stroke Conference, 2008 State-of-the-Art Stroke Nursing Symposium in New Orleans, La. (Feb. 19, 2008)
    • The Self-management TO Prevent (STOP) Stroke Clinic: Teaching, translational research and technology.

      Anderson J, Willson PC, Kent TA

    International Symposium on ALS/MND
    18th Annual Meeting in Toronto, Canada (Dec. 1-3, 2007)
    American Epilepsy Society (AES)
    61st Annual Meeting in Philadelphia, Penn. (Nov. 30 - Dec. 4, 2007)
    • Growth curve analysis of changes in spatial and verbal learning characteristics after anterior temporal lobectomy.

      Dulay MF, Levin HS, Mizrahi EM, York MK, Li X, Goldsmith IL, et al.

    • Masking epilepsy by combining two epilepsy mutations.

      Glasscock E, Qian J, Yoo JW, Noebels JL

    • Genomic research in the era of identifiable genetic information.

      Goldman AM, McGuire AL, Hilsenbeck SG, Noebels JL

    • Retrospective analysis of levetiracetam prescribing patterns and trends among women of reproductive age from 2003 to 2007.

      Gupta P, Agostini M, Diaz-Arrastia R, Van Ness P

    • Usage pattern of intravenous levetiracetam in an inner city hospital.

      Haneef Z, Vendrame M, Vincent CD, Jacobson MP

    • Mirtazapine induced complex partial epilepsy.

      Jacobson MP, Haneef Z, Vendrame M

    • Persistent focal neocortical abnormalities in the TTX model of infantile spasms.

      Lee CL, Antalffy B, Frost JD Jr, Hrachovy RA, Swann JW

    • Transient brain MRI changes after prolonged seizures.

      Repanshek ZD, Haneef Z, Vendrame M, Jacobson MP, Azizi S

    • Varied roles of BK-type potassium channels in the regulation of neuronal excitability: Which are important for epilepsy?

      Sanchez RM, Storm JF, Richerson GB, Barth A, Noebels JL

    • Topiramate does not significantly diminish hemiparesis during the amobarbital Wada test.

      Van Ness PC, Agostini MA, Diaz-Arrastia R

    • Complex partial status epilepticus (CPSE) and acute repetitive complex partial seizures (ARCPS): retrospective review of incidence and management at TUH.

      Vendrame M, Haneef Z, Jacobson MP

    Michael E. DeBakey Veterans Affairs Medical Center
    Advanced Practice Nursing Conference on the Management of Chronic Disease in Houston, Texas (November 2007)
    • Stroke secondary prevention: an exemplar for the chronic care model.

      Anderson J

    National Academy of Neuropsychology (NAN)
    27th Annual Meeting in Scottsdale, Ariz. (Nov. 14-18, 2007)
    American Public Health Association (APHA)
    135th Annual Meeting in Washington, DC (Nov. 3-7, 2007)
    • Exploring correlates of youth violence in South Africa.

      Hudson D, Khan A, Zimmerman M, Devnarain B

    Mexican Academy of Neurology
    31st Annual Meeting in Monterrey, Mexico (Oct. 31 - Nov. 5, 2007)
    European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS)
    23rd Congress in Prague, Czech Republic (Oct. 11-14, 2007)
    American Neurological Association (ANA)
    132nd Annual Meeting in Washington, DC (Oct. 7-10, 2007)
    Association of Academic Physiatrists (AAP)
    Annual Meeting in San Juan, Puerto Rico (Sept. 27-30, 2007)
    • Uncovering the etiology of bilateral lower extremity fasciculations and hypertrophy using electrodiagnosis: A case report.

      Button J, Kass JS, Chiou-Tan FY

    American Psychological Association (APA)
    115th Annual Convention in San Francisco, Calif. (Aug. 17-20, 2007)
    • I'm not an environmentalist, I just think like one.

      Amel EL, Manning C, Scott BA, Stinson JM

    Colombian Academy of Neurology
    VIII Meeting in Cali, Colombia (Aug. 16-19, 2007)
    Society for Behavioral Neuroendocrinology (SBN)
    11th Annual Meeting in Pacific Grove, Calif. (June 21-24, 2007)
    • Central vasopressin receptor 1a activation is necessary for partner preference formation and expression but not consolidation in prairie voles.

      Donaldson ZR, Spiegel L, Young LJ

    American Nurses Association (ANA)
    Symposium on Nursing Care in Life, Death and Disaster in Atlanta, Ga. (June 2007)
    • Real world response to Katrina.

      Lockhart MC, Anderson JA

    Memorial Sloan-Kettering Cancer Research Center
    Poster Session in New York, N.Y. (June 2007)
    • Point mutation in signal receptor inhibits retinoic acid-induced neuronal differentiation via Cdk5-p27 signaling in neuroblastoma cell.

      Chu J, Kim F, Zhang Y, Pasternak G

    2nd International Frontotemporal Dementia in ALS Research Conference
    London, Ontario Canada (June 10-13, 2007)
    Alzheimer's Association International Conference (AAIC)
    Washington, DC (June 9-12, 2007)
    Movement Disorder Society (MDS)
    11th International Congress of Parkinson's Disease and Movement Disorders in Istanbul, Turkey (June 3-7, 2007)
    Consortium of Multiple Sclerosis Centers (CMSC)
    21st Annual Meeting in Washington, DC (May 30 - June 2, 2007)
    International Society for Cerebral Blood Flow and Metabolism (ISCBFM)
    Brain 2007, 23rd International Symposium on Cerebral Blood Flow, Metabolism, and Function in Osaka, Japan (May 20-24, 2007)
    • The concept of "functional uncoupling" as a cause of vascular dysfunction following neonatal hypoxic/ischemic injury.

      Fabian RH, Perez-Polo JR, Kent TA

    American Academy of Neurology (AAN)
    59th Annual Meeting in Boston, Mass. (April 28 - May 5, 2007)
    • Malignant Tourette syndrome.

      Cheung MC, Shahed J, Jankovic J

    • Results of the Avonex Combination Trial (ACT).

      Cohen J, Calabresi P, Eickenhorst T, Edwards K, Felton W, Fisher E, et al.

    • Three parkin mutations in a family with Parkinson's disease.

      Deng H, Le W, Shahed J, Jankovic J

    • Dimebon improves cognition, function, and behavior in patients with mild- moderate Alzheimer's disease: Results of a randomized, double-blind, placebo-controlled study.

      Doody R, Gavrilova S, Sano M, Thomas R, Aisen P, Seely L, et al.

    • Autopsy-proven Huntington disease with 29 trinucleotide repeats.
      [Previously Presented]

      Kenney C, Powell S, Jankovic J

    • Autophagy induction and its neuroprotection on neurotoxin-induced cell injury relevant to Parkinson's disease.

      Pan T, Li X, Zhu W, Xie W, Jankovic J, Le W

    • Ongoing evaluation of the safety and tolerability of mitoxantrone in worsening multiple sclerosis: The RENEW study.

      Rivera VM, Al-Sabbagh A, Bennett R, Coyle P, Mikol D, Panitch H, et al.

    • Motor overflow, contralateral dystonia and mirror movements in focal hand dystonia.

      Sitburana O, Wu LJC, Sheffield KJ, Davidson A, Jankovic J

    • Head injury with amnesia and risk of multiple system atrophy (MSA).

      Tanner C, Kukrull W, Shults C, Comyns K, Bhudhikanok G, May S, et al.

    • Novel brain permeable iron chelators prevent lactacystin induced ubiquitin-proteasome inhibition and degeneration of nigrostriatal dopamine neurons.

      Zhu W, Pan T, Xie W, Xu P, Zheng H, Fridkin M, et al.

    • Proteasome inhibition in substantial nigra induces sustained dopamine cells degeneration.

      Zhu W, Pan T, Zhang X, Xie W, Jankovic J, Le W

    Center for Behavioral Neuroscience (CBN)
    Research Colloquium in Atlanta, Ga. (April 2007)
    • Vasopressin is critical for pair bond formation and expression in prairie voles.
      [Previously Presented]

      Spiegel LL, Donaldson ZR, Young LJ

    Emory University
    Undergraduate Research Symposium in Atlanta, Ga. (April 2007)
    • Vasopressin is critical for pair bond formation and expression in prairie voles.

      Spiegel LL, Donaldson ZR, Young LJ

    Emory University
    Chemistry Department Undergraduate Poster Session in Atlanta, Ga. (April 2007)
    • Vasopressin is critical for pair bond formation and expression in prairie voles.
      [Previously Presented]

      Spiegel LL, Donaldson ZR, Young LJ

    University of Michigan
    17th Annual Students of Color of Rackham (SCOR) Graduate and Professional Conference in Ann Arbor, Mich. (March 2007)
    • Exploring factors of youth violence in South Africa.

      Hudson D, Khan A, Zimmerman M, Devnarain B

    8th International Conference on Alzheimer's and Parkinson's Diseases (ADPD)
    Salzburg, Austria (March 14-18, 2007)
    American Heart Association
    47th Annual Conference on Cardiovascular Disease Epidemiology and Prevention in Orlando, Fla. (Feb. 28 - March 3, 2007)
    • Agreement between stage of change and measured behavioral endpoints: Implications for intervention design.

      Pavlik, VN, Hyman DJ, Goodrick KG

    • Association between serum c-peptide levels and the risk of cardiovascular disease in nondiabetic individuals: Data from the National Health and Nutrition Examination Survey.

      Rustveld LO, Pavlik VN

    Texas Scottish Rite Hospital for Children
    29th Annual Carrell-Krusen Neuromuscular Symposium in Dallas, Texas (Feb. 22-23, 2007)
    • Unusual cause of rhabdomyolysis.

      Biliciler S, Harati Y, Kwan J, Lindsay A

    • Progressive muscle weakness and joint contractures.

      Kwan J, Harati Y

    • Recurrent compartment syndrome.

      Lindsay A, Harati Y, Kwan J, Biliciler S

    North American Neuro-Ophthalmology Society (NANOS)
    33rd Annual Meeting in Snowbird, Utah (Feb. 10-15, 2007)
    International Neuropsychological Society (INS)
    35th Annual Meeting in Portland, Ore. (Feb. 7-10, 2007)
    • Development of child and parent report measures of subjective memory.

      Chapieski L, Evankovich K, Collins R, Hiscock M

    American Stroke Association
    2007 International Stroke Conference in San Francisco, Calif. (Feb. 7-9, 2007)
    • Factors associated with good outcome following intra-arterial therapy for acute ischemic stroke: a severity-adjusted systematic review.

      Mandava P, Kent TA

    • Treatment of subarachnoid hemorrhage with human albumin: the ALISAH pilot trial.

      Suarez JI, Murphy C, Feen ES, Bershad E, for the ALISAH Investigators

    Emory University
    Behavioral Research Advancements in Neuroscience Symposium in Atlanta, Ga. (2007)
    • Pair bonding behavior in voles correlates with anxiety and paternal care.

      Spiegel LL, McGraw LA, Young LJ

    American Epilepsy Society (AES)
    60th Annual Meeting in San Diego, Calif. (Dec. 1-5, 2006)
    • Expression profile of voltage-gated sodium channel genes in two knockout mouse models exhibiting spontaneous seizures.

      Ernst SJ, Isom L, Burgess DL, Noebels JL

    • Development of a transgenic mouse model of spike-wave epilepsy by overexpression of α1G T-type calcium channels.

      Ernst WL, Yoo JW, Burgess DL, Noebels JL

    • The prevalence of inter-ictal cardiac arrhythmias and LQT gene variants in patients with idiopathic epilepsy.

      Goldman AM, Burgess DL, Gibbs RA, Chapman KE, Wilfong AA, Hrachovy RA, et al.

    • Neonatal blockade of cortical or hippocampal activity: A possible model of infantile spasms.

      Lee CL, Frost JD Jr, Swann JW, Hrachovy RA

    • Efficacy of bisphosphonates in treatment of osteoporosis in men receiving antiepileptic drugs.

      Mostofi N, Jacobson MP, Haneef Z, Elliott JO

    International Symposium on ALS/MND
    17th Annual Meeting in Yokohama, Japan (Nov. 30 - Dec. 2, 2006)
    Neurocritical Care Society (NCS)
    4th Annual Meeting in Baltimore, Md. (Nov. 4-5, 2006)
    • Coagulopathy is an independent predictor of in-hospital mortality in patients with acute subdural hematoma.

      Suarez JI, Feen ES, Suri MFK, Bershad E, Mirabelli J, Lynch G, et al.

    Mexican Academy of Neurology
    30th Annual Meeting in Merida, Yucatan, Mexico (Oct. 30 - Nov. 4, 2006)
    Movement Disorder Society (MDS)
    10th International Congress of Parkinson's Disease and Movement Disorders in Kyoto, Japan (Oct. 30 - Nov. 2, 2006)
    American Neurological Association (ANA)
    131st Annual Meeting in Chicago, Ill. (Oct. 8-11, 2006)
    University of Michigan
    Undergraduate Research Forum in Ann Arbor, Mich. (Oct. 1, 2006)
    • International disability: a growing epidemic.

      Khan A

    International Congress of Clinical Neurophysiology (ICCN)
    28th Meeting in Edinburgh, Scotland (Sept. 10-14, 2006)
    • The use of intraoperative transcranial motor evoked potential (TcMEPs) monitoring in the surgical management of cerebral aneurysms.

      Lopez JR, Chen DK, Cho SC, Chang S, Steinberg G

    5th International Conference on Frontotemporal Dementia
    San Francisco, Calif. (Sept. 6-8, 2006)
    International Society for Developmental Neuroscience (ISDN)
    16th Biennial Meeting in Banff, Canada (Aug. 24-28, 2006)
    • Functional uncoupling of endothelial nitric oxide and superoxide radical following neonatal hypoxia/ischemia.

      Fabian RH, Perez-Polo JR, Kent TA

    • Relation of blood oxygenation in the first hours of life and school age outcomes in "healthy" children born at very low birthweight.

      Smith KE, Keeney SE, Susabda A, Rassin DK, Kent TA, Fabian RH, et al.

    Yerkes National Primate Research Center
    Institute on Neuroscience Meeting in Atlanta, Ga. (August 2006)
    • Intra-and interspecies nucleotide variation in the vasopressin receptor 1a gene of microtine voles.
      [Oral Presentation]

      Spiegel LL, Donaldson ZR, Young LJ

    Mechanisms of Epilepsy and Neuronal Synchronization
    Gordon Research Conference in Waterville, Maine (Aug. 6-11, 2006)
    • Ion channel gene interactions in inherited epilepsy.

      Glasscock E, Yoo J, Noebels JL

    10th International Conference on Alzheimer's Disease and Related Disorders
    Madrid, Spain (July 15-20, 2006)
    World Federation of Neurology (WFN)
    11th International Congress on Neuromuscular Diseases in Istanbul, Turkey (July 2-7, 2006)
    Center for Advanced Biotechnology and Medicine
    Piscataway, N.J. (June 2006)
    • Induction of carcinogenesis by concurrent inactivation of p53 and Pten in mouse ovary.
      [Oral Presentation]

      Chu J

    American Academy of Neurology (AAN)
    Guidelines, Practice and Advocacy Open House in San Diego, Calif. (April 3, 2006)
    • Use of serum prolactin in diagnosing epileptic seizures.

      Chen DK, So YT, Fisher RS

    American Academy of Neurology (AAN)
    58th Annual Meeting in San Diego, Calif. (April 1-8, 2006)
    American Heart Association/National Heart, Lung, and Blood Institute
    46th Annual Conference on Cardiovascular Disease Epidemiology and Prevention in Phoenix, Ariz. (March 2-5, 2006)
    • Association between cognitive function and metabolic control parameters in treated patients with type 2 diabetes.

      Pavlik VN, Hyman DJ, Balasubramanyam A, Doody R

    North American Neuro-Ophthalmology Society (NANOS)
    32nd Annual Meeting in Tucson, Ariz. (Feb. 25 - March 2, 2006)
    • The implication of glutamic acid decarboxylase autoantibodies in nystagmus: A case report.

      Pacheco VH, Selhorst JB, Chung SM

    American Stroke Association
    2006 International Stroke Conference in Kissimmee, Fla. (Feb. 16-18, 2006)
    • A systematic review of mortality and functional outcome in catheter-based therapy for acute ischemic stroke: comparison to predictive models.

      Mandava P, Kent TA

    • Relationship between admission glucose and outcome in the intravenous abciximab/heparin in acute stroke phase 1 study.

      Martini S, Anderson JA, Mandava P, Kent TA

    Texas Scottish Rite Hospital for Children
    28th Annual Carrell-Krusen Neuromuscular Symposium in Dallas, Texas (Feb. 16-17, 2006)
    • Progressive numbness and weakness in a diabetic patient: Is it all diabetic neuropathy?

      Kwan J, Harati Y

    • Spontaneous mutilating acral ulcers in nondiabetic patients: The spectrum of differential diagnosis.

      Kwan J, Harati Y, Phan C

    International Neuropsychological Society (INS)
    34th Annual Meeting in Boston, Mass. (Feb. 1-4, 2006)
    American Epilepsy Society (AES)
    59th Annual Meeting in Washington, DC (Dec. 2-6, 2005)
    • Subclinical rhythmic epileptiform discharge of adults (SREDA): Atypical SREDA in an adolescent.

      Baker N, Van Ness PC

    • What is the duration of EEG needed to diagnose childhood absence epilepsy (CAE)?

      Dlugos D, Mizrahi E, Moshe S, Shinnar S, Berg A, Conry J, et al.

    • Verbal memory declines are largest for patients with depression and anxiety after anterior temporal lobectomy.

      Dulay MF, Levin HS, York MK, Yoshor D, Grossman RG, Verma A, et al.

    • Efficacy and safety of rufinamide monotherapy for the treatment of patients with refractory partial seizures.

      Lesser RP, Biton V, Sackellares JC, Van Ness PC, Perdomo C, Arroyo S

    • Impaired semantic memory in temporal lobe epilepsy — What is the role of anterior temporal lobectomy?

      Schmolck H, York MK, Verma A, Goldsmith IL, Yoshor D, Levin HS, et al.

    • Epilepsy disability and applying for social supplemental income (SSI) and or social security disability income (SSDI).

      Wierzbinski MJ, Van Ness PC

    • Measurement of cerebral blood flow regulation by transcranial Doppler during complex partial seizures.

      Wright RJ, Verma A, Goldsmith IL, Mizrahi EM

    Society for Neuroscience (SFN)
    35th Annual Meeting in Washington, DC (Nov. 12-16, 2005)
    Mexican Academy of Neurology
    29th Annual Meeting in Chihuahua, Mexico (Oct. 29 - Nov. 3, 2005)
    American Neurological Association (ANA)
    130th Annual Meeting in San Diego, Calif. (Sept. 25-28, 2005)
    • Meta-analysis of 6-month memantine clinical trials in Alzheimer's disease.

      Doody RS, Tariot PN, Pfeiffer E, Olin JT, Graham SM, Bell JM

    • Botulinum toxin type B Observational Study (BOS).

      Jankovic J, Hunter CB, the BOS Study Group

    Michael E. DeBakey Veterans Affairs Medical Center
    Nurse Education Lecture Series in Houston, Texas (Sept. 9, 2005)
    • The nurse's role in diagnosis and treatment of acute stroke.

      Anderson J

    Memorial Sloan-Kettering Cancer Research Center
    Poster Session in New York, N.Y. (August 2005)
    • SiRNA knockdown of signal receptor in human embryonic kidney cells.

      Chu J, Zhang Y, Kim F, Pasternak G

    European Federation of Neurological Societies (EFNS)
    20th Annual National Conference in Fort Lauderdale, Fla. (June 17-21, 2005)
    • A novel approach in transitional cardiac rehabilitation.

      Anderson J, Willson P

    • Videophone exercise motivation for peripheral arterial disease patients.
      [Previously Presented]

      Willson P, Anderson J, Smith D, Stonecypher K, Petersen N

    Rutgers/UMDNJ-Robert Wood Johnson University Hospital
    New Brunswick, N.J. (June 2005)
    • Diabetes care, management and future research directions.
      [Oral Presentation]

      Chu J

    2nd Alzheimer's Association International Conference (AAIC)
    Washington, DC (June 9-12, 2005)
    • Meta-analysis of 6-month memantine clinical trials in Alzheimer's disease.

      Doody RS, Tariot PN, Pfeiffer E, Olin JT, Graham SM, Bell JM

    • Donepezil and vitamin E in the progression of mild cognitive impairment to Alzheimer's disease: A hazard-ratio analysis.

      Thal LJ, Thomas RG, Grundman M, Bennett DA, Doody RS, Ferris SH, et al.

    International Society for Cerebral Blood Flow and Metabolism (ISCBFM)
    Brain 2005, 22nd International Symposium on Cerebral Blood Flow, Metabolism, and Function in Amsterdam, The Netherlands (June 7-11, 2005)
    • Ultrasound-augmented thrombolysis improves outcome in hyperglycaemic stroke.
      [Platform Presentation]

      Martini S, Hill MD, Alexandrov AV, Molina CA, Kent TA

    • Oxygen treatment after perinatal hypoxia-ischemia reduces neuronal damage at short survival times, but worsens injury with long-term survival.
      [Platform Presentation]

      Noppens KM, Perez-Polo JR, Rassin DK, Westlund KN, Fabian R, Kent TA, et al.

    American Telemedicine Association (ATA)
    10th Annual Meeting in Denver, Colo. (April 17-20, 2005)
    • Videophone exercise motivation for peripheral arterial disease patients.
      [Previously Presented]

      Willson P, Anderson J, Smith D, Stonecypher K, Petersen N

    American Academy of Neurology (AAN)
    57th Annual Meeting in Miami Beach, Fla. (April 9-16, 2005)
    • Genetic analysis of G309D and W4370PA mutations of PINK1 in Parkinson's disease.

      Deng H, Le W, Zhang X, Pan T, Jankovic J

    • New version of the UPDRS: Development methods and working document for field testing.

      Goetz CG, Fahn S, Martinez-Martin P, Poewe W, Sampaio C, Stebbins G, et al.

    • A variant in the HS1-BP3 gene is associated with familial essential tremor.

      Higgins JJ, Lombardi RQ, Pucilowska J, Jankovic J, Tan EK, Rooney JP

    • Mild cognitive impairment types and their outcomes.

      Issa A, Rountree S, Waring S, Yeh S, Doody RS

    • ADAS-Cog change rates in MMSE Strata relevant to clinical trials.

      Massman P, Doody RS

    • Convergence spasm and other psychogenic eye movement disorders.

      Mejia NI, Jankovic J

    • Tics associated with other disorders.

      Mejia NI, Jankovic J

    • HSP70 inducer VPA inhibits rotenone-induced apoptosis in SH-SY5Y cells.

      Pan T, Xie W, Jankovic J, Le W

    • Relationship of premorbid IQ and education to progression of Alzheimer's disease.

      Pavlik V, Doody RS, Massman P, Chan W, Yeh S

    • Characteristics of Parkinson's disease in patients with childhood-onset essential tremor.
      [Previously Presented]

      Shahed J, Diamond AL, Vuong KD, Jankovic J

    • Botulinum toxin treatment for oromandibular dystonia and bruxism in patients with Tourette syndrome.

      Silay YS, Jankovic J

    Veterans Health Administration
    Care Coordination and Leadership Forum in Salt Lake City, Utah (April 5, 2005)
    • Videophone exercise motivation for peripheral arterial disease patients.
      [Previously Presented]

      Willson P, Anderson J, Smith D, Stonecypher K, Petersen N

    Central Texas Veterans Health Care System
    19th Annual Nursing Research Day in Waco, Texas (April 1, 2005)
    • Videophone exercise motivation for peripheral arterial disease patients.
      [Previously Presented]

      Willson P, Anderson J, Smith D, Stonecypher K, Petersen N

    Michael E. DeBakey Veterans Affairs Medical Center
    Advanced Cardiac Life Support Course in Houston, Texas (April 1, 2005)
    • Brain attack - Time lost is brain lost.

      Anderson J

    VA Research Day
    Michael E. DeBakey Veterans Affairs Medical Center in Houston, Texas (March 29, 2005)
    • Determining preoperative indicators for transitional cardiac rehabilitation after heart surgery.

      Anderson J, Willson P

    • Videophone exercise motivation for peripheral arterial disease patients.

      Willson P, Anderson J, Smith D, Stonecypher K, Petersen N

    Movement Disorder Society (MDS)
    9th International Congress of Parkinson's Disease and Movement Disorders in New Orleans, La. (March 5-8, 2005)
    International Neuropsychological Society (INS)
    33rd Annual Meeting in St. Louis, Mo. (Feb. 2-5, 2005)
    American Stroke Association
    30th International Stroke Conference in New Orleans, La. (Feb. 2-4, 2005)
    • Resolution of "Dense Dot Sign" after acute ischemic stroke is associated with better outcome.

      Mandava P, Kent TA

    • Faster and complete recanalization may overcome the negative effect of hyperglycemia on stroke outcome.

      Martini SR, Hill M, Alexandrov A, Molina C, Kent TA

    American Epilepsy Society (AES)
    58th Annual Meeting in New Orleans, La. (Dec. 3-7, 2004)
    • Absence of mossy fibers in NeuroD/BETA2 null mice prevents pilocarpine-induced status epilepticus.

      Mori M, Liu M, Cho JH, Ming-Jer TL, Noebels JL

    • Utility of intermittent bedside electroencephalographic monitoring in the pediatric intensive care setting.

      Richards KC, Hrachovy RA, Mizrahi EM, Jefferson LS

    • Secretion and functional analysis of LGI/Epitempin family members.

      Senechal KR, Noebels JL

    • A relational database for neurophysiology report generation and research.

      Van Ness PC, Agostini MA, Diaz-Arrastia R, Baker NS

    Baylor College of Medicine (BCM)
    Center for Cell and Gene Therapy Annual Retreat in Houston, Texas (Nov. 18-19, 2004)
    • Improved method for the production of concentrated Epstein Barr virus.

      Nunez-Wallace K

    American Neurological Association (ANA)
    129th Annual Meeting in Toronto, Canada (Oct. 4-5, 2004)
    Etiology, Pathogenesis, and Treatment of Parkinson's Disease and Other Movement Disorders
    18th Annual Symposium in Toronto, Canada (Oct. 3, 2004)
    European Federation of Neurological Societies (EFNS)
    8th Congress in Paris, France (Sept. 4-7, 2004)
    • Donepezil is safe and well-tolerated in AD patients at doses of up to 20 mg/day.

      Schindler R, Corey-Bloom J, Doody R, Zhang R, Leni JR, Li H

    • Functional effects of memantine treatment in patients with moderate to severe Alzheimer's disease.

      Wirth Y, Doody RS, Schmitt FA, Mobius HJ, Stoffler A

    Memorial Sloan-Kettering Cancer Research Center
    Poster Session in New York, N.Y. (August 2004)
    • Immunohistochemical labeling of RGSZ2 protein in mouse CNS.

      Chu J, Zhang Y, Pasternak G

    9th International Conference on Alzheimer's Disease and Related Disorders
    Philadelphia, Penn. (July 17-22, 2004)
    • Vascular dementia patients who receive donepezil treatment for 12 to 18 months maintain cognitive benefits.

      Doody R, Pratt R, Posner H, Kumar D

    • Longitudinal analysis of the Alzheimer's Disease assessment scale in a large cohort of probable AD patients.

      Massman P, Doody R

    • Memantine treatment for mild to severe Alzheimer's disease: Clinical trials summary.

      Tariot P, Doody R, Peskind E, Winblad B, Reisberg B, Stoffler A, et al.

    • Functional benefits of memantine treatment for patients with moderate to severe Alzheimer's disease.

      Wirth Y, Doody RS, Schmitt FA, Mobius HJ

    International Stroke Society (ISS)
    5th World Stroke Congress in Vancouver, British Columbia, Canada (June 23-26, 2004)
    • Intravenous abciximab in complicated cardioembolic stroke patients with high NIHSS.

      Mandava P, Lick SD, Rahman AM, Kent TA

    XXIVth Collegium Internationale Neuro-Psychopharmacologicum (CINP) Congress
    Paris, France (June 20-24, 2004)
    • Memantine treatment is beneficial for functional capacities of patients with moderate to severe Alzheimer's disease.

      Wirth Y, Doody R, Schmitt F, Mobius HJ, Stoffler A

    International Stroke Society (ISS)
    8th International Symposium on Thrombolysis and Acute Stroke Therapy in Whistler, British Columbia, Canada. (June 19-22, 2004)
    • Reversibility of dense CT "dot" sign predicts recovery after abciximab and heparin.

      Mandava P, Reddy K, Kent TA

    Movement Disorder Society (MDS)
    8th International Congress of Parkinson's Disease and Movement Disorders in Rome, Italy (June 13-17, 2004)
    American Academy of Neurology (AAN)
    56th Annual Meeting in San Francisco, Calif. (April 24 - May 1, 2004)
    American Society for Experimental NeuroTherapeutics (ASENT)
    6th Annual Meeting in Bethesda, Md. (March 11-13, 2004)
    International Neuropsychological Society (INS)
    32nd Annual Meeting in Baltimore, Md. (Feb. 4-7, 2004)
    American Epilepsy Society (AES)
    57th Annual Meeting in Boston, Mass. (Dec. 5-10, 2003)
    • Regional and developmental localization of ion-channel genes coexpressed in heart and brain.

      Goldman AM, Burgess DL, Armstrong DD, Mori M, Noebels JL

    • Use of video-EEG monitoring in the differential diagnosis of post-traumatic seizure disorders.

      Hudak A, Agostini MA, Van Ness PC, Harper C, Diaz-Arrastia R

    • Persistent changes in seizure susceptibility and GABAergic neurotransmission after recurrent early-life seizures.

      Kim DK, Hrachovy RA, Swann JW

    • Expression of apoptosis inhibitor protein MCL1 linked to neuroprotection in CNS neurons.

      Mori M, Burgess DL, Gefrides LA, Armstrong D, Foreman PJ, Opferman JT, et al.

    • Presidential symposium: The developing epileptic brain.

      Noebels JL, Walsh CA, Levitt PR, Barres BA

    • Seizures recorded in patients with mesial temporal sclerosis seen on MRI: Should we "scan and cut" or still rely on long-term video-EEG monitoring?

      Van Ness PC, Agostini MA, Diaz-Arrastia R, Baker NS

    • Elevated T-type calcium currents in thalamic neurons are associated with spike-wave seizure generation in the mouse mutant Coloboma (Cm/+).

      Zhang Y, Vilaythong AP, Noebels JL

    25th International Epilepsy Congress (IEC)
    Lisbon, Portugal (Oct. 12-16, 2003)
    • Expression pattern of candidate epilepsy ion channel genes in mouse and human brains.

      Goldman AM, Burgess DL, Armstrong DD, Mori M, Noebels JL

    Memorial Sloan-Kettering Cancer Research Center
    Poster Session in New York, N.Y. (August 2003)
    • Immunohistochemical labeling of the mu opioid receptor carboxy terminal splice variants MOR-1C and MOR-1 in the mouse spleen and kidney.

      Chu J, Zhang Y, Pasternak G

    American Academy of Neurology (AAN)
    55th Annual Meeting in Honolulu, Hawaii (March 29 - April 5, 2003)
    • Donepezil-treated patients demonstrate global benefits on the Clinician's Interview-Based Impression of Change-Plus version: A comparison of Alzheimer's disease versus vascular dementia.

      Doody RS, Pratt RD, Perdomo CA, the Donepezil 307 and 308 VaD Study Groups

    • Long-term treatment with the NMDA antagonist, memantine: Results of a 24-week, open-label extension study in moderate to severe Alzheimer's disease.

      Ferris SH, Schmitt FA, Doody RS, Moebius H-J, Stoeffler A, Reisberg BJ

    • Haplotype analysis of unrelated individuals with familial essential tremor.

      Higgins JJ, Jankovic J, Lombardi RQ, Pucilowska J, Tan EK, Ashizawa T, et al.

    • Comparison of postoperative improvement of staged bilateral subthalamic stimulation in patients with advanced Parkinson's disease.

      Kuniyoshi S, Tintner R, Ondo W, Simpson R, Jankovic J

    • Apolipoprotein E controls risk and age at onset of Parkinson disease.

      Li Y-J, Martin ER, Scott WK, Haines JL, Nance MA, Hubble JP, et al.

    • Glutathione S-Transferase, Omega-1 (GSTO1) modifies age at onset of Alzheimer disease and Parkinson disease.

      Li Y-J, Oliveria AS, Hauser MA, Hauser ER, Scott WK, Stenger JE, et al.

    • A double blind placebo controlled parallel trial of botulinum toxin B (Myobloc™) for the treatment of sialorrhea in Parkinson disease.

      Ondo WG, Hunter CB, Moore W

    • The epidemiology of myoclonus in the medical and surgical intensive care unit (ICU).

      Tintner R, Kuniyoshi SM, Gonzalez A, Jankovic J

    • Specific mitochondrial haplogroups affect risk for late-onset Parkinson disease.

      Van der Walt JM, Nicodemus KK, Martin ER, Scott WK, Haines JL, McLaurin AC, et al.

    • Dual-task functioning in mild and moderately severe Parkinson's disease patients.

      York MK, Lai EC, Levin HS, Grossman RG

    International Neuropsychological Society (INS)
    31th Annual Meeting in Honolulu, Hawaii (Feb. 5-8, 2003)
    American Epilepsy Society (AES)
    56th Annual Meeting in Seattle, Wash. (Dec. 6-11, 2002)
    • Clinical, electroencephalographic and neuroradiologic characteristics of secondary bilateral synchrony in localization-related epilepsy.

      Agostini MA, Garcia MC, Diaz-Arrastia R, Van Ness PC

    • Utility of continuous video-EEG monitoring in a veteran population: Review of 144 consecutive patients.

      Foreman PJ, Wilder LM, Hrachovy RA

    • Memory assessment in Spanish-speaking patients with lateralized temporal lobe epilepsy: Can differences be detected?

      Lacritz LH, Marquez C, Van Ness P, Agostini M, Diaz-Arrastia R, Cullum CM

    • EEG abnormalities and epilepsy in Smith-Magenis syndrome and in a genetic mouse model.

      Lynch JK, Walz K, Glaze DG, Potocki L, Lupski JR, Noebels JL

    • The effect of topiramate on excitatory synaptic transmission in mouse hippocampus.

      Qian J, Noebels JL

    • Anosognosia during the intracarotid amobarbital (Wada) test is unrelated to memory score or side of injection.

      Van Ness PC, Agostini MA, Diaz-Arrastia R, Baker NS, Chason DP

    Movement Disorder Society (MDS)
    7th International Congress of Parkinson's Disease and Movement Disorders in Miami, Fla. (Nov. 10-14, 2002)
    • Treatment of hypophonia with collagen vocal fold augmentation in patients with parkinsonism.

      Hill AN, Jankovic J, Vuong KD, Donovan D

    • Age-related tolerability of tetrabenazine.

      Hunter CB, Wang A, Vuong KD, Jankovic J

    • Tetrabenazine in the treatment of Tourette syndrome.

      Hunter CB, Wang A, Vuong KD, Jankovic J

    • Premonitory sensations in tics.

      Kwak CH, Jankovic J

    • Reduced Nurr1 expression increases the susceptibility to dopaminergic toxins via nitric oxide.

      Le W, Imam SZ, Xie W, Ali S, Jankovic J

    • Computerized posturography balance assessment of patients with bilateral vim deep brain stimulation.

      Ondo WG, Cohen H, Almaguer M, Jankovic J

    • Upregulation of Nurr1 gene expression by dopamine receptor agonist pramipexole in human neuroblastoma SHSY-5Y cells.

      Pan TH, Xu PY, Xie WJ, Hunter C, Jankovic J, Le WD

    • Reliability of limits of stability measures in Parkinson's disease.

      Protas EJ, Thomas M, Cunha IT, Caroline KS, Wankadia S, Jankovic J

    • Minocycline in Huntington's disease: A pilot study.

      Thomas M, Ashizawa T, Jankovic J

    • Gait and Balance Scale (GABS): Validation and utilization.

      Thomas M, Jankovic J, Suteerawattanon M, Wankadia S, Caroline K, Protas E

    • Experience with bilateral subthalamic nucleus (STN) stimulation for Parkinson's disease (PD).

      Tintner R, Almaguer M, Sanghera M, Simpson R, Ondo WG, Jankovic J

    • Predictors of response to bilateral subthalamic nucleus stimulation for Parkinson's disease.

      Tintner R, Almaguer M, Vuong KD, Ondo WG, Jankovic J, Sanghera M

    • Pleuropulmonary fibrosis after 11 years of pergolide treatment.

      Tintner R, Manian P, Gauthier P, Jankovic J

    • The efficacy and safety of Dysport (botulinum type A toxin) in cervical dystonia: Results of the first US study.

      Truong DD, Duane DD, Jankovic J, Singer C, Comella CL, the US Dysport Dystonia Study Group

    • Working memory functioning in mild and moderately severe Parkinson's disease patients.

      York MK, Lai EC, Levin HS, Grossman RG

    American Neurological Association (ANA)
    127th Annual Meeting in New York City, N.Y. (Oct. 12-16, 2002)
    • Dystonia in Friedreich's ataxia.

      Hou JG, Jankovic J

    Barany Society
    6th NASA Symposium on The Role of the Vestibular Organs in the Exploration of Space (Sept. 30 - Oct. 3, 2002)
    • Assessment of neurologic function following short duration spaceflight utilizing a standardized rating scale.

      Clark JB

    • Neurovestibular effects of long-duration spaceflight: a summary of Mir phase 1 experiences.

      Richards JT, Clark JB, Oman CM, Marshburn TH

    Society for the Advancement of Chicanos and Native Americans in Science (SACNAS)
    Annual Meeting in Anaheim, Calif. (Sept. 26-29, 2002)
    • Genetic analysis of auxin function in Arabidopsis thaliana.

      Nunez-Wallace K

    8th International Conference on Alzheimer's Disease and Related Disorders
    Stockholm, Sweden (July 20-25, 2002)
    • How well do cerebral spinal fluid tau levels discriminate autopsy confirmed Alzheimer's disease from other dementia diagnoses?

      Clark C, Eubank D, Peskind E, Galasko D, Morris J, McKeel D, et al.

    • Pathogenesis and treatment strategies for selected therapies under development.

      Doody RS

    • Long term treatment with the NMDA antagonist memantine: results of a 24-week, open label extension study in moderately severe to severe Alzheimer's disease.

      Reisberg B, Mobius H, Stoffler A, Schmitt F, Doody R, Ferris S

    Society for Epidemiologic Research (SER)
    35th Annual Meeting in Palm Desert, Calif. (June 19-21, 2002)
    • Cognitive function and cardiovascular risk factors in adults 30-59 years old (NHANES III).

      Pavlik VN, Hyman DJ, Doody R

    Basic and Therapeutic Aspects of Botulinum and Tetanus Toxins
    International Conference in Hannover, Germany (June 8, 2002)
    American Society of Hypertension (ASH)
    17th Annual Meeting in New York, N.Y. (May 14-18, 2002)
    • Selective physician blood pressure remeasurement in the office setting may contribute to poor hypertension control.

      Pavlik VN, Hyman DJ, Vallbona C, Grim C

    World Federation of Neurology (WFN)
    Research Group on Neuroepidemiology. Regional North American Annual Meeting in Denver, Colo. (April 19, 2002)
    • Survival in patients with dementia from a large multi ethnic population.

      Waring S, Doody RS

    International Neuropsychological Society (INS)
    30th Annual Meeting in Toronto, Canada (Feb. 13-16, 2002)
    • Diagnosis of post-concussional disorder in brain injury and extra-cranial trauma.

      Boake C, McCauley SR, Levin HS, Brown SA, Goodman HS

    • Relationship between gender and psychiatric disorders after TBI.

      Brown SA, McCauley SR, Levin HS, Boake C, Contant C, Song J

    • Neuropsychological test scores among complicated mild head injury subtypes.

      Collins RL, Hannay HJ, Cass J, Valadka A

    • Growth curve analysis of decline in instrumental activities of daily living in AD patients.

      Davis R, Atchison T, Massman P, Doody R

    • Measurement invariance of the WAIS-R in AD among patients at higher versus lower levels of dementia severity.

      Davis R, Massman P, Doody R

    • WAIS-R factor structure in AD: Comparison of alternative models and assessment of generalizability.

      Davis R, Massman P, Doody R

    • Comparison of the CIQ and EGOS as measures of outcome n mild to moderate TBI and a matched general trauma sample.

      Evans C, McCauley S, Levin H, Boake C, Contant C, Song J

    • Health-related quality of life perceptions in patients with postconcussional disorder.

      McCauley SR, Brown SA, Levin HS, Boake C, Contant C, Song J

    American Epilepsy Society (AES)
    55th Annual Meeting in Philadelphia, Penn. (Nov. 30 - Dec. 5, 2001)
    • Ten year outcome of infantile spasms treated with high vs. low dose ACTH.

      Chadwick DJ, Glaze DG, Wise MS, Frost JD, Hrachovy RA

    • Estimated and current intellectual function in patients with intractable epilepsy.

      Frol AB, Garcia MC, Agostini MA, Van Ness PC

    • Temporal intermittent rhythmic delta activity: Prevalence, lateralization and MRI correlation in an adult, outpatient population.

      Garcia M, Agostini MA, Diaz-Arrastia R, Van Ness PC

    • Magnetoencephalography mislocalizes interictal epileptogenic activity in mesial temporal epilepsy.

      Goldman AM, Wheless JW, Venkataraman V, Kim HL, Papanicolaou AC

    • The effect of Ammon's horn sclerosis and atypical sclerosis on memory functioning following temporal lobectomy.

      Levin HS, York MK, Mizrahi EM, Armstrong DD, Hamilton WJ, Rettig GM, et al.

    • Neurological impairment, developmental delay and postneonatal seizures two years after EEG-video documented seizures in near-term and full-term neonates: Report of the clinical research centers for neonatal seizures.

      Mizrahi EM, Clancy RR, Dunn JK, Hirtz D, Chapieski L, McGuan S, et al.

    • Differential early expression of novel genes in the hippocampus after pilocarpine-induced status epilepticus in inbred mouse strains with high and low seizure susceptibility.

      Mori M, Burgess DL, Gefrides L, Foreman PJ, Naffah-Mazzacoratti MG, Noebels JL

    • Vagus nerve stimulation: Correlation of changes in spike morphology with seizure control.

      Verma A, Mizrahi EM, Frost JD Jr

    • The effect of Ammon's horn sclerosis and atypical sclerosis on seizure frequency following temporal lobectomy.

      York MK, Mizrahi EM, Levin HS, Armstrong DD, Rettig GM, Hamilton WJ, et al.

    • Increased calcium currents in thalamocortical relay cells of tottering and lethargic mice.

      Zhang Y, Noebels JL

    North American Primary Care Research Group (NAPCRG)
    29th Annual Meeting in Halifax, Nova Scotia, Canada (Oct. 13-16, 2001)
    • Self-assessed knowledge of diabetes management in a low-income, minority patient population.

      Pavlik VN, Maldonado M, Karlsson F, Schindler J, Spann SJ

    Society for the Advancement of Chicanos and Native Americans in Science (SACNAS)
    Annual Meeting in Phoenix, Ariz. (Sept. 27-30, 2001)
    • Genetic analysis of indole-3-butyric acid (IBA) function in Arabidopsis thaliana.

      Nunez-Wallace K

    World Federation of Neurology (WFN)
    Research Group on Neuroepidemiology. Regional North American Annual Meeting in Philadelphia, Penn. (May 9, 2001)
    • Racial differences among patients with Alzheimer's disease from a large multi ethnic population.

      Waring S, Doody RS

    American Academy of Neurology (AAN)
    53rd Annual Meeting in Philadelphia, Penn. (May 5-11, 2001)
    • The prevalence of restless legs syndrome in patients with Parkinson's disease.

      Atassi F, Vuong KD, Jankovic J, Ondo WG

    • The cognitive benefits of galantamine are sustained for at least 24 months: Results of a long-term extension trial in Alzheimer's disease.

      Doody RS, Kershaw P

    • Exploring the relationship between Parkinson's disease and restless legs syndrome.

      Ondo WG, Vuong KD, Jankovic J

    International Neuropsychological Society (INS)
    29th Annual Meeting in Chicago, Ill. (Feb. 14-17, 2001)
    • Outcome of complicated mild head injury subtypes.

      Hannay H, Collins R, Cass J, Valadka A

    American Epilepsy Society (AES)
    54th Annual Meeting in Los Angeles, Calif. (Dec. 1-6, 2000)
    • Genetic aggregation of calcium channel defects in mice simulates non-Mendelian inherited human epilepsy.

      Burgess DL, Gefrides LA, Davis CF, Noebels JL

    • Bilateral memory dysfunction in epilepsy surgery candidates detected by the intracarotid amobarbital procedure (Wada) test.

      Diaz-Arrastia RR, Frol AB, Agostini MA, Lacritz LJ, Van Ness PC

    • Wada difference a Wada makes: Comparison of two Wada memory tests.

      Epker MO, Lacritz LH, Ringe W, Van Ness PC, Agostini MA, Cullum CM

    • Expression of a family of calcium channel γ-subunits (CACNG 1-8) in mice.

      Foreman PJ, Burgess DL, Gefrides LA, Noebels JL

    • Absence of pilocarpine-induced status epilepticus in NeuroD knock out mice.

      Mori M, Min L, Ming TJ, Noebels JL

    • Changes in presynaptic Ca currents and transmitter release are synapse-dependent in epileptic mice with calcium channel mutations.

      Qian J, Noebels JL

    • QOLIE-31 in idiopathic generalized epilepsy.

      Van der Sluis RW, Van Ness PC, Agostini MA, Garcia MD, Lacritz LH

    • Gender differences in psychogenic nonepileptic seizure etiologies and semiologies.

      Van Ness PC, Agostini MA, Diaz-Arrastia RR

    • Altered calcium currents in thalamocortical relay cells of stargazer, a mouse epilepsy model caused by a calcium channel gamma sub-unit mutation.

      Zhang Y, Noebels JL

    North American Primary Care Research Group (NAPCRG)
    28th Annual Meeting in Amelia Island, Fla. (Nov. 4-7, 2000)
    • Improvement in systolic blood pressure control in a predominantly African-American health center.

      Pavlik VN, Hyman DJ, Vallbona C

    7th International Conference on Alzheimer's Disease and Related Disorders
    Washington, DC (July 9-18, 2000)
    • Cholinesterase inhibitors: Benefits and limitations.

      Doody RS

    Movement Disorder Society (MDS)
    6th International Congress of Parkinson's Disease and Movement Disorders in Barcelona, Spain (June 11-15, 2000)
    • Olanzapine treatment for dopaminergic induced hallucinations.

      Ondo WG, Hunter C, Vuong KD, Jankovic J

    • Daytime sleepiness in patients with Parkinson's disease.

      Ondo WG, Vuong KD, Atassi F, Khan H, Kwak C, Jankovic J

    American Academy of Neurology (AAN)
    52nd Annual Meeting in San Diego, Calif. (April 29 - May 6, 2000)
    • Donepezil preserves activities of daily living in Alzheimer's disease patients: Results from a 1-year placebo-controlled functional survival study.

      Mohs R, Doody R, Morris J, Ieni J, Perdomo C, Pratt R

    • Profoundly advanced Alzheimer's disease: Patient characteristics, functional status, disease progression, and care burden.

      Sumaira R, Doody R, Lai EC

    • Unilateral thalamic deep brain stimulation for essential tremor and Parkinson's disease: Effects of stimulation on the non-target limb and rebound augmentation.

      Vuong KD, Ondo WG, Almaguer M, Simpson RK, Jankovic J

    Genetics Society of America (GSA)
    41st Annual Drosophila Research Conference in Pittsburgh, Penn. (March 22-26, 2000)
    • A role for PAR-1 in oocyte determination.
      [Platform Presentation]

      Shulman JM

    American Society of Consultant Pharmacists (ASCP)
    30th Annual Meeting in St. Loius, Mo. (Nov. 10-13, 1999)
    • Uninterrupted long-term donepezil treatment results in optimal efficacy with retained safety.

      Doody R, Geldmacher DS, Pratt RD, Perdoma CA

    Society for Neuroscience (SFN)
    29th Annual Meeting in Miami Beach, Fla. (Oct. 23-28, 1999)
    • Kappa-opioid receptors in the substantia nigra pars reticulata mediate the U-50,488-induced locomotor activity of preweanling rats.

      Collins RL, Zavala AR, Nazarian A, McDougall SA

    European College of Neuropsychopharmacology (ECNP)
    12th Congress in London, UK (Sept. 21-25, 1999)
    • Donepezil preserves functional status in Alzheimer's disease patients: Results from a 1-year placebo-controlled attrition study.

      Mohs R, Doody R, Morris J, Ieni J, Rogers S, Perdomo C, et al.

    International Society for Cerebral Blood Flow and Metabolism (ISCBFM)
    Brain 1999, 19th International Symposium on Cerebral Blood Flow, Metabolism, and Function in Copenhagen, Denmark (June 13-17, 1999)
    • The pattern of synaptophysin expression after middle cerebral artery occlusion and post-infarction MK-801 treatment.

      Kent TA, Bolanos SH, Fabian RH, Rea C

    European Neurological Society (ENS)
    9th Annual Meeting in Milan, Italy (June 5-9, 1999)
    • Optimal donepezil efficacy in Alzheimer's disease is dependent on continued administration.

      Doody RS, Geldmacher DS, Pratt RD, Perdomo CA

    American Academy of Neurology (AAN)
    51st Annual Meeting in Toronto, Canada (April 17-24, 1999)
    • Does ApoE4 correlate with MRI changes in Alzheimer's disease?

      Azher S, Doody RS, Haykal H, Dunn JK, Liao T-Y

    • Clinical benefits of donepezil: Results from a long-term phase III extension trial.

      Doody RS, Pratt R, Perdomo C

    British Society for Developmental Biology (BSDB)
    BSCB/BSDB Joint Spring Meeting in Manchester, England (April 13-16, 1999)
    • A drosophila homologue of c. elegans PAR-1.
      [Platform Presentation]

      Shulman JM

    Genetics Society of America (GSA)
    40th Annual Drosophila Research Conference in Bellevue, Wash. (March 24-28, 1999)
    • A drosophila homologue of c. elegans PAR-1.
      [Platform Presentation]

      Shulman JM

    European College of Neuropsychopharmacology (ECNP)
    11th Congress in Paris, France (Oct. 31 - Nov. 4, 1998)
    • Donepezil improves cognition and global function in Alzheimer's disease: Results from U.S. and multinational phase III clinical trials.

      Petit H, Doody RS, Pratt R

    6th International Conference on Alzheimer's Disease and Related Disorders
    Amsterdam, The Netherlands (July 18-23, 1998)
    • Chronic donepezil treatment is associated with slowed cognitive decline in Alzheimer's disease patients.

      Doody RS, Clark C, Farlow M, Foster N, Gonzales N, Liao J, et al.

    • The presence of APO E4 does not influence rate of decline in Alzheimer's disease.

      Kataki M, Doody RS, Liao J, Sims J

    American Society of Hypertension (ASH)
    13th Annual Meeting in New York, N.Y. (May 13-16, 1998)
    • Ethnic differences in 24-hour blood pressure control in treated hypertensives.

      Hyman DJ, Ogbonnaya K, Pavlik VN, Taylor AA, Ho K

    Fifth International Geneva/Springfield Symposium on Advances in Alzheimer Therapy
    Geneva, Switzerland (April 15-18, 1998)
    • Current therapeutic standards in the treatment of Alzheimer's disease.

      Doody RS

    • Research outcome measures in Alzheimer's disease: Statistical significance, effect size and responder analysis - How do they translate to clinical relevance?

      Rogers S, Mohs R, Friedhoff L, Doody RS

    Genetics Society of America (GSA)
    39th Annual Drosophila Research Conference in Washington, DC (March 25-29, 1998)
    • Subcellular relocalization of dishevelled mediates polarity signaling.
      [Platform Presentation]

      Shulman JM

    American Epilepsy Society (AES)
    51st Annual Meeting in Boston, Mass. (Dec. 7-10, 1997)
    • Mutation of the voltage-dependent calcium channel beta subunit gene Cchb4 is associated with absence seizures and ataxia in the lethargic (lh) mouse.

      Burgess DL, Jones JM, Meisler MH, Zilinski CA, Noebels JL

    • A mutation in the sodium/hydrogen exchanger-1 gene causes ataxia and epilepsy in the slow-wave epilepsy mutant mouse.

      Cox GA, Lutz CM, Biemesderfer D, Bronson RT, Aronson PS, Noebels JL, et al.

    • Risk factors for neonatal seizures: A population-based study, Harris County, TX, 1992-1994.

      Saliba RM, Annegers JF, Waller DK, Mizrahi EM

    • Subtype-specific downregulation of glutamate transporter gene expression in three models of temporal lobe epilepsy.

      Sutherland ML, Delaney TA, Noebels JL

    International Society for Cerebral Blood Flow and Metabolism (ISCBFM)
    Brain 1997, 18th International Symposium on Cerebral Blood Flow, Metabolism, and Function in Baltimore, Md. (June 15-19, 1997)
    • Relationship between reduction in cerebral blood flow and superoxide anion following fluid percussion injury of the brain.

      Fabian RH, DeWitt DS, Kent TA

    Aerospace Medical Association (AsMA)
    68th Annual Meeting in Chicago, Ill. (May 11-15, 1997)
    • Neuro-otologic evaluation of spatial disorientation and vestibular dysfunction in naval aviation personnel.

      Clark JB, Hopkins III EW

    • Case report II. Severe and prolonged drowsiness, fatigue, and mood changes in the aviator referred for air sickness.

      Lawson BD, Mead AM, Clark JB

    • Cardiovascular responses to a mixed-gas breathing paradigm for hypoxia induction.

      Sausen KP, Chimiak JM, Bower EA, Stiney ME, Clark JB

    American Academy of Neurology (AAN)
    49th Annual Meeting in Boston, Mass. (April 15-17, 1997)
    • Outcome measures in dementia trials-video CIBIC validity and reliability.

      Quinn JF, Benson DF, Clark C, Doody RS, Jagust W, Knopman D, et al.

    American Heart Association
    22nd International Joint Conference on Stroke and Cerebral Circulation in Anaheim, Calif. (Feb. 6-8, 1997)
    • Superoxide production by neutrophils in stroke.

      Fabian RH, Kent TA

    American College of Neuropsychopharmacology (ACNP)
    35th Annual Meeting in San Juan, Puerto Rico (Dec. 9-13, 1996)
    • Donepezil HCI (E2020) improves cognitive and global function in patients with mild and moderately severe Alzheimer's disease: Results of a 15-week phase III study.

      Rogers SL, Doody RS, Mohs RC, Friedhoff LT

    Society for Neuroscience (SFN)
    26th Annual Meeting in Washington, DC (Nov. 16-21, 1996)
    • Production of extracellular superoxide anion during reperfusion following cerebral ischemia correlates with cerebral infarction.

      Fabian RH, Kent TA

    Aerospace Medical Association (AsMA)
    67th Annual Meeting in Atlanta, Ga. (May 5-9, 1996)
    • Spatial orientation mobile field laboratory assessment of U.S. Navy divers exposed to underwater sound.

      Clark JB, Ferreira EA, McGrath BJ

    • Implementation of a marine aircraft wing sustained operations plan during combat (Operation Desert Storm).

      Clark JB, Schuyler CL

    • Assessment of eye movements during high intensity underwater (U/W) sound exposures in U.S. Navy divers.

      Ferreira EA, McGrath BJ, Clark JB

    • U.S. Navy experience with type II decompression sickness and the association with patent foramen ovale.

      Gallagher KL, Hopkins EW, Clark JB, Hawley TA

    International Behavioral Neuroscience Society (ISBN)
    5th Annual Meeting in Cancun, Mexico (May 2-5, 1996)
    • Prevalence of uncontrolled hypertension in a population of Alzheimer's patients.

      Kashani A, Doody RS, Wayner MJ, Phelix CF

    Undersea and Hyperbaric Medical Society (UHMS)
    1996 Annual Scientific Meeting in Anchorage, Alaska (April 30 - May 5, 1996)
    • Assessment of vestibular function of divers exposed to high intensity low frequency underwater sound.

      Clark JB, Russell KL, Knafelc ME, Steevens CC

    Genetics Society of America (GSA)
    37th Annual Drosophila Research Conference in San Diego, Calif. (April 27 - May 1, 1996)
    • Dishevelled is a multifunctional signal transducer.
      [Platform Presentation]

      Shulman JM

    American Academy of Neurology (AAN)
    48th Annual Meeting in San Francisco, Calif. (March 23-30, 1996)
    • Rate of dementia of the Alzheimer's type (DAT) in subjects with mild cognitive impairment.

      Grundman M, Petersen R, Morris J, Ferris S, Sano M, Farlow M, et al.

    • E-2020 Produces both clinical global and cognitive test improvement in patients with mild to moderately severe Alzheimer's disease (AD): Results of a 30-week phase III trial.

      Rogers S, Doody RS, Mohs R, Friedhoff L

    • Pharmacologic evidence for autonomic sudomotor dysfunction in patients with Alzheimer's disease.

      Sabbagh N, Smith RG, Lynn P, Doody RS, Appel SH, Killian JH

    International Neuropsychological Society (INS)
    24th Annual Meeting in Chicago, Ill. (Feb. 14-17, 1996)
    • Reliability and validity of a new clinical global rating scale for Alzheimer's clinical trials.

      Olin J, Clark C, Doody RS, Schmitt F, Ferris S, Morris J, et al.

    Gerontological Society of America (GSA)
    50th Annual Meeting in Los Angeles, Calif. (Nov. 15-19, 1995)
    • A new clinical global rating scale for Alzheimer's clinical trials.

      Olin J, Schneider L, Clark C, Doody RS, Ferris S, Morris J, et al.

    American Neuropsychiatric Association (ANPA)
    7th Annual Meeting in Pittsburgh, Penn. (Oct. 12-15, 1995)
    • Estrogen and psychomotor performance.

      Doody RS, Young R, Lynn P, Cooke N, Rosenfield JE

    Aerospace Medical Association (AsMA)
    66th Annual Meeting in Anaheim, Calif. (May 7-11, 1995)
    • Human factors in navy/marine fixed and rotary wing class-a mishaps involving 3rd generation night vision goggles (NVG) 1987-1993.

      Clark JB, Patterson FR

    • Atrial fibrillation associated with airsickness.

      Schindler ES, Clark JB

    American Academy of Neurology (AAN)
    47th Annual Meeting in Seattle, Wash. (May 6-13, 1995)
    • A calculated measure to predict rate of progression in Alzheimer's disease.

      Doody RS, Lynn P, Massman PJ

    International Neuropsychological Society (INS)
    23rd Annual Meeting in Seattle, Wash. (Feb. 8-11, 1995)
    • Sex differences involving naming in Alzheimer's disease: Stronger relationships with left hemisphere functioning in men.

      Massman PJ, Doody RS

    American Academy of Neurology (AAN)
    46th Annual Meeting in Washington, DC (May 1-7, 1994)
    • Psychometric profiles of Alzheimer's disease (AD) with/without white matter changes compared to subcortical ischemic vascular dementia (IVD).

      Doody RS, Massman PJ, Nance ML

    • Neuropsychological distinctions between cortico-basal ganglionic degeneration (CBGD) and Alzheimer's disease with extrapyramidal signs.

      Massman PJ, Kreiter KT, Jankovic J, Doody RS

    International Neuropsychological Society (INS)
    22nd Annual Meeting in Cincinnati, Ohio (Feb. 2-5, 1994)
    • Neuropsychological differentiation of corticobasal degeneration from Alzheimer's disease.

      Massman PJ, Kreiter KT, Jankovic J, Doody RS

    American Neurological Association (ANA)
    118th Annual Meeting in Boston, Mass. (Oct. 18-20, 1993)
    • Dysfluency in the speech of AD patients.

      Doody RS, Massman P

    • Literacy and cognition in northern Thailand.

      Doody RS, Welsh K

    • The impact of extended deprenyl treatment in Parkinson's disease patients not requiring levodopa therapy.

      Shoulson I, Parkinson Study Group

    American Society of Human Genetics (ASHG)
    43rd Annual Meeting in New Orleans, La. (Oct. 5-9, 1993)
    • Simulation analysis of a large British pedigree segregating a newly characterized autosomal dominant language disorder: Familial developmental dysphasia.

      Dunn W, Doody RS, Gopnik M, Ashizawa T

    American Psychiatric Association (APA)
    146th Annual Meeting in San Francisco, Calif. (May 22-27, 1993)
    • Neuroimaging findings and clinical variables associated with psychosis in Alzheimer's disease.

      Kotrla K, Chacko R, Jhingran S, Doody RS

    International Neuropsychological Society (INS)
    21st Annual Meeting in Galveston , Texas (Feb. 24-27, 1993)
    • Correlates of asymmetric motor speed in Alzheimer's disease.

      Massman P, Doody RS

    National Academy of Neuropsychology (NAN)
    12th Annual Meeting in Pittsburgh, Penn. (Nov. 5-7, 1992)
    • Neuropsychological correlates of apraxia in Alzheimer's disease patients.

      Massman P, Doody RS

    American Anthropological Association (AAA)
    90th Annual Meeting in Chicago, Ill. (Nov. 20-24, 1991)
    American Neurological Association (ANA)
    116th Annual Meeting in Seattle, Wash. (Sept. 28 - Oct. 2, 1991)
    • Single photon emission computerized tomography (SPECT) in Alzheimer's disease and multiple-infarct dementia.

      Doody RS, Strittmatter WJ, Jhingran S

    • Establishing the limits of the mini-mental state: MMS "subtests" versus a full neuropsychological battery.

      Feher E, Mahurin R, Doody RS, Cooke N, Simms J, Pirozzolo F

    • Positive and negative psychiatric symptoms in Alzheimer's disease.

      Mahurin R, Feher E, Doody RS, Inbody S

    Aerospace Medical Association (AsMA)
    62nd Annual Meeting in Cincinnati, Ohio (May 5-9, 1991)
    • Patent foramen ovale and type II altitude decompression sickness.

      Clark JB, Hayes GB

    American Academy of Neurology (AAN)
    43rd Annual Meeting in Boston, Mass. (April 21-27, 1991)
    • The alien hand and related signs.

      Doody RS, Jankovic J

    American Anthropological Association (AAA)
    89th Annual Meeting in New Orleans, La. (Nov. 27 - Dec. 2, 1990)
    American Association of Neuromuscular and Electrodiagnostic Medicine (AANEM)
    37th Annual Meeting in Chicago, Ill. (Sept. 7-8, 1990)
    • Recurrent posterior-type aphasia associated with a seizure focus.

      Doody RS, Hrachovy RA

    American Academy of Neurology (AAN)
    42nd Annual Meeting in Miami, Fla. (April 2-4, 1990)
    • Progressive nonfluent aphasia.

      Feher E, Doody RS, Whitehead J, Priozzolo F

    Society for Neuroscience (SFN)
    13th Annual Meeting in Boston, Mass. (Nov. 6-11, 1983)
    • Quantitative 2-DG study of the brainstem of the rat during nystagmus produced by lesion of the lateral semicircular ampulla.

      Kutyna FA, Patrickson JW, Bryant HJ, Kadekaro M, Clark JB

    Society for Neuroscience (SFN)
    12th Annual Meeting in Minneapolis, Minn. (Oct. 31 - Nov. 5, 1982)
    • Central nervous system glucose utilization rate in the nystagmic rat.

      Patrickson JW, Kutyna FA, Bryant HJ, Kadekaro M, Clark JB

    American College of Cardiology (ACC)
    31st Annual Scientific Session in Atlanta, Ga. (April 25-29, 1982)
    • Effects of stress management and dietary changes in treating ischemic heart disease.

      Ornish DM, Scherwitz LW, Doody RS, et al.